mouse Mapt antibody | antibody review based on formal publications

This is a Validated Antibody Database (VAD) review about mouse Mapt, based on 433 published articles (read how Labome selects the articles), using Mapt antibody in all methods. It is aimed to help Labome visitors find the most suited Mapt antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.

Mapt synonym: AI413597; AW045860; Mtapt; Tau

Knockout validation

Invitrogen mouse monoclonal (Tau-5) MA5-12808	western blot; human; 1:500; fig 2 western blot knockout validation; mouse; 1:500; loading ...; fig 2	Invitrogen Mapt antibody (Thermo Scientific, MA5-12808) was used in western blot on human samples at 1:500 (fig 2) and in western blot knockout validation on mouse samples at 1:500 (fig 2). Int J Mol Sci (2022) ncbi
Invitrogen domestic rabbit polyclonal 44-752G	western blot knockout validation; human; 1:500; tbl 1 immunocytochemistry; human; 1:100; tbl 2 western blot; mouse	In order to validate antibodies against tau protein and its variants, Invitrogen Mapt antibody (Thermo Fisher, 44-752G) was used in western blot knockout validation on human samples at 1:500 (tbl 1), in immunocytochemistry on human samples at 1:100 (tbl 2) and in western blot on mouse samples . Mol Neurodegener (2017) ncbi
Invitrogen domestic rabbit polyclonal 44-744	western blot knockout validation; human; 1:500; tbl 1 immunocytochemistry; human; 1:100; tbl 2 western blot; mouse	In order to validate antibodies against tau protein and its variants, Invitrogen Mapt antibody (Thermo Fisher, 44-744) was used in western blot knockout validation on human samples at 1:500 (tbl 1), in immunocytochemistry on human samples at 1:100 (tbl 2) and in western blot on mouse samples . Mol Neurodegener (2017) ncbi
Invitrogen domestic rabbit recombinant (5H9L11) 701530	western blot knockout validation; human; 1:500; tbl 1 immunocytochemistry; human; 1:100; tbl 2 western blot; mouse	In order to validate antibodies against tau protein and its variants, Invitrogen Mapt antibody (Thermo Fisher, 701530) was used in western blot knockout validation on human samples at 1:500 (tbl 1), in immunocytochemistry on human samples at 1:100 (tbl 2) and in western blot on mouse samples . Mol Neurodegener (2017) ncbi
Invitrogen domestic rabbit recombinant (2H23L4) 701054	western blot; mouse western blot knockout validation; human; 1:500; tbl 1 immunocytochemistry; human; 1:100; tbl 2	In order to validate antibodies against tau protein and its variants, Invitrogen Mapt antibody (Thermo Fisher, 701054) was used in western blot on mouse samples , in western blot knockout validation on human samples at 1:500 (tbl 1) and in immunocytochemistry on human samples at 1:100 (tbl 2). Mol Neurodegener (2017) ncbi
Invitrogen domestic rabbit polyclonal 44-768G	western blot knockout validation; human; 1:500; tbl 1 immunocytochemistry; human; 1:100; tbl 2 western blot; mouse	In order to validate antibodies against tau protein and its variants, Invitrogen Mapt antibody (Thermo Fisher, 44-768G) was used in western blot knockout validation on human samples at 1:500 (tbl 1), in immunocytochemistry on human samples at 1:100 (tbl 2) and in western blot on mouse samples . Mol Neurodegener (2017) ncbi
Invitrogen mouse monoclonal (T46) 13-6400	western blot knockout validation; mouse; 1:1000; loading ...; fig 1b	In order to show that the tau family members MAP2 and MAP4 are subject to reversible acetylation, Invitrogen Mapt antibody (Thermofisher, T46) was used in western blot knockout validation on mouse samples at 1:1000 (fig 1b). PLoS ONE (2016) ncbi
Invitrogen mouse monoclonal (Tau-5) AHB0042	western blot knockout validation; mouse; 1:1000; loading ...; fig 4b	In order to find no functional or morphological deficits upon tau reduction or depletion in aged mice, Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in western blot knockout validation on mouse samples at 1:1000 (fig 4b). PLoS ONE (2016) ncbi
Invitrogen mouse monoclonal (Tau-5) AHB0042	immunocytochemistry; human; fig 3 immunocytochemistry knockout validation; mouse; fig 3	In order to suggest that Tau regulates neuronal pericentromeric heterochromatin integrity, Invitrogen Mapt antibody (Biosource, AHB0042) was used in immunocytochemistry on human samples (fig 3) and in immunocytochemistry knockout validation on mouse samples (fig 3). Sci Rep (2016) ncbi
Invitrogen mouse monoclonal (AT8) MN1020	western blot knockout validation; mouse; 1:1000; fig 2	In order to study the specificity of a panel of commonly used anti-tau antibodies and issues likely to be encounted in Western blot experiments using material from murine Alzheimer's disease models, Invitrogen Mapt antibody (Fisher, MN1020) was used in western blot knockout validation on mouse samples at 1:1000 (fig 2). PLoS ONE (2014) ncbi
Abcam mouse monoclonal (Tau-5) ab80579	western blot; mouse western blot knockout validation; human; 1:1000; tbl 1 immunocytochemistry; human; 1:50; tbl 2	In order to validate antibodies against tau protein and its variants, Abcam Mapt antibody (Abcam, Tau5) was used in western blot on mouse samples , in western blot knockout validation on human samples at 1:1000 (tbl 1) and in immunocytochemistry on human samples at 1:50 (tbl 2). Mol Neurodegener (2017) ncbi
MilliporeSigma mouse monoclonal (Tau46) T9450	western blot knockout validation; mouse; 1:500; loading ...; fig 1b	MilliporeSigma Mapt antibody (Sigma Aldrich, T9450) was used in western blot knockout validation on mouse samples at 1:500 (fig 1b). Neuroscience (2016) ncbi

others

monoclonal (Tau-5)

577801

western blot; human; loading ...; fig 1a

Mapt antibody (Merck, Tau5) was used in western blot on human samples (fig 1a). J Alzheimers Dis (2018) ncbi

Invitrogen

mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:1000; loading ...; fig 4a	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunohistochemistry on mouse samples at 1:1000 (fig 4a). Cell Rep (2022) ncbi
domestic rabbit polyclonal 44-752G	western blot; mouse; 1:500; loading ...	Invitrogen Mapt antibody (Thermo Fischer, 44-752G) was used in western blot on mouse samples at 1:500. Front Aging Neurosci (2022) ncbi
mouse monoclonal (Tau-5) AHB0042	immunocytochemistry; mouse; 1:500; loading ...; fig 1a immunocytochemistry; human; 1:200; loading ...; fig 3e western blot; human; 1:1000; loading ...; fig s2	Invitrogen Mapt antibody (Thermo Scientific, AHB0042) was used in immunocytochemistry on mouse samples at 1:500 (fig 1a), in immunocytochemistry on human samples at 1:200 (fig 3e) and in western blot on human samples at 1:1000 (fig s2). Mol Ther Nucleic Acids (2022) ncbi
mouse monoclonal (AT8) MN1020	immunocytochemistry; mouse; 1:250; loading ...; fig 6d immunohistochemistry; mouse; 1:200; loading ...; fig 7f western blot; mouse; 1:1000; loading ...; fig 5c, 6a immunocytochemistry; human; 1:250; loading ...; fig 6d immunohistochemistry; human; 1:200; loading ...; fig 7f western blot; human; 1:1000; loading ...; fig 6a, 7a	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunocytochemistry on mouse samples at 1:250 (fig 6d), in immunohistochemistry on mouse samples at 1:200 (fig 7f), in western blot on mouse samples at 1:1000 (fig 5c, 6a), in immunocytochemistry on human samples at 1:250 (fig 6d), in immunohistochemistry on human samples at 1:200 (fig 7f) and in western blot on human samples at 1:1000 (fig 6a, 7a). Nat Commun (2022) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:200; loading ...; fig s1a1, s1b1	Invitrogen Mapt antibody (Invitrogen, AT8) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig s1a1, s1b1). Brain Commun (2022) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; loading ...; fig 1c	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunohistochemistry - paraffin section on human samples (fig 1c). Acta Neuropathol Commun (2022) ncbi
domestic rabbit polyclonal 44-752G	other; human; fig 3d	Invitrogen Mapt antibody (Invitrogen, 44-752G) was used in other on human samples (fig 3d). ACS Chem Neurosci (2022) ncbi
mouse monoclonal (AT8) MN1020	other; human; fig 3c immunohistochemistry - free floating section; human; loading ...; fig 4d western blot; human; 1:1000; loading ...; fig s9	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in other on human samples (fig 3c), in immunohistochemistry - free floating section on human samples (fig 4d) and in western blot on human samples at 1:1000 (fig s9). ACS Chem Neurosci (2022) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - frozen section; mouse; loading ...; fig 5c	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunohistochemistry - frozen section on mouse samples (fig 5c). EBioMedicine (2022) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:5000; loading ...; fig 1a	Invitrogen Mapt antibody (Thermo, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:5000 (fig 1a). Cell Mol Life Sci (2022) ncbi
mouse monoclonal (Tau-5) MA5-12808	western blot; human; 1:500; fig 2 western blot knockout validation; mouse; 1:500; loading ...; fig 2	Invitrogen Mapt antibody (Thermo Scientific, MA5-12808) was used in western blot on human samples at 1:500 (fig 2) and in western blot knockout validation on mouse samples at 1:500 (fig 2). Int J Mol Sci (2022) ncbi
domestic rabbit polyclonal 44-752G	western blot; mouse; 1:1000; loading ...; fig s2a	Invitrogen Mapt antibody (Thermo Fischer, 44-752G) was used in western blot on mouse samples at 1:1000 (fig s2a). J Neurochem (2022) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; loading ...; fig s9b	Invitrogen Mapt antibody (ThermoFisher, MN1020) was used in immunohistochemistry on mouse samples (fig s9b). Sci Transl Med (2021) ncbi
mouse monoclonal (AT8) MN1020	immunocytochemistry; human; 1:100; loading ...; fig 2e western blot; human; loading ...; fig 2f	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunocytochemistry on human samples at 1:100 (fig 2e) and in western blot on human samples (fig 2f). Nat Commun (2021) ncbi
mouse monoclonal (Tau-5) MA5-12808	western blot; human; loading ...; fig s5f	Invitrogen Mapt antibody (Thermo Fisher, MA5-12808) was used in western blot on human samples (fig s5f). Nat Commun (2021) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1c	Invitrogen Mapt antibody (Thermofisher, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1c). Acta Neuropathol (2021) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; mouse; loading ...; fig 6c western blot; mouse; 1:1000; loading ...; fig 6d	Invitrogen Mapt antibody (Life Technologies, MN1020) was used in immunohistochemistry - paraffin section on mouse samples (fig 6c) and in western blot on mouse samples at 1:1000 (fig 6d). Front Neurol (2021) ncbi
domestic rabbit polyclonal 44-750G	western blot; human; 1:1000; loading ...; fig 1a	Invitrogen Mapt antibody (Life Technologies, 44-750G) was used in western blot on human samples at 1:1000 (fig 1a). Front Neurol (2021) ncbi
mouse monoclonal (AT8) MN1020	western blot; rat; 1:1000; loading ...; fig 2a	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in western blot on rat samples at 1:1000 (fig 2a). Signal Transduct Target Ther (2021) ncbi
domestic rabbit polyclonal 44-734G	western blot; rat; 1:2000; loading ...; fig 2a	Invitrogen Mapt antibody (Invitrogen, 44734G) was used in western blot on rat samples at 1:2000 (fig 2a). Signal Transduct Target Ther (2021) ncbi
mouse monoclonal (AT8) MN1020	immunocytochemistry; human; 1:400; loading ...; fig 7f	Invitrogen Mapt antibody (Thermofisher, MN1020) was used in immunocytochemistry on human samples at 1:400 (fig 7f). Antioxidants (Basel) (2021) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; loading ...; fig 1a	Invitrogen Mapt antibody (Thermo, MN1020) was used in western blot on mouse samples (fig 1a). Clin Transl Med (2021) ncbi
domestic rabbit polyclonal 44-734G	western blot; mouse; loading ...; fig 1a	Invitrogen Mapt antibody (Invitrogen, 44734G) was used in western blot on mouse samples (fig 1a). Clin Transl Med (2021) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; rat; 1:500; loading ...; fig 2f	Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in western blot on rat samples at 1:500 (fig 2f). Life Sci Alliance (2021) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:500; loading ...; fig 3a	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunohistochemistry on mouse samples at 1:500 (fig 3a). J Alzheimers Dis (2021) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig s1a	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig s1a). Aging Cell (2021) ncbi
mouse monoclonal (T46) 13-6400	western blot; fruit fly ; 1:1000; loading ...; fig 3g	Invitrogen Mapt antibody (Invitrogen, 13-6400) was used in western blot on fruit fly samples at 1:1000 (fig 3g). Nat Commun (2021) ncbi
mouse monoclonal (AT8) MN1020	western blot; fruit fly ; 1:1000; loading ...; fig 3g immunohistochemistry; mouse; 1:200; loading ...; fig s6d	Invitrogen Mapt antibody (Invitrogen, MN1020) was used in western blot on fruit fly samples at 1:1000 (fig 3g) and in immunohistochemistry on mouse samples at 1:200 (fig s6d). Nat Commun (2021) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:500; loading ...; fig 2n	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in western blot on mouse samples at 1:500 (fig 2n). Int J Mol Sci (2021) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:1000; loading ...; fig 4d	Invitrogen Mapt antibody (Thermo, MN1020) was used in immunohistochemistry on mouse samples at 1:1000 (fig 4d). elife (2021) ncbi
mouse monoclonal (Tau-5) MA5-12805	western blot; rat; 1:1000; loading ...; fig 5a	Invitrogen Mapt antibody (Thermo, MA5-12805) was used in western blot on rat samples at 1:1000 (fig 5a). elife (2021) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:500; loading ...; fig 5b	Invitrogen Mapt antibody (Thermo Fisher Scientific, MN1020) was used in western blot on mouse samples at 1:500 (fig 5b). Acta Neuropathol Commun (2021) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:200; loading ...; fig 2b	Invitrogen Mapt antibody (ThermoFisher, MN1020) was used in western blot on mouse samples at 1:200 (fig 2b). Commun Biol (2021) ncbi
domestic rabbit polyclonal 44-752G	western blot; mouse; 1:1000; loading ...; fig s5a	Invitrogen Mapt antibody (Thermo, 44-752G) was used in western blot on mouse samples at 1:1000 (fig s5a). Cell Death Dis (2021) ncbi
domestic rabbit polyclonal 44-752G	western blot; human; 1:1000; loading ...; fig 3	Invitrogen Mapt antibody (Life Technologies, 44752G) was used in western blot on human samples at 1:1000 (fig 3). Acta Neuropathol (2021) ncbi
domestic rabbit polyclonal 44-758G	western blot; human; 1:1000; loading ...; fig 3	Invitrogen Mapt antibody (Life Technologies, 44758G) was used in western blot on human samples at 1:1000 (fig 3). Acta Neuropathol (2021) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; loading ...; fig 4a	Invitrogen Mapt antibody (Invitrogen, MN1020) was used in western blot on human samples (fig 4a). Cell Rep (2021) ncbi
mouse monoclonal (T46) 13-6400	western blot; mouse; loading ...; fig 4a	Invitrogen Mapt antibody (Thermo Fisher Scientific, 13-6400) was used in western blot on mouse samples (fig 4a). Cell (2021) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; loading ...	Invitrogen Mapt antibody (Invitrogen, MN1020) was used in immunohistochemistry on human samples . Front Aging Neurosci (2021) ncbi
mouse monoclonal (AT8) MN1020	western blot; rat; 1:600	Invitrogen Mapt antibody (ThermoFisher, MN1020) was used in western blot on rat samples at 1:600. Animals (Basel) (2021) ncbi
mouse monoclonal (AT8) MN1020	western blot; rat; 1:600	Invitrogen Mapt antibody (ThermoFisher, MN1020) was used in western blot on rat samples at 1:600. Aging (Albany NY) (2021) ncbi
mouse monoclonal (AT8) MN1020	western blot; rat; 1:600	Invitrogen Mapt antibody (ThermoFisher, MN1020) was used in western blot on rat samples at 1:600. Acta Neuropathol Commun (2021) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; loading ...; fig 3a	Invitrogen Mapt antibody (Pierce, MN1020) was used in immunohistochemistry - paraffin section on human samples (fig 3a). Acta Neuropathol (2021) ncbi
mouse monoclonal (Tau-5) AHB0042	immunocytochemistry; human; 0.5 ug/ml; loading ...; fig 6d	Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in immunocytochemistry on human samples at 0.5 ug/ml (fig 6d). Acta Neuropathol (2021) ncbi
mouse monoclonal (AT8) MN1020	western blot; rat; loading ...; fig 4	Invitrogen Mapt antibody (Thermo, MN1020) was used in western blot on rat samples (fig 4). Brain Pathol (2021) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; rat; 1:400; loading ...; fig s2b	Invitrogen Mapt antibody (Pierce, MN1020) was used in immunohistochemistry on rat samples at 1:400 (fig s2b). Alzheimers Dement (N Y) (2021) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; 1:1000; loading ...; fig s1a	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in western blot on human samples at 1:1000 (fig s1a). Front Neurol (2020) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; loading ...; fig 4a western blot; mouse; 1:300; loading ...; fig 4c	Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry on mouse samples (fig 4a) and in western blot on mouse samples at 1:300 (fig 4c). Alzheimers Res Ther (2021) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 1:800	Invitrogen Mapt antibody (ThermoFisher, MN1020) was used in immunohistochemistry on human samples at 1:800. Acta Neuropathol (2021) ncbi
mouse monoclonal (Tau-5) AHB0042	immunocytochemistry; mouse; 1:200; loading ...; fig 1a	Invitrogen Mapt antibody (Thermo Fisher, AHB0042) was used in immunocytochemistry on mouse samples at 1:200 (fig 1a). Nat Commun (2021) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig 2f	Invitrogen Mapt antibody (Invitrogen, MN1020) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 2f). Acta Neuropathol Commun (2021) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:500; loading ...	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunohistochemistry on mouse samples at 1:500. J Neuroinflammation (2020) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:500; loading ...; fig 4d western blot; mouse; loading ...; fig 4a	Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry on mouse samples at 1:500 (fig 4d) and in western blot on mouse samples (fig 4a). Cell Death Dis (2020) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:500; loading ...; fig 2a	Invitrogen Mapt antibody (Invitrogen, MN1020) was used in immunohistochemistry on mouse samples at 1:500 (fig 2a). Acta Neuropathol Commun (2020) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; human; 1:1000; loading ...; fig 2a	Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in western blot on human samples at 1:1000 (fig 2a). Nat Commun (2020) ncbi
domestic rabbit polyclonal 44-752G	western blot; human; 1:1000; loading ...; fig 2a	Invitrogen Mapt antibody (Invitrogen, 44752G) was used in western blot on human samples at 1:1000 (fig 2a). Nat Commun (2020) ncbi
mouse monoclonal (Tau-5) AHB0042	immunohistochemistry; mouse; loading ...; fig 3a	Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in immunohistochemistry on mouse samples (fig 3a). iScience (2020) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:100; loading ...; fig 2a	Invitrogen Mapt antibody (Thermofisher, MN1020) was used in immunohistochemistry on mouse samples at 1:100 (fig 2a). Front Neurosci (2020) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; fruit fly ; 1:250; loading ...; fig 4a	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunohistochemistry on fruit fly samples at 1:250 (fig 4a). elife (2020) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - frozen section; mouse; loading ...; fig 3a immunohistochemistry - paraffin section; mouse; loading ...; fig 2d western blot; mouse; loading ...; fig 1a, 1b	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunohistochemistry - frozen section on mouse samples (fig 3a), in immunohistochemistry - paraffin section on mouse samples (fig 2d) and in western blot on mouse samples (fig 1a, 1b). Neuropsychiatr Dis Treat (2020) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 1:2000; loading ...; tbl 1	Invitrogen Mapt antibody (Fisher Scientific, AT8) was used in immunohistochemistry on human samples at 1:2000 (tbl 1). Acta Neuropathol Commun (2020) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 1:2000; loading ...; fig 1g	Invitrogen Mapt antibody (Invitrogen, MN1020) was used in immunohistochemistry on human samples at 1:2000 (fig 1g). JCI Insight (2020) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 5a western blot; mouse; 1:2000; loading ...; fig 4a	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 5a) and in western blot on mouse samples at 1:2000 (fig 4a). J Neuroinflammation (2020) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:1000; loading ...; fig 4k	Invitrogen Mapt antibody (Thermo Fisher Scientific, MN1020) was used in western blot on mouse samples at 1:1000 (fig 4k). Aging Cell (2020) ncbi
mouse monoclonal (AT8) MN1020		Invitrogen Mapt antibody (Thermo Fisher Scientific, Rockford, IL, USA, AT8) was used . Nutrients (2020) ncbi
mouse monoclonal (AT8) MN1020	immunocytochemistry; human; 1:1000; loading ...; fig 2a	Invitrogen Mapt antibody (ThermoFisher, MN1020) was used in immunocytochemistry on human samples at 1:1000 (fig 2a). Int J Mol Sci (2020) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1c	Invitrogen Mapt antibody (Thermo, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1c). Acta Neuropathol Commun (2020) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 3e	Invitrogen Mapt antibody (Thermo Fisher, AT8) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 3e). Brain Sci (2020) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:3000; loading ...; fig 5d	Invitrogen Mapt antibody (ThermoFisher, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:3000 (fig 5d). Int J Mol Sci (2020) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; mouse; loading ...; fig 4c western blot; mouse; loading ...; fig 4a	Invitrogen Mapt antibody (Thermo, MN1020) was used in immunohistochemistry - paraffin section on mouse samples (fig 4c) and in western blot on mouse samples (fig 4a). Mol Neurodegener (2020) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 1:200; loading ...; fig 1, s2b western blot; human; loading ...; fig 5, 6	Invitrogen Mapt antibody (ThermoFisher Scientific, MN1020/AT8) was used in immunohistochemistry on human samples at 1:200 (fig 1, s2b) and in western blot on human samples (fig 5, 6). Nat Commun (2020) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:100; loading ...; fig 4s2a	Invitrogen Mapt antibody (Thermo, MN1020) was used in western blot on mouse samples at 1:100 (fig 4s2a). elife (2020) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - free floating section; human; 1:2000; loading ...; fig 3a	Invitrogen Mapt antibody (Pierce Biotechnology, AT8) was used in immunohistochemistry - free floating section on human samples at 1:2000 (fig 3a). J Neuropathol Exp Neurol (2020) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:1000; loading ...; fig 2f	Invitrogen Mapt antibody (Thermo Scientific,, MN1020) was used in western blot on mouse samples at 1:1000 (fig 2f). Nat Commun (2020) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 2a	Invitrogen Mapt antibody (Thermofisher, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2a). Aging (Albany NY) (2020) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:600; loading ...; fig 2a13	Invitrogen Mapt antibody (Thermo, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:600 (fig 2a13). Neurobiol Aging (2020) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig 5s1b western blot; mouse; loading ...; fig 5a	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 5s1b) and in western blot on mouse samples (fig 5a). J Neurosci (2020) ncbi
domestic rabbit recombinant (2H23L4) 701054	ELISA; human; loading ...; fig 1a	Invitrogen Mapt antibody (Thermo Fisher, 701,054) was used in ELISA on human samples (fig 1a). Acta Neuropathol Commun (2019) ncbi
domestic rabbit polyclonal 44-768G	ELISA; human; loading ...; fig 1a	Invitrogen Mapt antibody (Thermo Fisher, 44-768G) was used in ELISA on human samples (fig 1a). Acta Neuropathol Commun (2019) ncbi
domestic rabbit polyclonal 44-752G	ELISA; human; loading ...; fig 1a	Invitrogen Mapt antibody (Thermo Fisher, 44-752G) was used in ELISA on human samples (fig 1a). Acta Neuropathol Commun (2019) ncbi
domestic rabbit polyclonal 44-744	ELISA; human; loading ...; fig 1a	Invitrogen Mapt antibody (Thermo Fisher, 44-C744) was used in ELISA on human samples (fig 1a). Acta Neuropathol Commun (2019) ncbi
domestic rabbit polyclonal 44-758G	ELISA; human; loading ...; fig 1a	Invitrogen Mapt antibody (Thermo Fisher, 44-758G) was used in ELISA on human samples (fig 1a). Acta Neuropathol Commun (2019) ncbi
domestic rabbit recombinant (5H9L11) 701530	ELISA; human; loading ...; fig 1a	Invitrogen Mapt antibody (Thermo Fisher, 701,530) was used in ELISA on human samples (fig 1a). Acta Neuropathol Commun (2019) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1f	Invitrogen Mapt antibody (Thermo Fischer, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1f). Acta Neuropathol Commun (2019) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 2h	Invitrogen Mapt antibody (Thermo Fisher Scientific, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 2h). Acta Neuropathol Commun (2019) ncbi
domestic rabbit polyclonal 44-750G	western blot; human; loading ...; fig 4c	Invitrogen Mapt antibody (Invitrogen, 44-750G) was used in western blot on human samples (fig 4c). PLoS ONE (2019) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 1:2000; loading ...; tbl 2	Invitrogen Mapt antibody (Thermo Fisher, AT8) was used in immunohistochemistry on human samples at 1:2000 (tbl 2). Neurology (2020) ncbi
mouse monoclonal (Tau-5) MA5-12808	western blot; mouse; 1:500; loading ...; fig s6e	Invitrogen Mapt antibody (Thermo Fisher, MA5-12808) was used in western blot on mouse samples at 1:500 (fig s6e). Nature (2019) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; loading ...; fig 1a	Invitrogen Mapt antibody (ThermoFisher, MN1020) was used in western blot on mouse samples (fig 1a). Nature (2019) ncbi
domestic rabbit polyclonal 44-768G	western blot; mouse; loading ...; fig e1a	Invitrogen Mapt antibody (ThermoFisher, 44-768G) was used in western blot on mouse samples (fig e1a). Nature (2019) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:200; loading ...; fig 3a	Invitrogen Mapt antibody (TFS, MN1020) was used in western blot on mouse samples at 1:200 (fig 3a). Aging Cell (2019) ncbi
mouse monoclonal (TauC3) AHB0061	immunohistochemistry - paraffin section; mouse; loading ...; fig 3d western blot; mouse; 1:200; loading ...; fig 3a	Invitrogen Mapt antibody (TFS, AHB0061) was used in immunohistochemistry - paraffin section on mouse samples (fig 3d) and in western blot on mouse samples at 1:200 (fig 3a). Aging Cell (2019) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; cat; 1:2000; loading ...; fig 1	Invitrogen Mapt antibody (Fisher Scientific, MN1020) was used in immunohistochemistry - paraffin section on cat samples at 1:2000 (fig 1). J Comp Neurol (2020) ncbi
domestic rabbit polyclonal 44-742G	immunohistochemistry - paraffin section; cat; 1:1000; loading ...; fig 3e	Invitrogen Mapt antibody (Invitrogen, 44-742G) was used in immunohistochemistry - paraffin section on cat samples at 1:1000 (fig 3e). J Comp Neurol (2020) ncbi
domestic rabbit polyclonal 44-738G	immunohistochemistry - paraffin section; cat; 1:1000; loading ...; fig 3b	Invitrogen Mapt antibody (Invitrogen, 44-738G) was used in immunohistochemistry - paraffin section on cat samples at 1:1000 (fig 3b). J Comp Neurol (2020) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - frozen section; human; loading ...; fig 4a	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunohistochemistry - frozen section on human samples (fig 4a). Eur J Nucl Med Mol Imaging (2019) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 6a	Invitrogen Mapt antibody (Pierce, AT8) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 6a). Acta Neuropathol Commun (2019) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:1000; loading ...; fig 6a western blot; mouse; 1:1000; loading ...; fig s9a	Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry on mouse samples at 1:1000 (fig 6a) and in western blot on mouse samples at 1:1000 (fig s9a). Nat Commun (2019) ncbi
mouse monoclonal (AT8) MN1020	western blot; rhesus macaque; 1:500; loading ...; fig 4b	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in western blot on rhesus macaque samples at 1:500 (fig 4b). Aging Cell (2019) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 1e	Invitrogen Mapt antibody (Fisher Sientific-Invitrogen, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 1e). Acta Neuropathol Commun (2019) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - frozen section; mouse; loading ...; fig 2a western blot; mouse; loading ...; fig s15a	Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry - frozen section on mouse samples (fig 2a) and in western blot on mouse samples (fig s15a). Acta Neuropathol (2019) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:1000; loading ...; fig 2c	Invitrogen Mapt antibody (Pierce, MN1020) was used in western blot on mouse samples at 1:1000 (fig 2c). Neurobiol Dis (2019) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; human; 1:1000; loading ...	Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in western blot on human samples at 1:1000. elife (2019) ncbi
domestic rabbit polyclonal 44-752G	western blot; human; 1:1000; loading ...	Invitrogen Mapt antibody (Invitrogen, 44752G) was used in western blot on human samples at 1:1000. elife (2019) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 1:300; loading ...; fig 1a	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunohistochemistry on human samples at 1:300 (fig 1a). Nature (2019) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1c, 1f	Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1c, 1f). BMC Neurol (2019) ncbi
mouse monoclonal (AT8) MN1020		Invitrogen Mapt antibody (Thermo Fisher Scientific, MN1020) was used . Cell Rep (2019) ncbi
mouse monoclonal (Tau-5) AHB0042	immunohistochemistry; mouse; loading ...; fig 1c	Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in immunohistochemistry on mouse samples (fig 1c). Cell Rep (2018) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; loading ...; fig 1e	Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry on mouse samples (fig 1e). Cell Rep (2018) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; loading ...; fig s4a	Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry on human samples (fig s4a). Front Cell Neurosci (2018) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; mouse; 1:1000; loading ...; fig 8b	Invitrogen Mapt antibody (Thermo Fisher, AHB0042) was used in western blot on mouse samples at 1:1000 (fig 8b). Cancer Res (2018) ncbi
mouse monoclonal (AT8) MN1020	immunocytochemistry; human; loading ...; fig s10b western blot; human; loading ...; fig s10a	Invitrogen Mapt antibody (Thermo Fisher Scientific, MN1020) was used in immunocytochemistry on human samples (fig s10b) and in western blot on human samples (fig s10a). Nat Med (2018) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; loading ...; fig 4	Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in western blot on mouse samples (fig 4). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - frozen section; African green monkey; 1:500; loading ...; fig 6a	Invitrogen Mapt antibody (ThermoScientific, MN1020) was used in immunohistochemistry - frozen section on African green monkey samples at 1:500 (fig 6a). Neurobiol Aging (2018) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 2c	Invitrogen Mapt antibody (Thermo Fisher Scientific, AT8) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 2c). J Alzheimers Dis (2018) ncbi
domestic rabbit polyclonal 44-768G	western blot knockout validation; human; 1:500; tbl 1 immunocytochemistry; human; 1:100; tbl 2 western blot; mouse	In order to validate antibodies against tau protein and its variants, Invitrogen Mapt antibody (Thermo Fisher, 44-768G) was used in western blot knockout validation on human samples at 1:500 (tbl 1), in immunocytochemistry on human samples at 1:100 (tbl 2) and in western blot on mouse samples . Mol Neurodegener (2017) ncbi
domestic rabbit recombinant (2H23L4) 701054	western blot; mouse western blot knockout validation; human; 1:500; tbl 1 immunocytochemistry; human; 1:100; tbl 2	In order to validate antibodies against tau protein and its variants, Invitrogen Mapt antibody (Thermo Fisher, 701054) was used in western blot on mouse samples , in western blot knockout validation on human samples at 1:500 (tbl 1) and in immunocytochemistry on human samples at 1:100 (tbl 2). Mol Neurodegener (2017) ncbi
domestic rabbit recombinant (5H9L11) 701530	western blot knockout validation; human; 1:500; tbl 1 immunocytochemistry; human; 1:100; tbl 2 western blot; mouse	In order to validate antibodies against tau protein and its variants, Invitrogen Mapt antibody (Thermo Fisher, 701530) was used in western blot knockout validation on human samples at 1:500 (tbl 1), in immunocytochemistry on human samples at 1:100 (tbl 2) and in western blot on mouse samples . Mol Neurodegener (2017) ncbi
domestic rabbit polyclonal 44-758G	western blot; mouse; 1:100 immunocytochemistry; human; 1:100; tbl 2 western blot; human; 1:500; tbl 1	In order to validate antibodies against tau protein and its variants, Invitrogen Mapt antibody (Thermo Fisher, 44-758G) was used in western blot on mouse samples at 1:100, in immunocytochemistry on human samples at 1:100 (tbl 2) and in western blot on human samples at 1:500 (tbl 1). Mol Neurodegener (2017) ncbi
domestic rabbit polyclonal 44-752G	western blot knockout validation; human; 1:500; tbl 1 immunocytochemistry; human; 1:100; tbl 2 western blot; mouse	In order to validate antibodies against tau protein and its variants, Invitrogen Mapt antibody (Thermo Fisher, 44-752G) was used in western blot knockout validation on human samples at 1:500 (tbl 1), in immunocytochemistry on human samples at 1:100 (tbl 2) and in western blot on mouse samples . Mol Neurodegener (2017) ncbi
domestic rabbit polyclonal 44-744	western blot knockout validation; human; 1:500; tbl 1 immunocytochemistry; human; 1:100; tbl 2 western blot; mouse	In order to validate antibodies against tau protein and its variants, Invitrogen Mapt antibody (Thermo Fisher, 44-744) was used in western blot knockout validation on human samples at 1:500 (tbl 1), in immunocytochemistry on human samples at 1:100 (tbl 2) and in western blot on mouse samples . Mol Neurodegener (2017) ncbi
domestic rabbit polyclonal 44-750G	western blot; mouse; 1:1000; loading ...; fig 8b	Invitrogen Mapt antibody (Invitrogen, 44750G) was used in western blot on mouse samples at 1:1000 (fig 8b). J Cell Biol (2017) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:1000; loading ...; fig 8b	Invitrogen Mapt antibody (Invitrogen, MN1020) was used in western blot on mouse samples at 1:1000 (fig 8b). J Cell Biol (2017) ncbi
domestic rabbit polyclonal 44-750G	immunocytochemistry; human; loading ...; fig 1d western blot; human; 1:1000; loading ...; fig s5b	In order to study the involvement of deacetylase HDAC6 in Tau pathology, Invitrogen Mapt antibody (Invitrogen, 44-750G) was used in immunocytochemistry on human samples (fig 1d) and in western blot on human samples at 1:1000 (fig s5b). Cell Rep (2017) ncbi
mouse monoclonal (Tau-5) AHB0042	immunocytochemistry; human; 1:500; loading ...; fig 1a	In order to study the involvement of deacetylase HDAC6 in Tau pathology, Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in immunocytochemistry on human samples at 1:500 (fig 1a). Cell Rep (2017) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 1:500; fig 1a	In order to study the involvement of deacetylase HDAC6 in Tau pathology, Invitrogen Mapt antibody (Thermo, MN1020) was used in immunohistochemistry on human samples at 1:500 (fig 1a). Cell Rep (2017) ncbi
domestic rabbit polyclonal 44-752G	western blot; human; 1:1000; loading ...; fig 6b	In order to study the involvement of deacetylase HDAC6 in Tau pathology, Invitrogen Mapt antibody (Invitrogen, 44-752G) was used in western blot on human samples at 1:1000 (fig 6b). Cell Rep (2017) ncbi
domestic rabbit polyclonal 44-734G	immunocytochemistry; human; loading ...; fig 1d western blot; human; 1:1000; loading ...; fig s5b	In order to study the involvement of deacetylase HDAC6 in Tau pathology, Invitrogen Mapt antibody (Invitrogen, 44-734G) was used in immunocytochemistry on human samples (fig 1d) and in western blot on human samples at 1:1000 (fig s5b). Cell Rep (2017) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; loading ...; fig 2a	In order to investigate the accumulation of TMEM230 in granulovacuolar degeneration bodies and dystrophic neurites of Alzheimers disease, Invitrogen Mapt antibody (Invitrogen, MN1020) was used in immunohistochemistry - paraffin section on human samples (fig 2a). J Alzheimers Dis (2017) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; loading ...; fig 4c western blot; mouse; fig 4a	In order to show that ALOX5 upregulation results in homocysteine-dependent worsening of the Alzheimer's disease phenotype, Invitrogen Mapt antibody (Thermo, MN1020) was used in immunohistochemistry on mouse samples (fig 4c) and in western blot on mouse samples (fig 4a). Sci Rep (2017) ncbi
domestic rabbit polyclonal 44-768G	western blot; mouse; 1:1000; loading ...; fig 2A	In order to elucidate how liraglutide affects disease and cognitive function in a mouse model of Alzheimer disease, Invitrogen Mapt antibody (Invitrogen, 44-768G) was used in western blot on mouse samples at 1:1000 (fig 2A). Neurochem Res (2017) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; mouse; 1:1000; loading ...; fig 2A	In order to elucidate how liraglutide affects disease and cognitive function in a mouse model of Alzheimer disease, Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in western blot on mouse samples at 1:1000 (fig 2A). Neurochem Res (2017) ncbi
domestic rabbit polyclonal 44-742G	western blot; mouse; 1:1000; loading ...; fig 2A	In order to elucidate how liraglutide affects disease and cognitive function in a mouse model of Alzheimer disease, Invitrogen Mapt antibody (Invitrogen, 44-742G) was used in western blot on mouse samples at 1:1000 (fig 2A). Neurochem Res (2017) ncbi
domestic rabbit polyclonal 44-744	western blot; mouse; 1:1000; loading ...; fig 2A	In order to elucidate how liraglutide affects disease and cognitive function in a mouse model of Alzheimer disease, Invitrogen Mapt antibody (Invitrogen, 44-744) was used in western blot on mouse samples at 1:1000 (fig 2A). Neurochem Res (2017) ncbi
domestic rabbit polyclonal 44-752G	western blot; mouse; 1:1000; loading ...; fig 2A	In order to elucidate how liraglutide affects disease and cognitive function in a mouse model of Alzheimer disease, Invitrogen Mapt antibody (Invitrogen, 44752G) was used in western blot on mouse samples at 1:1000 (fig 2A). Neurochem Res (2017) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; mouse; loading ...; fig 5a	In order to assess the role of MECP2 in tau pathology using several mouse models, Invitrogen Mapt antibody (Thermo Fisher Scientific, AHB0042) was used in western blot on mouse samples (fig 5a). Front Mol Neurosci (2017) ncbi
domestic rabbit polyclonal 44-740G	western blot; human; loading ...; fig 4a	In order to elucidate how SLM attenuates tau hyperphosphorylation, Invitrogen Mapt antibody (ThermoFisher, 44740G) was used in western blot on human samples (fig 4a). Eur J Pharm Sci (2017) ncbi
mouse monoclonal (AT8) MN1020	immunocytochemistry; human; loading ...; fig 5 western blot; human; loading ...; fig 4a	In order to elucidate how SLM attenuates tau hyperphosphorylation, Invitrogen Mapt antibody (ThermoFisher, MN1020) was used in immunocytochemistry on human samples (fig 5) and in western blot on human samples (fig 4a). Eur J Pharm Sci (2017) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; loading ...; fig 4	In order to evaluate the efficacy of an orally bioactive and brain permeable gamma-secretase inhibitor in a mouse model of Alzheimer's disease, Invitrogen Mapt antibody (Thermo, MN1020) was used in immunohistochemistry on mouse samples (fig 4). Nat Commun (2017) ncbi
mouse monoclonal (Tau-5) MA5-12805	western blot; mouse; 1:1000; loading ...; fig 4b	In order to evaluate the efficacy of an orally bioactive and brain permeable gamma-secretase inhibitor in a mouse model of Alzheimer's disease, Invitrogen Mapt antibody (Thermo, MA5-12805) was used in western blot on mouse samples at 1:1000 (fig 4b). Nat Commun (2017) ncbi
mouse monoclonal (T46) 13-6400	immunoprecipitation; human western blot; human; 1:1000; fig 1b	In order to study the mechanisms of pathogenesis via tau acetylation in Alzheimer's disease, Invitrogen Mapt antibody (Thermo Fisher, 13-6400) was used in immunoprecipitation on human samples and in western blot on human samples at 1:1000 (fig 1b). Sci Rep (2017) ncbi
domestic rabbit polyclonal 44-752G	western blot; human; fig 6a	In order to study the mechanisms of pathogenesis via tau acetylation in Alzheimer's disease, Invitrogen Mapt antibody (Millipore, 44-752G) was used in western blot on human samples (fig 6a). Sci Rep (2017) ncbi
domestic rabbit polyclonal 44-750G	western blot; human; 1:1000; fig 1a	In order to study the mechanisms of pathogenesis via tau acetylation in Alzheimer's disease, Invitrogen Mapt antibody (Thermo Fisher, 44-750G) was used in western blot on human samples at 1:1000 (fig 1a). Sci Rep (2017) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; 1:1000; fig 1a immunocytochemistry; mouse; 1:1000; loading ...; fig 1d	In order to study the mechanisms of pathogenesis via tau acetylation in Alzheimer's disease, Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in western blot on human samples at 1:1000 (fig 1a) and in immunocytochemistry on mouse samples at 1:1000 (fig 1d). Sci Rep (2017) ncbi
mouse monoclonal (Tau-5) AHB0042	immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 2e	In order to investigate the expression patterns of HA synthases in the murine central nervous system, Invitrogen Mapt antibody (Life Technologies, AHB0042) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 2e). J Alzheimers Dis (2017) ncbi
domestic rabbit polyclonal 44-752G	western blot; mouse; loading ...; fig 4a	In order to analyze the effects of Resveratrol on Neuro-2a cells prior to and after formaldehyde exposure, Invitrogen Mapt antibody (Invitrogen, 44752G) was used in western blot on mouse samples (fig 4a). Front Neurosci (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; mouse; loading ...; fig 3a western blot; mouse; 0.2 ug/ml; loading ...; fig 2a	In order to generate and characterize a new mouse model of Alzheimer's disease, Invitrogen Mapt antibody (Sigma, MN1020) was used in immunohistochemistry - paraffin section on mouse samples (fig 3a) and in western blot on mouse samples at 0.2 ug/ml (fig 2a). Aging Cell (2017) ncbi
domestic rabbit polyclonal 44-758G	western blot; mouse; loading ...; fig 2e	In order to generate and characterize a new mouse model of Alzheimer's disease, Invitrogen Mapt antibody (Thermo Scientific, 44-758G) was used in western blot on mouse samples (fig 2e). Aging Cell (2017) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - free floating section; mouse; 1:500; loading ...; fig 1a	In order to report the formation of mature tangles in Alzheimer's diseases is associated with excitatory cell loss and deficits in grid cell function, Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunohistochemistry - free floating section on mouse samples at 1:500 (fig 1a). Neuron (2017) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; mouse; 1:5000; loading ...; fig 4b	In order to report that docosahexaenoic acid is an inducer of cellular protein aggregates, Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in western blot on mouse samples at 1:5000 (fig 4b). Exp Mol Med (2017) ncbi
mouse monoclonal (AT8) MN1020	immunocytochemistry; mouse; loading ...; fig 3a western blot; mouse; loading ...; fig 3b	In order to identify Otub1 as a Tau-deubiquitinating enzyme, Invitrogen Mapt antibody (Thermo Fisher, AT8) was used in immunocytochemistry on mouse samples (fig 3a) and in western blot on mouse samples (fig 3b). Acta Neuropathol (2017) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 1:500; loading ...; fig 7c	In order to see that the granulin Alzheimer's disease risk variant has no significant effects on florbetapir positron emission tomographic amyloid imaging and cerebrospinal fluid Abeta levels, Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunohistochemistry on human samples at 1:500 (fig 7c). Acta Neuropathol (2017) ncbi
domestic rabbit recombinant (5H9L11) 701530	western blot; human; 1:1000; loading ...; fig 7a	In order to see that the granulin Alzheimer's disease risk variant has no significant effects on florbetapir positron emission tomographic amyloid imaging and cerebrospinal fluid Abeta levels, Invitrogen Mapt antibody (Thermo Fisher, 701530) was used in western blot on human samples at 1:1000 (fig 7a). Acta Neuropathol (2017) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; human; 1:2000; loading ...; fig 7a	In order to see that the granulin Alzheimer's disease risk variant has no significant effects on florbetapir positron emission tomographic amyloid imaging and cerebrospinal fluid Abeta levels, Invitrogen Mapt antibody (Thermo Fisher, AHB0042) was used in western blot on human samples at 1:2000 (fig 7a). Acta Neuropathol (2017) ncbi
domestic rabbit polyclonal 44-758G	western blot; human; 1:2000; loading ...; fig 7a	In order to see that the granulin Alzheimer's disease risk variant has no significant effects on florbetapir positron emission tomographic amyloid imaging and cerebrospinal fluid Abeta levels, Invitrogen Mapt antibody (Thermo Fisher, 44-758G) was used in western blot on human samples at 1:2000 (fig 7a). Acta Neuropathol (2017) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 1:1000; loading ...; fig 3d	In order to analyze autopsied corpses and reveal that progressive supranuclear palsy may be more common than previously thought, Invitrogen Mapt antibody (Endogen, AT8) was used in immunohistochemistry on human samples at 1:1000 (fig 3d). Acta Neuropathol (2017) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - frozen section; human; loading ...	In order to design a [11C]THK-5351 structure for selectively imaging tau protein aggregates, Invitrogen Mapt antibody (Thermo, AT8) was used in immunohistochemistry - frozen section on human samples . Nucl Med Biol (2017) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 3m	In order to examine the mutation spectrum of the TANK-Binding Kinase 1 gene and its associated phenotypic spectrum in patients with FTD, ALS or FTD plus ALS, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3m). Hum Mutat (2017) ncbi
mouse monoclonal (T46) 13-6400	western blot knockout validation; mouse; 1:1000; loading ...; fig 1b	In order to show that the tau family members MAP2 and MAP4 are subject to reversible acetylation, Invitrogen Mapt antibody (Thermofisher, T46) was used in western blot knockout validation on mouse samples at 1:1000 (fig 1b). PLoS ONE (2016) ncbi
domestic rabbit polyclonal 44-738G	immunohistochemistry; mouse; 1:250; loading ...; fig s5d	In order to characterize mice with a forebrain-specific loss of O-GlcNAc glycosylation, Invitrogen Mapt antibody (Life Technologies, 44738G) was used in immunohistochemistry on mouse samples at 1:250 (fig s5d). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:1000; loading ...; fig 5c	In order to characterize mice with a forebrain-specific loss of O-GlcNAc glycosylation, Invitrogen Mapt antibody (Pierce, MN1020) was used in western blot on mouse samples at 1:1000 (fig 5c). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (T46) 13-6400	immunocytochemistry; rat; 1:100; loading ...; fig 4b	In order to report the effects of okadaic acid-induced tau hyperphosphorylation on secreted and cellular levels of brain-derived neurotrophic factor in primary cortical neurons, Invitrogen Mapt antibody (Thermofisher, 13-6400) was used in immunocytochemistry on rat samples at 1:100 (fig 4b). J Chem Neuroanat (2017) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:500; fig 5	In order to examine the effects of carnosic acid in models of Alzheimer's disease, Invitrogen Mapt antibody (Pierce, AT8) was used in immunohistochemistry on mouse samples at 1:500 (fig 5). Cell Death Dis (2016) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; loading ...; fig 2	In order to examine postmortem brain tissues from five institutionalized patients with schizophrenia and history of surgical leucotomy with subsequent survival of at least another 40 years, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in western blot on human samples (fig 2). Acta Neuropathol (2017) ncbi
mouse monoclonal (T46) 13-6400	immunocytochemistry; human; 1:200; fig 2c western blot; human; 1:1000; fig 2e	In order to discuss the contribution of leucine-rich repeat kinase 2 mutations to Parkinson's disease, Invitrogen Mapt antibody (Invitrogen, 136400) was used in immunocytochemistry on human samples at 1:200 (fig 2c) and in western blot on human samples at 1:1000 (fig 2e). J Neuroinflammation (2016) ncbi
domestic rabbit polyclonal 44-768G	immunohistochemistry - paraffin section; human; 1:5000; loading ...; fig 6	In order to evaluate chronic traumatic encephalopathy-like changes during routine neuropathology services, Invitrogen Mapt antibody (Invitrogen, 44-768G) was used in immunohistochemistry - paraffin section on human samples at 1:5000 (fig 6). J Neuropathol Exp Neurol (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:3000; loading ...; fig 1	In order to evaluate chronic traumatic encephalopathy-like changes during routine neuropathology services, Invitrogen Mapt antibody (ThermoFisher Scientific, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:3000 (fig 1). J Neuropathol Exp Neurol (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 1:600; loading ...; fig 3	In order to characterize preclinical subjects with corticobasal degeneration, Invitrogen Mapt antibody (Thermo scientific, MN1020) was used in immunohistochemistry on human samples at 1:600 (fig 3). Brain (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; loading ...; fig 3a	In order to study the role of eukaryotic elongation factor-2 kinase in Alzheimer's disease pathogenesis, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry - paraffin section on human samples (fig 3a). Acta Neuropathol (2017) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot knockout validation; mouse; 1:1000; loading ...; fig 4b	In order to find no functional or morphological deficits upon tau reduction or depletion in aged mice, Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in western blot knockout validation on mouse samples at 1:1000 (fig 4b). PLoS ONE (2016) ncbi
domestic rabbit polyclonal 44-750G	western blot; human; 1:2500; loading ...; fig 4a	In order to demonstrate that microtubule affinity-regulating kinase is a target of methylene blue, Invitrogen Mapt antibody (Life Technologies, 44750G) was used in western blot on human samples at 1:2500 (fig 4a). Sci Rep (2016) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	immunocytochemistry; rat; 1:1000; loading ...; fig s1a	In order to study the role of SNARE machinery in neuronal polarity and selective protein targeting, Invitrogen Mapt antibody (Invitrogen, Tau-5) was used in immunocytochemistry on rat samples at 1:1000 (fig s1a). PLoS ONE (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; fig 4	In order to suggest that Tau regulates neuronal pericentromeric heterochromatin integrity, Invitrogen Mapt antibody (Pierce, MN1020) was used in immunohistochemistry on human samples (fig 4). Sci Rep (2016) ncbi
mouse monoclonal (Tau-5) AHB0042	immunocytochemistry; human; fig 3 immunocytochemistry knockout validation; mouse; fig 3	In order to suggest that Tau regulates neuronal pericentromeric heterochromatin integrity, Invitrogen Mapt antibody (Biosource, AHB0042) was used in immunocytochemistry on human samples (fig 3) and in immunocytochemistry knockout validation on mouse samples (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; loading ...; fig 7d	In order to report that chronic mild TLR4 stimulation attenuates Alzheimer's disease-related tauopathy, Invitrogen Mapt antibody (Thermo Fisher, AT8) was used in immunohistochemistry on mouse samples (fig 7d). J Immunol (2016) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; human; loading ...; fig 3d	In order to examine S-guanylation of tau and report its effects on tau aggregation, Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in western blot on human samples (fig 3d). J Biol Chem (2016) ncbi
mouse monoclonal (S.125.0) MA5-15108	immunocytochemistry; human; 1:300; fig 5b	In order to investigate 20nm citrate-coated and polyvinylpyrrolidone-coated silver nanoparticle-induced neurotoxicity, Invitrogen Mapt antibody (Pierce, MA5-15108) was used in immunocytochemistry on human samples at 1:300 (fig 5b). Neurotoxicology (2016) ncbi
domestic rabbit polyclonal 44-742G	immunohistochemistry - paraffin section; mouse; loading ...; fig 6c	In order to describe the molecular and behavioral features of R3m/4 transgenic mice expressing human non-mutated truncated tau protein and assess these mice as a model for Alzheimer's disease, Invitrogen Mapt antibody (Invitrogen, 44742G) was used in immunohistochemistry - paraffin section on mouse samples (fig 6c). J Alzheimers Dis (2016) ncbi
domestic rabbit polyclonal 44-752G	western blot; mouse; loading ...; fig 3a	In order to describe the molecular and behavioral features of R3m/4 transgenic mice expressing human non-mutated truncated tau protein and assess these mice as a model for Alzheimer's disease, Invitrogen Mapt antibody (Invitrogen, 44752G) was used in western blot on mouse samples (fig 3a). J Alzheimers Dis (2016) ncbi
domestic rabbit polyclonal 44-738G	western blot; mouse; loading ...; fig 3a	In order to describe the molecular and behavioral features of R3m/4 transgenic mice expressing human non-mutated truncated tau protein and assess these mice as a model for Alzheimer's disease, Invitrogen Mapt antibody (Invitrogen, 44738G) was used in western blot on mouse samples (fig 3a). J Alzheimers Dis (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; mouse; loading ...; fig 6g	In order to describe the molecular and behavioral features of R3m/4 transgenic mice expressing human non-mutated truncated tau protein and assess these mice as a model for Alzheimer's disease, Invitrogen Mapt antibody (Pierce, MN1020) was used in immunohistochemistry - paraffin section on mouse samples (fig 6g). J Alzheimers Dis (2016) ncbi
domestic rabbit polyclonal 44-734G	western blot; mouse; loading ...; fig 3a	In order to describe the molecular and behavioral features of R3m/4 transgenic mice expressing human non-mutated truncated tau protein and assess these mice as a model for Alzheimer's disease, Invitrogen Mapt antibody (Invitrogen, 44734G) was used in western blot on mouse samples (fig 3a). J Alzheimers Dis (2016) ncbi
domestic rabbit polyclonal 44-758G	western blot; mouse; loading ...; fig 3a	In order to describe the molecular and behavioral features of R3m/4 transgenic mice expressing human non-mutated truncated tau protein and assess these mice as a model for Alzheimer's disease, Invitrogen Mapt antibody (Invitrogen, 44758G) was used in western blot on mouse samples (fig 3a). J Alzheimers Dis (2016) ncbi
domestic rabbit polyclonal 44-740G	western blot; mouse; loading ...; fig 3a	In order to describe the molecular and behavioral features of R3m/4 transgenic mice expressing human non-mutated truncated tau protein and assess these mice as a model for Alzheimer's disease, Invitrogen Mapt antibody (Invitrogen, 44740G) was used in western blot on mouse samples (fig 3a). J Alzheimers Dis (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; rat; 1:50; fig 6 western blot; rat; 1:1000	In order to characterize an Alzheimer's disease model that utilizes Octodon degus, Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunohistochemistry - paraffin section on rat samples at 1:50 (fig 6) and in western blot on rat samples at 1:1000. Acta Neuropathol Commun (2016) ncbi
mouse monoclonal (S.125.0) MA5-15108	immunohistochemistry - paraffin section; human; 1:2000; fig 2d	In order to describe a role for HMGB1 in Alzheimer's disease pathogenesis, Invitrogen Mapt antibody (Thermo Fisher, MA5-15108) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 2d). Sci Rep (2016) ncbi
domestic rabbit polyclonal 44-750G	western blot; mouse; loading ...; fig 6a	In order to report that reduced exosome secretion due to nSMase2 loss improves pathology and cognition in a mouse model of Alzheimer's disease, Invitrogen Mapt antibody (Biosource, 44-750G) was used in western blot on mouse samples (fig 6a). J Neurosci (2016) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:500; loading ...; fig 3a western blot; human; 1:500; loading ...; fig 8	In order to describe the role of miR-132 in amyloid and TAU pathology associated with Alzheimer's disease, Invitrogen Mapt antibody (BD Biosciences, MN1020) was used in western blot on mouse samples at 1:500 (fig 3a) and in western blot on human samples at 1:500 (fig 8). EMBO Mol Med (2016) ncbi
domestic rabbit polyclonal 44-740G	western blot; human; 1:1000; fig 3	In order to identify and characterize a DYRK1A inhibitor, Invitrogen Mapt antibody (Invitrogen, 44740G) was used in western blot on human samples at 1:1000 (fig 3). Dis Model Mech (2016) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; loading ...; fig 1c	In order to test if antibody effector function is required for limiting the spread of tau, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in western blot on human samples (fig 1c). Cell Rep (2016) ncbi
mouse monoclonal (TauC3) AHB0061	western blot; rat; 1:1000; fig 9	In order to ascertain the effects of severe penetrating traumatic brain injury on APP and tau cleavage processing, Invitrogen Mapt antibody (Invitrogen, AHB0061) was used in western blot on rat samples at 1:1000 (fig 9). PLoS ONE (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - free floating section; mouse; 1:1000; loading ...; fig 5a	In order to identify NFE2L2/NRF2 as a regulator of autophagy gene expression and study its role in Alzheimer disease, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry - free floating section on mouse samples at 1:1000 (fig 5a). Autophagy (2016) ncbi
domestic rabbit polyclonal 44-752G	western blot; mouse; 1:1000; fig 3	In order to elucidate the mechanistic relationship between amyloid beta1-42 and Tau, Invitrogen Mapt antibody (Invitrogen, 44752G) was used in western blot on mouse samples at 1:1000 (fig 3). Aging Cell (2016) ncbi
domestic rabbit polyclonal 44-750G	western blot; mouse; 1:1000; fig 3	In order to elucidate the mechanistic relationship between amyloid beta1-42 and Tau, Invitrogen Mapt antibody (Invitrogen, 44750G) was used in western blot on mouse samples at 1:1000 (fig 3). Aging Cell (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; mouse; 1:25; fig 2	In order to elucidate the mechanistic relationship between amyloid beta1-42 and Tau, Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunohistochemistry - paraffin section on mouse samples at 1:25 (fig 2). Aging Cell (2016) ncbi
mouse monoclonal (AT8) MN1020	western blot; domestic rabbit; 1:1000; fig 3	In order to characterize the role of endolysosomes in skeletal muscle pathology observed in a model of Alzheimer's disease with a cholesterol-fed rabbit, Invitrogen Mapt antibody (Pierce, MN1020) was used in western blot on domestic rabbit samples at 1:1000 (fig 3). Front Aging Neurosci (2016) ncbi
domestic rabbit polyclonal 44-752G	immunohistochemistry - paraffin section; mouse; 1:1000; fig 1	In order to elucidate the pathological conversion of tau facilitated by the neuritic plaque in an Alzheimer's disease mouse model, Invitrogen Mapt antibody (Invitrogen, 44752) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 2a	In order to detail the neuropathological features of the anti-IgLON5 syndrome in order to diagnose patients, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2a). Acta Neuropathol (2016) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; human; fig s3	In order to investigate the axon initial segment in neurological disorders, Invitrogen Mapt antibody (Life Technologies, AHB0042) was used in western blot on human samples (fig s3). Mol Neurodegener (2016) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; fig s3 western blot; human; fig s3	In order to investigate the axon initial segment in neurological disorders, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in western blot on mouse samples (fig s3) and in western blot on human samples (fig s3). Mol Neurodegener (2016) ncbi
domestic rabbit polyclonal 44-752G	blocking or activating experiments; human; fig 3	In order to assess the accumulation in the cerebrospinal fluid of seed-competent HMW tau specis in an Alzheimer's disease mouse model and in human patients, Invitrogen Mapt antibody (Life Technologies, 44752) was used in blocking or activating experiments on human samples (fig 3). Ann Neurol (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:2000; fig 7	In order to characterize the cerebral cortex during the progression of Alzheimer disease pathology by visualizing subcellular changes in bridging integrator 1 protein expression, Invitrogen Mapt antibody (Pierce, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 7). J Neuropathol Exp Neurol (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - free floating section; human; fig 2	In order to characterize nuclear indentations that are tau-positive in P301S tauopathy mice, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry - free floating section on human samples (fig 2). Brain Pathol (2017) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:500; fig 6	In order to study the attenuation of Alzheimer's pathology in mice due to kallikrein-8 inhibition, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in western blot on mouse samples at 1:500 (fig 6). Alzheimers Dement (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:80 western blot; mouse; 1:500	In order to It is never too late to start late running regarding Alzheimer's pathology, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry on mouse samples at 1:80 and in western blot on mouse samples at 1:500. Neurobiol Dis (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:2000; fig 1	In order to study the human brain after blast exposure in post-mortem cases to characterize the interface astroglial scarring, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 1). Lancet Neurol (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; fig 2	In order to assess the correlation with levels of phosphotau and autophagy-related proteins and tau inclusions in PSP, Pick, and AD disease and levels of a key component of clathrin-mediated endocytosis, PICALM, Invitrogen Mapt antibody (Pierce, MN1020) was used in immunohistochemistry - paraffin section on human samples (fig 2). Neurobiol Dis (2016) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; fig 6	In order to analyze the mitigation that increases PHF1 levels and lipofuscin puncta and rescues memory deficits by TFEB overexpression in the P301S model of tauopathy, Invitrogen Mapt antibody (Thermo, MN1020) was used in western blot on mouse samples (fig 6). Eneuro (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; loading ...; fig 3c	In order to examine the role of Tom1 in protein degradation in Alzheimer's disease models, Invitrogen Mapt antibody (Thermo Fisher, AT8) was used in immunohistochemistry - paraffin section on human samples (fig 3c). J Neurol Sci (2016) ncbi
mouse monoclonal (AT8) MN1020	western blot; fruit fly ; fig 3 immunohistochemistry - free floating section; mouse; fig 4 immunohistochemistry - free floating section; human; fig 4	In order to identify PTK2B as an in vivo modulator and early marker of Tau pathology due to functional screening of Alzheimer risk loci, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in western blot on fruit fly samples (fig 3), in immunohistochemistry - free floating section on mouse samples (fig 4) and in immunohistochemistry - free floating section on human samples (fig 4). Mol Psychiatry (2017) ncbi
domestic rabbit polyclonal 44-740G	western blot; human; 1:3000; fig 1	In order to study kinase DYRK1A selective inhibition by targeting its folding process, Invitrogen Mapt antibody (Life technologies, 44740G) was used in western blot on human samples at 1:3000 (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - free floating section; human; 1:250; fig 2	In order to analyze reactive glial nets in Alzheimer's disease by high resolution dissection, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry - free floating section on human samples at 1:250 (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - frozen section; human; 1:500; fig 6 western blot; human; 1:2500; fig 5	In order to study behavioral deficits without pathological interaction by humanized tau mice with regionalized amyloid, Invitrogen Mapt antibody (Pierce, MN-1020) was used in immunohistochemistry - frozen section on human samples at 1:500 (fig 6) and in western blot on human samples at 1:2500 (fig 5). PLoS ONE (2016) ncbi
mouse monoclonal (Tau-5) AHB0042	immunocytochemistry; human; 1:600; fig 4 western blot; human; 1:1000; fig 2	In order to determine modulation of cellular release of tau by FRMD4A-cytohesin signaling, Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in immunocytochemistry on human samples at 1:600 (fig 4) and in western blot on human samples at 1:1000 (fig 2). J Cell Sci (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:1000	In order to suggest that the clinical feature of choreoathetosis in behavioral variant of frontotemporal dementia might be associated with the basophilic inclusion body disease subtype of frontotemporal lobar degeneration, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry - paraffin section on human samples at 1:1000. Acta Neuropathol Commun (2016) ncbi
mouse monoclonal (Tau-5) AHB0042	immunohistochemistry - frozen section; mouse; 1:500; tbl 1 western blot; mouse; 1:500; tbl 1	In order to utilize a time course study of sciatic nerves from aging mice to gain a neurogenic perspective of sarcopenia, Invitrogen Mapt antibody (Biosource International, AHB0042) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (tbl 1) and in western blot on mouse samples at 1:500 (tbl 1). J Neuropathol Exp Neurol (2016) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:1000; fig 3	In order to characterize the seeding of tau protein aggregation in a threshold-dependent manner via extracellular vesicles isolated from the brains of rTg4510 mice, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in western blot on mouse samples at 1:1000 (fig 3). J Biol Chem (2016) ncbi
domestic rabbit polyclonal 44-752G	western blot; mouse; 1:1000; loading ...; fig 4e	In order to characterize epigenetic changes in 5XFAD mice, Invitrogen Mapt antibody (Invitrogen, 44752G) was used in western blot on mouse samples at 1:1000 (fig 4e). Aging (Albany NY) (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; fruit fly ; 1:1000; fig 4 western blot; fruit fly ; 1:2000; fig 4	In order to study suppression of pathogenesis of human neuronal tauopathies in drosophila by limiting tau hyperphosphorylation and heterochromatin relaxation by targeted downregulation of dMyc, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry - paraffin section on fruit fly samples at 1:1000 (fig 4) and in western blot on fruit fly samples at 1:2000 (fig 4). Mol Neurobiol (2017) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; human; fig 2	In order to study enhanced degradation of proteasomal substrates that are associated with neurodegenerative disease and the effect of inactivation of USP14, Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in western blot on human samples (fig 2). F1000Res (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; fig 4	In order to study the predecessor for Alzheimer's disease-related microvascular cerebral amyloid angiopathy caused by tau pathology-dependent remodeling of cerebral arteries, Invitrogen Mapt antibody (ThermoFisher Scientific, MN1020) was used in immunohistochemistry - paraffin section on human samples (fig 4). Acta Neuropathol (2016) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	western blot; human; 1:10,000; fig 3f	In order to investigate the role of channel gating in mammalian proteasomes, Invitrogen Mapt antibody (Invitrogen, Tau-5) was used in western blot on human samples at 1:10,000 (fig 3f). Nat Commun (2016) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; 1:2000; fig 4	In order to elucidate the exacerbation of human Tau neurotoxicity in vivo by acetylation mimic of lysine 280, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in western blot on human samples at 1:2000 (fig 4). Sci Rep (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:1000; tbl 2	In order to characterize autophagic and lysosomal defects in human tauopathies from post-mortem brain from patients with familial Alzheimer disease, progressive supranuclear palsy, and coricobasal degeneration, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (tbl 2). Acta Neuropathol Commun (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - frozen section; human; fig 3	In order to learn the cause of age-dependent neuronal dysfunction and loss in transgenic mice by expression of A152T human tau, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry - frozen section on human samples (fig 3). EMBO Rep (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - free floating section; human; 1:800; tbl 2	In order to characterize the frontal cortex of wild mountain gorillas (Gorilla beringei beringei) for early Alzheimer's disease-type pathology, Invitrogen Mapt antibody (Therno Fisher, MN1020) was used in immunohistochemistry - free floating section on human samples at 1:800 (tbl 2). Neurobiol Aging (2016) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:1000; tbl 1	In order to study novelty-induced and brain-specific basal alternations in PI3K-Akt and MAPK/ERK signaling in a middle-aged A-betaPP/PS1 mouse model of Alzheimer's disease, Invitrogen Mapt antibody (Thermo, MN1020) was used in western blot on mouse samples at 1:1000 (tbl 1). J Alzheimers Dis (2016) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; human; fig 1	In order to investigate survival and neuronal differentiation of human BM-MSCs by pulsed electromagnetic fields, Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in western blot on human samples (fig 1). Life Sci (2016) ncbi
domestic rabbit polyclonal 44-740G	western blot; human; 1:1000; loading ...; fig 3	In order to identify and characterize inhibitors of Dyrk1A and Clk1, Invitrogen Mapt antibody (Life Technologies, 444-740 g) was used in western blot on human samples at 1:1000 (fig 3). Eur J Med Chem (2016) ncbi
mouse monoclonal (AT8) MN1020	western blot; rat; 1:1000; fig 2	In order to research blockade of a toxic acetylcholinesterase-derived peptide increased in Alzheimer's brains by pharmacological profiling of the novel modulator of the alpha7 nicotinic receptor, Invitrogen Mapt antibody (ThermoFisher Scientific, MN1020) was used in western blot on rat samples at 1:1000 (fig 2). Neuropharmacology (2016) ncbi
domestic rabbit polyclonal 44-734G	western blot; mouse; fig 8	In order to characterize chronic white matter inflammation and dendritic spine loss in a mouse model of highly repetitive head trauma, Invitrogen Mapt antibody (Thermo Fisher, 44734G) was used in western blot on mouse samples (fig 8). Am J Pathol (2016) ncbi
domestic rabbit polyclonal 44-738G	western blot; mouse; fig 8	In order to characterize chronic white matter inflammation and dendritic spine loss in a mouse model of highly repetitive head trauma, Invitrogen Mapt antibody (Thermo Fisher, 44738G) was used in western blot on mouse samples (fig 8). Am J Pathol (2016) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; fig 8	In order to characterize chronic white matter inflammation and dendritic spine loss in a mouse model of highly repetitive head trauma, Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in western blot on mouse samples (fig 8). Am J Pathol (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 1:100; fig 5	In order to utilize an in vitro cell culture modeling neurodegenerative diseases to learn about brain aggregates, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry on human samples at 1:100 (fig 5). J Neuropathol Exp Neurol (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; mouse; 1:500; fig 1	In order to elucidate a mouse model of frontotemporal dementia by decreased social exploration, impulsivity, and executive dysfunction, Invitrogen Mapt antibody (Thermo Scientifi, AT8) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 1). Neurobiol Learn Mem (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; fig 3 western blot; mouse; 1:1000; fig 3 immunohistochemistry; human; fig 3 western blot; human; 1:1000; fig 3	In order to elucidate modification microglial phenotype and neuroprotection in P301S tau transgenic mice via TREM2, Invitrogen Mapt antibody (Pierce, MN1020) was used in immunohistochemistry on mouse samples (fig 3), in western blot on mouse samples at 1:1000 (fig 3), in immunohistochemistry on human samples (fig 3) and in western blot on human samples at 1:1000 (fig 3). Neuropharmacology (2016) ncbi
mouse monoclonal (T46) 13-6400	western blot; mouse; 1:1000; fig 7	In order to assess rescue of Alzheimer's disease in the mouse by improved proteostasis in the secretory pathway, Invitrogen Mapt antibody (Invitrogen, T46) was used in western blot on mouse samples at 1:1000 (fig 7). Brain (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:100; fig 7 western blot; mouse; 1:750; fig 7	In order to assess rescue of Alzheimer's disease in the mouse by improved proteostasis in the secretory pathway, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry on mouse samples at 1:100 (fig 7) and in western blot on mouse samples at 1:750 (fig 7). Brain (2016) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	western blot; human; 1:1000; tbl 1 western blot; mouse; 1:1000; tbl 1	In order to study reduction of hyperphosphorilated Tau by beta-secretase 1's targeting implying autophagy actors in 3xTg-AD mice, Invitrogen Mapt antibody (Thermo Fisher, TAU-5) was used in western blot on human samples at 1:1000 (tbl 1) and in western blot on mouse samples at 1:1000 (tbl 1). Front Cell Neurosci (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:1000; tbl 1 western blot; human; 1:1000; tbl 1	In order to study reduction of hyperphosphorilated Tau by beta-secretase 1's targeting implying autophagy actors in 3xTg-AD mice, Invitrogen Mapt antibody (Thermo Fisher, AT8) was used in western blot on mouse samples at 1:1000 (tbl 1) and in western blot on human samples at 1:1000 (tbl 1). Front Cell Neurosci (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:1000; fig 3	In order to examine the impact of type 2 diabetes on tau phosphorylation in diabetic mouse model, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in western blot on mouse samples at 1:1000 (fig 3). Neurobiol Dis (2016) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; fig 3e	In order to analyze astragaloside IV and its role in microglia activation via glucocorticod receptor mediated signaling pathways, Invitrogen Mapt antibody (Pierce, MN1020) was used in western blot on mouse samples (fig 3e). Sci Rep (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 1:800; tbl 2	In order to analyze astrocytes in Alzheimer's disease pathology by an increased occurrence of protein kinase CK2, Invitrogen Mapt antibody (Pierce, AT8) was used in immunohistochemistry on human samples at 1:800 (tbl 2). J Neuroinflammation (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:500; loading ...; fig 3a	In order to test if a LXR agonist affects cognitive impairment in amyloid and Tau Alzheimer's disease mouse models, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry on mouse samples at 1:500 (fig 3a). PLoS ONE (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; 1:500; fig 2	In order to characterize tau pathology mouse models via obesity, diabetes, and leptin resistance, Invitrogen Mapt antibody (Pierce, AT8) was used in western blot on human samples at 1:500 (fig 2). Neuroscience (2016) ncbi
domestic rabbit polyclonal 44-742G	western blot; human; 1:3000; fig 3	In order to research how cAMP-PKA signaling activation can prevent tau-driven 26S proteasome impairment and cognitive dysfunction, Invitrogen Mapt antibody (Life Technologies, 44-742G) was used in western blot on human samples at 1:3000 (fig 3). Nat Med (2016) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; human; fig 3	In order to survey the activation of a synapse weakening pathway by human Val66, not Met66 in proBDNF, Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in western blot on human samples (fig 3). Pharmacol Res (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:1000; fig 1	In order to analysis of neurofibrillary tangles and granulovacuolar degeneration in Alzheimer's disease and tauopathy brains and the common feature of hypersialylation, Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 1). Neuropathology (2016) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:1000; fig 3	In order to assess the impairment in synaptic plasticity and learning due to amyloid-beta dimers in the absence of plaque pathology, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in western blot on mouse samples at 1:1000 (fig 3). Brain (2016) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	western blot; cat; 1:1000; fig 4	In order to study Alzheimer's disease by use of a domestic cat animal model, Invitrogen Mapt antibody (Life Technologies, TAU-5) was used in western blot on cat samples at 1:1000 (fig 4). Acta Neuropathol Commun (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; cat; 1:100; fig 6	In order to study Alzheimer's disease by use of a domestic cat animal model, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry - paraffin section on cat samples at 1:100 (fig 6). Acta Neuropathol Commun (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; fig 3	In order to study the effect of G2019S on neuronal subtypes, Invitrogen Mapt antibody (Thermo, MN1020) was used in western blot on human samples (fig 3). Stem Cell Reports (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; fig 7	In order to characterize the release of insulin-like growth factor-binding protein 3 from astrocytes in the pathology of Alzheimer's disease, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in western blot on human samples (fig 7). Mol Brain (2015) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; mouse; 1:5000; fig 5	In order to assess the deletion of Ccr2 and cavity size and tau pathology after mild traumatic brain injury, Invitrogen Mapt antibody (Invitrogen, ahb0042) was used in western blot on mouse samples at 1:5000 (fig 5). J Neuroinflammation (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; fig 3	In order to investigate the reactivity of isolated natural antibodies against tau protein, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in western blot on human samples (fig 3). J Neuroimmunol (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; fig 1c	In order to discover why mercury is found in locus ceruleus neurons in people with autism, Invitrogen Mapt antibody (Thermo Fisher Scientific, MN1020) was used in immunohistochemistry on human samples (fig 1c). Biometals (2016) ncbi
domestic rabbit polyclonal 44-752G	western blot; mouse; 1:3000; fig 1	In order to test if short-term treadmill exercise changes tau modifications, Invitrogen Mapt antibody (Invitrogen, 44-752G) was used in western blot on mouse samples at 1:3000 (fig 1). Neurosci Lett (2016) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; human; 1,000 ug/ml; fig 10	In order to characterize chronic traumatic encephalopathy to determine if phosphorylated tau is unique in epileptic brain and chronic traumatic encephalopathy, Invitrogen Mapt antibody (Life Technologies, AHB0042) was used in western blot on human samples at 1,000 ug/ml (fig 10). Brain Res (2016) ncbi
domestic rabbit polyclonal 44-738G		In order to discuss the use of CDK5 biomarkers, Invitrogen Mapt antibody (Invitrogen, 44-738G) was used . BMC Cancer (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:500; fig 5	In order to characterize linalool that reverses behavioral and neuropathological impairments in old triple transgenic Alzheimer's mice, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry on mouse samples at 1:500 (fig 5). Neuropharmacology (2016) ncbi
mouse monoclonal (T46) 13-6400	immunohistochemistry; human; 1:500; fig 6 western blot; human; fig 2	In order to assess using the biochemical properties of tau to classify tauopathies, Invitrogen Mapt antibody (Thermo Scientific, T46) was used in immunohistochemistry on human samples at 1:500 (fig 6) and in western blot on human samples (fig 2). Acta Neuropathol (2016) ncbi
domestic rabbit polyclonal 44-738G		In order to characterize postmortem behavior and the rapid alteration of protein phosphorylation, Invitrogen Mapt antibody (Invitrogen, 44738G) was used . Sci Rep (2015) ncbi
domestic rabbit polyclonal 44-752G		In order to characterize postmortem behavior and the rapid alteration of protein phosphorylation, Invitrogen Mapt antibody (Invitrogen, 44752G) was used . Sci Rep (2015) ncbi
domestic rabbit polyclonal 44-742G		In order to characterize postmortem behavior and the rapid alteration of protein phosphorylation, Invitrogen Mapt antibody (Invitrogen, 44742G) was used . Sci Rep (2015) ncbi
domestic rabbit polyclonal 44-758G		In order to characterize postmortem behavior and the rapid alteration of protein phosphorylation, Invitrogen Mapt antibody (Invitrogen, 44758G) was used . Sci Rep (2015) ncbi
domestic rabbit polyclonal 44-740G		In order to characterize postmortem behavior and the rapid alteration of protein phosphorylation, Invitrogen Mapt antibody (Invitrogen, 44740G) was used . Sci Rep (2015) ncbi
domestic rabbit polyclonal 44-734G		In order to characterize postmortem behavior and the rapid alteration of protein phosphorylation, Invitrogen Mapt antibody (Invitrogen, 44734G) was used . Sci Rep (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; 1:5000; fig 7	In order to use a pharmaceutical screen to discover new mechanisms of autophagy activation, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in western blot on human samples at 1:5000 (fig 7). Nat Commun (2015) ncbi
mouse monoclonal (AT8) MN1020	ELISA; mouse; fig 2 ELISA; human; fig 2	In order to study in vivo turnover of tau by use of a mouse model of tauopathy, Invitrogen Mapt antibody (Pierce, AT8) was used in ELISA on mouse samples (fig 2) and in ELISA on human samples (fig 2). Mol Neurodegener (2015) ncbi
mouse monoclonal (TauC3) AHB0061	immunohistochemistry - paraffin section; human; 1:200; fig 3	In order to study the relationship between neurofibrillary tangles and raft domains, Invitrogen Mapt antibody (Invitrogen, Tau-C3) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Neuropathol Appl Neurobiol (2016) ncbi
domestic rabbit polyclonal 44-750G		In order to research Alzheimer's disease brain and neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau, Invitrogen Mapt antibody (Life Technologies, 44750G) was used . Nat Commun (2015) ncbi
domestic rabbit polyclonal 44-758G		In order to research Alzheimer's disease brain and neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau, Invitrogen Mapt antibody (Life Technologies, 44758G) was used . Nat Commun (2015) ncbi
domestic rabbit polyclonal 44-734G		In order to research Alzheimer's disease brain and neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau, Invitrogen Mapt antibody (Life Technologies, 44734G) was used . Nat Commun (2015) ncbi
domestic rabbit polyclonal 44-738G		In order to research Alzheimer's disease brain and neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau, Invitrogen Mapt antibody (Life Technologies, 44738G) was used . Nat Commun (2015) ncbi
domestic rabbit polyclonal 44-752G		In order to research Alzheimer's disease brain and neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau, Invitrogen Mapt antibody (Life Technologies, 44752G) was used . Nat Commun (2015) ncbi
domestic rabbit polyclonal 44-760G		In order to research Alzheimer's disease brain and neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau, Invitrogen Mapt antibody (Life Technologies, 44760G) was used . Nat Commun (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; mouse; 1:100	In order to investigate the unfolded protein response in neurodegenerative disorders, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. Acta Neuropathol (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 0.3 ug/ml; fig 1 western blot; human; 1:1000; fig 3	In order to report that the di-phenyl-pyrazole anle138b binds to and inhibits tau aggregation in vitro and in vivo, Invitrogen Mapt antibody (ThermoScientific, AT8) was used in immunohistochemistry on human samples at 0.3 ug/ml (fig 1) and in western blot on human samples at 1:1000 (fig 3). Acta Neuropathol (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:500; fig 1 western blot; mouse; 1:500; fig 5	In order to investigate how tau propagation is interrupted due to microglia depletion and exosome synthesis inhibition, Invitrogen Mapt antibody (Thermo Fisher Scientific, MN1020) was used in immunohistochemistry on mouse samples at 1:500 (fig 1) and in western blot on mouse samples at 1:500 (fig 5). Nat Neurosci (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - frozen section; mouse; fig 2 western blot; mouse; fig 2	In order to utilize an Alzheimer's disease model in mice to show colocalization of phosphorylated forms of CRMP2, WAVE1, and tau that identify an involvement of Cdk5 phosphorylation and an affect of ATRA treatment, Invitrogen Mapt antibody (ThermoFisher Scientific, MN1020) was used in immunohistochemistry - frozen section on mouse samples (fig 2) and in western blot on mouse samples (fig 2). J Neurosci Res (2016) ncbi
mouse monoclonal (Tau-5) AHB0042	immunoprecipitation; human; fig 1 western blot; human; fig 1	In order to investigate the effects of tau acetylation at Lys174, Invitrogen Mapt antibody (Life Technologies, AHB0042) was used in immunoprecipitation on human samples (fig 1) and in western blot on human samples (fig 1). Nat Med (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; fig 4	In order to investigate the effects of tau acetylation at Lys174, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in western blot on mouse samples (fig 4). Nat Med (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; mouse; fig 1	In order to determine the therapeutic window to prevent the formation of Tau aggregates, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Neurobiol Dis (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; fig 3	In order to investigate the role of miR-132/212 in tauopathies, Invitrogen Mapt antibody (ThermoFisher, Ser202/Thr205) was used in western blot on mouse samples (fig 3). Hum Mol Genet (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; fig s1 western blot; human; fig s2	In order to study protection of transgenic P301S mice against tau aggregation in Alzheimer's disease by doubly phosphorylated peptied vaccines, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry on human samples (fig s1) and in western blot on human samples (fig s2). Vaccines (Basel) (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:2500	In order to present data from the first donated Lothian Birth Cohort of 1936 and compare it with other aged and diseased samples, Invitrogen Mapt antibody (Thermo, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:2500. Acta Neuropathol Commun (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; tbl 1	In order to characterize the neuropathologic evaluation of Alzheimer's disease by multisite assessment of NIA-AA guidelines, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry on human samples (tbl 1). Alzheimers Dement (2016) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:1000; fig 3	In order to analyze a mouse model where human neural stem cells alleviate Alzheimer-like pathology, Invitrogen Mapt antibody (Thermo Fisher Scientific, MN1020) was used in western blot on mouse samples at 1:1000 (fig 3). Mol Neurodegener (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; degu; 1:200; fig 5 western blot; degu; fig 5n	In order to study the retina of Octodon degus for Alzheimer's disease-related protein expression, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry on degu samples at 1:200 (fig 5) and in western blot on degu samples (fig 5n). PLoS ONE (2015) ncbi
domestic rabbit polyclonal 44-734G	western blot; mouse western blot; rat western blot; dogs; 1:1000; fig 7 western blot; human	In order to study canine cognitive impairment syndrome, Invitrogen Mapt antibody (Life Technologies, 44734G) was used in western blot on mouse samples , in western blot on rat samples , in western blot on dogs samples at 1:1000 (fig 7) and in western blot on human samples . J Comp Neurol (2016) ncbi
domestic rabbit polyclonal 44-758G	western blot; mouse western blot; dogs; 1:1000; fig 7 western blot; rat	In order to study canine cognitive impairment syndrome, Invitrogen Mapt antibody (Life Technologies, 44758G) was used in western blot on mouse samples , in western blot on dogs samples at 1:1000 (fig 7) and in western blot on rat samples . J Comp Neurol (2016) ncbi
domestic rabbit polyclonal 44-740G	western blot; domestic sheep western blot; African green monkey western blot; mouse western blot; rat western blot; human immunohistochemistry - paraffin section; dogs western blot; dogs; 1:1000; fig 7 western blot; bovine western blot; baboons	In order to study canine cognitive impairment syndrome, Invitrogen Mapt antibody (Life Technologies, 44740G) was used in western blot on domestic sheep samples , in western blot on African green monkey samples , in western blot on mouse samples , in western blot on rat samples , in western blot on human samples , in immunohistochemistry - paraffin section on dogs samples , in western blot on dogs samples at 1:1000 (fig 7), in western blot on bovine samples and in western blot on baboons samples . J Comp Neurol (2016) ncbi
domestic rabbit polyclonal 44-750G	western blot; mouse western blot; rat immunohistochemistry - paraffin section; dogs; 1:1000	In order to study canine cognitive impairment syndrome, Invitrogen Mapt antibody (Life Technologies, 44750G) was used in western blot on mouse samples , in western blot on rat samples and in immunohistochemistry - paraffin section on dogs samples at 1:1000. J Comp Neurol (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; dogs; 1:1000; fig 3	In order to study canine cognitive impairment syndrome, Invitrogen Mapt antibody (Life Technologies, MN1020) was used in immunohistochemistry - paraffin section on dogs samples at 1:1000 (fig 3). J Comp Neurol (2016) ncbi
mouse monoclonal (PHF13.6) 35-5300	immunohistochemistry - paraffin section; dogs; 1:1000 western blot; rat western blot; mouse	In order to study canine cognitive impairment syndrome, Invitrogen Mapt antibody (Life Technologies, 355300) was used in immunohistochemistry - paraffin section on dogs samples at 1:1000, in western blot on rat samples and in western blot on mouse samples . J Comp Neurol (2016) ncbi
domestic rabbit polyclonal 44-744	immunohistochemistry; rat western blot; rat western blot; domestic sheep western blot; bovine immunohistochemistry - paraffin section; dogs; 1:1000 western blot; baboons western blot; African green monkey western blot; mouse	In order to study canine cognitive impairment syndrome, Invitrogen Mapt antibody (Life Technologies, 44-744) was used in immunohistochemistry on rat samples , in western blot on rat samples , in western blot on domestic sheep samples , in western blot on bovine samples , in immunohistochemistry - paraffin section on dogs samples at 1:1000, in western blot on baboons samples , in western blot on African green monkey samples and in western blot on mouse samples . J Comp Neurol (2016) ncbi
domestic rabbit polyclonal 44-738G	western blot; mouse western blot; human immunohistochemistry - paraffin section; dogs western blot; dogs; 1:1000; fig 7 western blot; rat	In order to study canine cognitive impairment syndrome, Invitrogen Mapt antibody (Life Technologies, 44738G) was used in western blot on mouse samples , in western blot on human samples , in immunohistochemistry - paraffin section on dogs samples , in western blot on dogs samples at 1:1000 (fig 7) and in western blot on rat samples . J Comp Neurol (2016) ncbi
domestic rabbit polyclonal 44-742G	western blot; human immunohistochemistry - paraffin section; dogs; fig 3 western blot; dogs; 1:1000; fig 7	In order to study canine cognitive impairment syndrome, Invitrogen Mapt antibody (Life Technologies, 44742G) was used in western blot on human samples , in immunohistochemistry - paraffin section on dogs samples (fig 3) and in western blot on dogs samples at 1:1000 (fig 7). J Comp Neurol (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:2000; fig 2 western blot; human; fig 5	In order to discuss protocols that monitor tau pathology development in Alzheimer's disease, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 2) and in western blot on human samples (fig 5). Methods Mol Biol (2016) ncbi
domestic rabbit polyclonal 44-752G		In order to characterize the death target of Alzheimer patient amyloid-beta assembly, Na, K-ATPase alpha3, Invitrogen Mapt antibody (Invitrogen, 44752G) was used . Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; fig 1	In order to study an increase in tau phosphorylation via P38 mitogen-activated protein kinase dye to glucose deprivation, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in western blot on mouse samples (fig 1). Aging Cell (2015) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; human	In order to test if BAG2 mediates the cold-induced accumulation of phosphorylated tau protein, Invitrogen Mapt antibody (Life Technologies, AHB0042) was used in western blot on human samples . Cell Mol Neurobiol (2016) ncbi
domestic rabbit polyclonal 44-740G		In order to identify a beta-carboline inhibitor to study the function of DYRK1A in biological studies, Invitrogen Mapt antibody (Invitrogen, 44740G) was used . PLoS ONE (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 10 ug/ml; fig 2	In order to investigate how microglia and iron contribute to Alzheimer's disease, Invitrogen Mapt antibody (Pierce Biotechnology, MN1020) was used in immunohistochemistry - paraffin section on human samples at 10 ug/ml (fig 2). Neurobiol Aging (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; mouse; fig 1	In order to investigate the relationship between neurofibrillary changes and degeneration of septal cholinergic neurons in P301L tau transgenic mice, Invitrogen Mapt antibody (Thermo Fisher, AT8) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Neuroreport (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 1:2000; fig 3	In order to report the neuropathologic autopsy findings of a man with the rare Tyr69His transthyretin gene variant, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry on human samples at 1:2000 (fig 3). Acta Neuropathol Commun (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; 1:3000	In order to study how microtubules and cations impact LRRK2-tau interactions, Invitrogen Mapt antibody (Life Technologies, MN1020) was used in western blot on human samples at 1:3000. J Neurosci Res (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; rat; 1:1000	In order to investigate the involvement of microRNA-195 in the effect of chronic brain hypoperfusion on rodent Cdk5/p25 and tau phosphorylation, Invitrogen Mapt antibody (ThermoFisher, MN1020) was used in western blot on rat samples at 1:1000. J Neurochem (2015) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; rat; 1:1000	In order to investigate the involvement of microRNA-195 in the effect of chronic brain hypoperfusion on rodent Cdk5/p25 and tau phosphorylation, Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in western blot on rat samples at 1:1000. J Neurochem (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:200; fig 3	In order to study amelioration of tau pathology and cognition in the offspring of triple transgenic AD mice by maternal dexamethasone exposure, Invitrogen Mapt antibody (Thermo, AT8) was used in western blot on mouse samples at 1:200 (fig 3). Mol Psychiatry (2016) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 1:500	In order to characterize the neuropathological features of dystonias, Invitrogen Mapt antibody (Thermo Fisher Scientific, MN1020) was used in immunohistochemistry on human samples at 1:500. Tremor Other Hyperkinet Mov (N Y) (2015) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; human; 1:5000; fig 1	In order to elucidate how methylene blue inhibits tau aggregation, Invitrogen Mapt antibody (Biosource, AHB0042) was used in western blot on human samples at 1:5000 (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; mouse; fig 4	In order to test the effects of high fat diet using a mouse model of familial Alzheimer disease, Invitrogen Mapt antibody (Biosource, AHB0042) was used in western blot on mouse samples (fig 4). Biochim Biophys Acta (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:1000	Invitrogen Mapt antibody (Pierce, AT8) was used in western blot on mouse samples at 1:1000. Brain (2015) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; human	In order to investigate the role of Apaf1 in axonogenesis, Invitrogen Mapt antibody (Life Technologies, AHB0042) was used in western blot on human samples . Cell Mol Life Sci (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 1:1000 ELISA; human	Invitrogen Mapt antibody (Thermo Scientific, clone AT8) was used in immunohistochemistry on human samples at 1:1000 and in ELISA on human samples . PLoS ONE (2015) ncbi
domestic rabbit recombinant (2H23L4) 701054	western blot; human; 1:1000	In order to study the effects of tau antibodies on in vitro tau phosphorylation, Invitrogen Mapt antibody (Invitrogen/Life Technologies, 2H23L4) was used in western blot on human samples at 1:1000. Exp Gerontol (2015) ncbi
mouse monoclonal (PHF13.6) 35-5300	western blot; human; 1:1000	In order to study the effects of tau antibodies on in vitro tau phosphorylation, Invitrogen Mapt antibody (Invitrogen/Life Technologies, 35-5300) was used in western blot on human samples at 1:1000. Exp Gerontol (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; fig 1b	In order to use rTg4510 mice to elucidate pathogenesis of tau-induced disease, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in western blot on human samples (fig 1b). Mol Neurodegener (2015) ncbi
domestic rabbit polyclonal 44-752G		In order to provide evidence that GSK-3beta-dependent downregulation of gamma-taxilin and alphaNAC regulate hypoxia-induced ER stress responses, Invitrogen Mapt antibody (Invitrogen, 44752G) was used . Cell Death Dis (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - frozen section; mouse	Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry - frozen section on mouse samples . J Neurosci (2015) ncbi
mouse monoclonal (T46) 13-6400	western blot; human	In order to identify small-molecules that inhibit the interaction between CDK5 and p25, Invitrogen Mapt antibody (Invitrogen, 13-6400) was used in western blot on human samples . Chem Biol (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; fig 3, 4	In order to characterize Alzheimer's disease-related tau pathology by HS3ST2 expression in critical for the abonormal phosphorylation of tau, Invitrogen Mapt antibody (Pierce, AT8) was used in western blot on human samples (fig 3, 4). Brain (2015) ncbi
mouse monoclonal (PHF13.6) 35-5300	western blot; human; fig 3, 4	In order to characterize Alzheimer's disease-related tau pathology by HS3ST2 expression in critical for the abonormal phosphorylation of tau, Invitrogen Mapt antibody (Pierce, PHF1) was used in western blot on human samples (fig 3, 4). Brain (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; 1:5000; fig 1a	In order to demonstrate that microglia promote tau pathology in a cell-autonomous manner, Invitrogen Mapt antibody (Pierce, AT8) was used in western blot on human samples at 1:5000 (fig 1a). Brain (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human	Invitrogen Mapt antibody (Thermo Scientific, clone AT-8) was used in immunohistochemistry - paraffin section on human samples . Front Neuroanat (2015) ncbi
mouse monoclonal (T46) 13-6400	western blot; human; 1:1000	In order to report a case of glial mixed tau and TDP-43 proteinopathies in a Japanese patient, Invitrogen Mapt antibody (Zymed, T46) was used in western blot on human samples at 1:1000. Brain Pathol (2016) ncbi
mouse monoclonal (AT8) MN1020	immunocytochemistry; human; 1:100; loading ...; fig 5e	In order to use a systems biology approach to identify and study factors that contribute to Alzheimer's disease, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunocytochemistry on human samples at 1:100 (fig 5e). PLoS ONE (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - free floating section; rat; 1:1000	In order to study the involvement of heat shock protein 27 (Hsp27) in a transgenic rat model of Alzheimer's disease, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry - free floating section on rat samples at 1:1000. Biochim Biophys Acta (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; rat; 1:1000; fig 1	In order to elucidate the neuroprotective mechanism of statins, Invitrogen Mapt antibody (Pierce, AT8) was used in western blot on rat samples at 1:1000 (fig 1). Neuroscience (2015) ncbi
mouse monoclonal (PHF13.6) 35-5300	western blot; rat; 1:1000; fig 1	In order to elucidate the neuroprotective mechanism of statins, Invitrogen Mapt antibody (Biosource, PHF-1) was used in western blot on rat samples at 1:1000 (fig 1). Neuroscience (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human	In order to assess the effect of voluntary running on several aspects of Alzheimer's disease, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry on human samples . Brain Pathol (2016) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse	In order to explore a nonpharmacological approach, repeated scanning ultrasound treatments, for removing Abeta and restoring memory function in a mouse model of Alzheimer's disease, Invitrogen Mapt antibody (Pierce Thermo Fisher, MN1020) was used in western blot on mouse samples . Sci Transl Med (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - free floating section; mouse; 1:1000	In order to use the APP/PS1 (APPSWE, PSEN1dE9) transgenic model of Alzheimer's disease to study the role of localized damage on disease progression, Invitrogen Mapt antibody (Thermo Fisher, MN1020) was used in immunohistochemistry - free floating section on mouse samples at 1:1000. Exp Neurol (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - free floating section; mouse; 1:500	In order to investigate if circulating miRNA levels can be used as biomarkers for Alzheimer's disease, Invitrogen Mapt antibody (Pierce, MN1020) was used in immunohistochemistry - free floating section on mouse samples at 1:500. Front Cell Neurosci (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - free floating section; human; 1:500	In order to elucidate the cell types and mechanisms underlying TREM2's contribution to neurodegeneration, Invitrogen Mapt antibody (Thermo, AT8) was used in immunohistochemistry - free floating section on human samples at 1:500. J Exp Med (2015) ncbi
domestic rabbit polyclonal 44-740G		In order to study selective inhibitors of DYRK1A called 10-iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acids, Invitrogen Mapt antibody (Invitrogen, 44740G) was used . J Med Chem (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; mouse	In order to investigate the spread of neuronal pathology, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry - paraffin section on mouse samples . Neuropathol Appl Neurobiol (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:50; fig 9	In order to discuss the limitations assessing axonal injury by microscopy, Invitrogen Mapt antibody (Pierce, MN-1020) was used in immunohistochemistry on mouse samples at 1:50 (fig 9). J Neurosci Methods (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:500 western blot; mouse; 1:500	In order to assess the neuroprotective effect of quercetin administration in the triple transgenic Alzheimer's disease model mice, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry on mouse samples at 1:500 and in western blot on mouse samples at 1:500. Neuropharmacology (2015) ncbi
domestic rabbit polyclonal 44-758G		In order to characterize cognitive and neuropathological Alzheimer's disease markers in a novel mouse model, Invitrogen Mapt antibody (Invitrogen, 44758G) was used . Age (Dordr) (2015) ncbi
domestic rabbit polyclonal 44-738G		In order to characterize cognitive and neuropathological Alzheimer's disease markers in a novel mouse model, Invitrogen Mapt antibody (Invitrogen, 44738G) was used . Age (Dordr) (2015) ncbi
domestic rabbit polyclonal 44-734G		In order to characterize cognitive and neuropathological Alzheimer's disease markers in a novel mouse model, Invitrogen Mapt antibody (Invitrogen, 44734G) was used . Age (Dordr) (2015) ncbi
domestic rabbit polyclonal 44-752G		In order to characterize cognitive and neuropathological Alzheimer's disease markers in a novel mouse model, Invitrogen Mapt antibody (Invitrogen, 44752G) was used . Age (Dordr) (2015) ncbi
domestic rabbit polyclonal 44-768G		In order to test if anesthetic choice affects cognitive impairment and neuroinflammation in elderly rat, Invitrogen Mapt antibody (Invitrogen Corporation, 44768G) was used . J Neuroimmune Pharmacol (2015) ncbi
domestic rabbit polyclonal 44-752G		In order to test if anesthetic choice affects cognitive impairment and neuroinflammation in elderly rat, Invitrogen Mapt antibody (Invitrogen Corporation, 44752G) was used . J Neuroimmune Pharmacol (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:500; fig 5 immunocytochemistry; mouse; 1:500; fig 8	In order to investigate the role of TERT in the adult human brain, Invitrogen Mapt antibody (Thermo, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 5) and in immunocytochemistry on mouse samples at 1:500 (fig 8). J Neurosci (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human	In order to validate the European Alzheimer's Disease Consortium Alzheimer's Disease Neuroimaging Initiative Center Harmonized Hippocampal Segmentation Protocol (HarP)., Invitrogen Mapt antibody (Thermo Fisher Scientific, MN1020) was used in immunohistochemistry - paraffin section on human samples . Alzheimers Dement (2015) ncbi
mouse monoclonal (AT8) MN1020	ELISA; mouse; fig 5	In order to generate reagents that selectively recognize toxic oligomeric tau, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in ELISA on mouse samples (fig 5). Neurobiol Aging (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:2500	In order to evaluate the role of DNA content in Lewy body diseases, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:2500. Neurobiol Aging (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:100	In order to study the pathophysiological mechanisms of chronic traumatic encephalopathy in a mouse model, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry on mouse samples at 1:100. Surg Neurol Int (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; fig 4	In order to quantify amyloid beta 42 and paired helical filament-tau in the frontal, temporal, and parietal cortices, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry - paraffin section on human samples (fig 4). J Neuropathol Exp Neurol (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; fig 2	In order to assess the effect of andrographolide in a mouse model of Alzheimer's disease, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in western blot on mouse samples (fig 2). Mol Neurodegener (2014) ncbi
mouse monoclonal (T46) 13-6400	western blot; human; fig 1	In order to characterize two mouse models overexpressing different human tau protein constructs, Invitrogen Mapt antibody (Invitrogen, 13-6400) was used in western blot on human samples (fig 1). Cell Mol Life Sci (2015) ncbi
mouse monoclonal (AT8) MN1020	immunocytochemistry; mouse; 1:40 western blot; mouse	In order to study how extracellular proteins are cleared from the brain, Invitrogen Mapt antibody (Pierce, AT8) was used in immunocytochemistry on mouse samples at 1:40 and in western blot on mouse samples . J Neurosci (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; mouse; 1:30 western blot; mouse; 1:100	In order to characterize the behavioral, biochemical, and neuropathologic effects of 8ISO in the triple transgenic mouse model of Alzheimer's disease, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry - paraffin section on mouse samples at 1:30 and in western blot on mouse samples at 1:100. Neurobiol Aging (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:1000	In order to investigate hypercholesterolemia at various stages of Alzheimer's disease, Invitrogen Mapt antibody (Thermo, MN1020) was used in immunohistochemistry on mouse samples at 1:1000. Mol Cell Neurosci (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - frozen section; mouse; 1:100 western blot; mouse; 1:1000	In order to determine whether there is a pathogenic interaction of the environmental toxin piericidin A from streptomyces spp. and the P301S mutation, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry - frozen section on mouse samples at 1:100 and in western blot on mouse samples at 1:1000. PLoS ONE (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:500; fig 2 western blot; human; 1:1000; fig 4	In order to evaluate motor function and tau pathology of P301S tau transgenic mice, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 2) and in western blot on human samples at 1:1000 (fig 4). Mol Neurodegener (2014) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	immunohistochemistry - paraffin section; human; 1:500; fig 2 western blot; human; 1:1000; fig 4	In order to evaluate motor function and tau pathology of P301S tau transgenic mice, Invitrogen Mapt antibody (Invitrogen, TAU5) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 2) and in western blot on human samples at 1:1000 (fig 4). Mol Neurodegener (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:200	In order to characterize the neuropathology of blast injury, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:200. Acta Neuropathol Commun (2014) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; 1:1000; fig 1	In order to determine seeding potencies of recombinant and native Tau aggregates due to conformation, Invitrogen Mapt antibody (Thermo (Pierce), AT8) was used in western blot on human samples at 1:1000 (fig 1). J Biol Chem (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; rat; fig 2 western blot; rat; fig 1	In order to study tau phosphorylation and its direct increase by dexmedetomidine, Invitrogen Mapt antibody (Thermo Fisher, AT8) was used in immunohistochemistry - paraffin section on rat samples (fig 2) and in western blot on rat samples (fig 1). J Alzheimers Dis (2015) ncbi
mouse monoclonal (TauC3) AHB0061	western blot; human; 1:500	In order to test if CHIP ameliorates the pathological changes associated with tau aggregation, Invitrogen Mapt antibody (Thermo, tauC3) was used in western blot on human samples at 1:500. J Alzheimers Dis (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; 1:500	In order to discuss decontaminating medical devices of pathological amyloid-beta-, tau- and alpha-synuclein aggregates, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in western blot on human samples at 1:500. Acta Neuropathol Commun (2014) ncbi
domestic rabbit polyclonal 44-758G		In order to identify abnormal phosphorylation in Alzheimer's disease samples, Invitrogen Mapt antibody (Invitrogen, 44758G) was used . Proteomics (2015) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	western blot; mouse; fig 2	In order to use triple transgenic Alzhemier's mice to study short- and long-term CDK5 knockdown and prevention of spatial memory dysfunction and tau pathology, Invitrogen Mapt antibody (Invitrogen, Tau5) was used in western blot on mouse samples (fig 2). Front Aging Neurosci (2014) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; fig 2	In order to use triple transgenic Alzhemier's mice to study short- and long-term CDK5 knockdown and prevention of spatial memory dysfunction and tau pathology, Invitrogen Mapt antibody (Pierce Biotechnology, AT8) was used in western blot on mouse samples (fig 2). Front Aging Neurosci (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - free floating section; rat; 1:200	In order to study the impact of amyloid-beta oligomers in the brains of rats and adult cynomolgus macaques, Invitrogen Mapt antibody (Thermo Scientific Pierce, MN1020) was used in immunohistochemistry - free floating section on rat samples at 1:200. J Neurosci (2014) ncbi
mouse monoclonal (PHF13.6) 35-5300	western blot; rat; fig 3	In order to study Zucker rats for deficient hippocampal insulin signaling and augmented Tau phosphorylation and their link to obesity and age-induced peripheral insulin resistance, Invitrogen Mapt antibody (Invitrogen, PHF13.6) was used in western blot on rat samples (fig 3). BMC Neurosci (2014) ncbi
mouse monoclonal (AT8) MN1020	immunocytochemistry; human; 1:200; fig 2	In order to report that CALM modulates autophagy and affects tau clearance, Invitrogen Mapt antibody (Thermo, MN1020) was used in immunocytochemistry on human samples at 1:200 (fig 2). Nat Commun (2014) ncbi
domestic rabbit polyclonal 44-734G		In order to study the role of glycogen synthase kinase-3beta and protein phosphatase 2A in regulation of tau hyperphosphorylation, Invitrogen Mapt antibody (Invitrogen, 44734G) was used . Neurobiol Aging (2015) ncbi
domestic rabbit polyclonal 44-752G		In order to study the role of glycogen synthase kinase-3beta and protein phosphatase 2A in regulation of tau hyperphosphorylation, Invitrogen Mapt antibody (Invitrogen, 44752G) was used . Neurobiol Aging (2015) ncbi
domestic rabbit polyclonal 44-738G		In order to study the role of glycogen synthase kinase-3beta and protein phosphatase 2A in regulation of tau hyperphosphorylation, Invitrogen Mapt antibody (Invitrogen, 44738G) was used . Neurobiol Aging (2015) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; mouse; 1:20,000	In order to investigate the role of membrane-anchored versus soluble CX3CL1 in regulating the microglia-mediated amelioration of Abeta pathology, Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in western blot on mouse samples at 1:20,000. J Neurosci (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - free floating section; mouse; 1:250 western blot; mouse; 1:2000	In order to investigate the role of membrane-anchored versus soluble CX3CL1 in regulating the microglia-mediated amelioration of Abeta pathology, Invitrogen Mapt antibody (Pierce, MN1020) was used in immunohistochemistry - free floating section on mouse samples at 1:250 and in western blot on mouse samples at 1:2000. J Neurosci (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - free floating section; human; 1:1000 western blot; human; 1:1000	In order to correlate TREM2 expression with neurodegenerative markers in Alzheimer's disease, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry - free floating section on human samples at 1:1000 and in western blot on human samples at 1:1000. Brain Pathol (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; fig 4	In order to assess the effect of aging on brain lipoxin A4 levels using non-transgenic and 3xTg-AD mice, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in western blot on human samples (fig 4). J Alzheimers Dis (2015) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:800	In order to determine the expression of abnormal serine phosphorylation of insulin receptor substrate 1 in healthy and diseased human brains, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry - paraffin section on human samples at 1:800. Acta Neuropathol (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - free floating section; mouse	In order to investigate the mechanisms by which anti-Tau antibodies alleviate Alzheimer's disease in mice, Invitrogen Mapt antibody (Pierce, MN1020) was used in immunohistochemistry - free floating section on mouse samples . Brain (2014) ncbi
mouse monoclonal (AT8) MN1020	immunocytochemistry; human; 1:50	In order to assess the presence of granulovacuolar degeneration and the activated unfolded protein response in two mouse models of Alzheimer's disease, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunocytochemistry on human samples at 1:50. Neurobiol Dis (2014) ncbi
mouse monoclonal (AT8) MN1020	immunocytochemistry; human; fig 3 western blot; human; fig 1	In order to assess transcription factor ED activity in Alzheimer's disease mouse models, Invitrogen Mapt antibody (Pierce, AT8) was used in immunocytochemistry on human samples (fig 3) and in western blot on human samples (fig 1). EMBO Mol Med (2014) ncbi
mouse monoclonal (AT8) MN1020	western blot; human	In order to study the relationship of an Alzheimer's disease-linked SNP in the CLU gene and Tau, Invitrogen Mapt antibody (Thermo Scientific Pierce, MN1020) was used in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	immunohistochemistry; mouse; 1:3000	In order to assess if tau reduction benefits intractable genetic epilepsies, Invitrogen Mapt antibody (Life Technologies, tau-5) was used in immunohistochemistry on mouse samples at 1:3000. Ann Neurol (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:80	In order to assess if tau reduction benefits intractable genetic epilepsies, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry on mouse samples at 1:80. Ann Neurol (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; mouse; fig 1 western blot; mouse; fig 1	In order to determine the pathology in tau transgenic mice due to tau-targeting passive immunization, Invitrogen Mapt antibody (Invitrogen, AT8) was used in immunohistochemistry - paraffin section on mouse samples (fig 1) and in western blot on mouse samples (fig 1). J Neurochem (2015) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; 1:1,000	In order to investigate the role of tau missplicing in the pathogenesis of Huntington disease, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in western blot on human samples at 1:1,000. Nat Med (2014) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse	Invitrogen Mapt antibody (Thermo Scientific, AT-8) was used in western blot on mouse samples . J Neurosci (2014) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; mouse	In order to investigate the abnormalites in hippocampal energy metabolism in the pathogenesis of Alzheimer disease, Invitrogen Mapt antibody (Biosource, AHB0042) was used in western blot on mouse samples . Biochim Biophys Acta (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:100 western blot; mouse; 1:500	In order to study the role of exagerated Ca(2+) signaling mediated by InsP3 receptor1 in the pathogenesis of mutant presenilin-linked Alzheimer's disease, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry on mouse samples at 1:100 and in western blot on mouse samples at 1:500. J Neurosci (2014) ncbi
mouse monoclonal (AT8) MN1020	western blot knockout validation; mouse; 1:1000; fig 2	In order to study the specificity of a panel of commonly used anti-tau antibodies and issues likely to be encounted in Western blot experiments using material from murine Alzheimer's disease models, Invitrogen Mapt antibody (Fisher, MN1020) was used in western blot knockout validation on mouse samples at 1:1000 (fig 2). PLoS ONE (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 0.1 ug/ml; loading ...; fig 2	In order to study the aggregation of U1 snRNPs in individuals with autosomal dominant Alzheimer's disease or Down syndrome, Invitrogen Mapt antibody (Thermo Fischer Scientific, AT8) was used in immunohistochemistry on human samples at 0.1 ug/ml (fig 2). Mol Neurodegener (2014) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse	In order to study the lack of involvementof GSK3-alpha/beta in the elevated tau phosphorylation observed in Tau.P30L hypothermic mice, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in western blot on mouse samples . Eur J Neurosci (2014) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	western blot; mouse; 1:500	In order to study how induction of Calyculin A in N2a cells can attenuate axonal transport impairment and axonopathy by Berberine, Invitrogen Mapt antibody (NeoMarkers, tau-5) was used in western blot on mouse samples at 1:500. PLoS ONE (2014) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; 1:150; fig s3b	In order to investigate the role of repressor element 1-silencing transcription factor in neurodegeneration during ageing, Invitrogen Mapt antibody (Thermo, MN1020) was used in western blot on human samples at 1:150 (fig s3b). Nature (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - free floating section; human; fig 1	In order to present data that suggests that pathological Abeta species induce changes in Tau that contribute to cognitive deficits correlating with synaptic deficits and hippocampal atrophy in an Alzheimer's disease model, Invitrogen Mapt antibody (Pierce, AT-8) was used in immunohistochemistry - free floating section on human samples (fig 1). FASEB J (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse	In order to study the beneficial effects of S100A9 deletion on memory and beta-amyloid pathology in a murine model of Alzheimer's disease, Invitrogen Mapt antibody (Pierce, NM1020) was used in immunohistochemistry on mouse samples . PLoS ONE (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; rat; 1:400	In order to discuss the molecular and cellular mechanisms that contribute to disease progression in sporadic tauopathies such as argyrophilic grain disorder and progressive supranuclear palsy, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry on rat samples at 1:400. Acta Neuropathol Commun (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:500; fig 4	In order to characterize two patients with multinodular and vacuolating neuronal tumors, Invitrogen Mapt antibody (Innogenetics, MN1020) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 4). Acta Neuropathol Commun (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 0.1 ug/ml	Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry on human samples at 0.1 ug/ml. J Alzheimers Dis (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 1:1000	In order to investigate the protein expression of G-CSF and its receptor in the adult human brain, Invitrogen Mapt antibody (Pierce Biotechnology, AT8) was used in immunohistochemistry on human samples at 1:1000. J Anat (2014) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; mouse; 1:1000	In order to investigate the murine tau isoforms in brain and peripheral organs, Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in western blot on mouse samples at 1:1000. PLoS ONE (2013) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	western blot; mouse; 1:4000	In order to identify a method for simultaneous use of both biochemistry and immunohistochemistry in regards to the same tissue, Invitrogen Mapt antibody (Thermo Fisher Scientific, Tau-5) was used in western blot on mouse samples at 1:4000. Eur J Neurosci (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - free floating section; mouse western blot; mouse	Invitrogen Mapt antibody (Thermo Fisher Scientific, AT8) was used in immunohistochemistry - free floating section on mouse samples and in western blot on mouse samples . Am J Pathol (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:25	Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry - paraffin section on human samples at 1:25. Acta Neuropathol (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - free floating section; mouse; 1:10,000	Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry - free floating section on mouse samples at 1:10,000. J Alzheimers Dis (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 1:2000	In order to investigate the neurobiologic basis of late-life depressive symptoms, Invitrogen Mapt antibody (Thermo Scientific, clone AT8) was used in immunohistochemistry on human samples at 1:2000. JAMA Psychiatry (2013) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; African green monkey; 1:1000 immunohistochemistry - free floating section; lowland gorilla; 1:1000	In order to study the pathology of Alzheimer's disease in the western lowland Gorilla, Invitrogen Mapt antibody (ThermoFisher, MN1020) was used in immunohistochemistry on African green monkey samples at 1:1000 and in immunohistochemistry - free floating section on lowland gorilla samples at 1:1000. J Comp Neurol (2013) ncbi
mouse monoclonal (Tau-5) AHB0042	immunohistochemistry - frozen section; mouse	In order to study the composition of pathological granules that appear in degenerative brain diseases, Invitrogen Mapt antibody (Biosource, AHB0042) was used in immunohistochemistry - frozen section on mouse samples . Age (Dordr) (2014) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; mouse; fig 6	In order to test if beta-amyloid accumulation affects prion infectivity and if different amounts of PrP affect beta-amyloid accumulation, Invitrogen Mapt antibody (Invitrogen, #AHB0042) was used in western blot on mouse samples (fig 6). Neurobiol Aging (2013) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; mouse; fig 2	In order to test if a primary proteinopathy might secondarily drive TDP-43 proteinopathy, Invitrogen Mapt antibody (Thermo-Fisher, AT8) was used in immunohistochemistry - paraffin section on mouse samples (fig 2). Acta Neuropathol (2013) ncbi
mouse monoclonal (Tau-5) MA5-12808	western blot; human; 1:200; fig 2	In order to study the ability of pharmacological activation of AMPK to protect a human neuroblastoma cell line against homocysteine-induced toxicity, Invitrogen Mapt antibody (Lab Vision, MS-247-P0) was used in western blot on human samples at 1:200 (fig 2). Neurochem Res (2013) ncbi
mouse monoclonal (AT8) MN1020	immunocytochemistry; fruit fly ; fig s4	In order to report that expression of human wild-type tau is sufficient to disrupt the survival of dopaminergic neurons in a Drosophila model, Invitrogen Mapt antibody (Thermo Fisher, AT8) was used in immunocytochemistry on fruit fly samples (fig s4). Acta Neuropathol (2013) ncbi
mouse monoclonal (AT8) MN1020	western blot; rat; 1:1000	In order to study the role of calpain-regulated p35/cdk5 in the mechanism by which the PDE5 inhibitor sildenafil protects against malonate-induced chemical hypoxia, Invitrogen Mapt antibody (Pierce Biotechnology, MN1020) was used in western blot on rat samples at 1:1000. Biochim Biophys Acta (2013) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 1:1000	In order to study changes in autophagy and the roles of Tau hyperphosphorylation and fractalkine in an animal model of Abeta42-induced Tau hyperphosphorylation, Invitrogen Mapt antibody (Biosource, AT8) was used in immunohistochemistry on human samples at 1:1000. Exp Neurol (2014) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	western blot; rat; 1:1000 immunohistochemistry; human; 1:1000 western blot; human; 1:1000; fig 3	In order to study changes in autophagy and the roles of Tau hyperphosphorylation and fractalkine in an animal model of Abeta42-induced Tau hyperphosphorylation, Invitrogen Mapt antibody (Thermo Scientific, Tau-5) was used in western blot on rat samples at 1:1000, in immunohistochemistry on human samples at 1:1000 and in western blot on human samples at 1:1000 (fig 3). Exp Neurol (2014) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; 1:50 immunohistochemistry; mouse; 1:50; loading ...; fig 1	In order to study the association of GSK3 activity with tau phosphorylation and neuronal tyrosine phosphorylation in a murine model expressing human P301L tau, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry on human samples at 1:50 and in immunohistochemistry on mouse samples at 1:50 (fig 1). Neurobiol Aging (2013) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - free floating section; mouse western blot; mouse	In order to study the effects of diet-induced obesity on tau pathology, Invitrogen Mapt antibody (Pierce, AT8) was used in immunohistochemistry - free floating section on mouse samples and in western blot on mouse samples . Diabetes (2013) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; mouse; 1:1000; fig 6	In order to elucidate the role of dietary resveratrol in SAMP8 mice, Invitrogen Mapt antibody (BioSource, AHB0042) was used in western blot on mouse samples at 1:1000 (fig 6). Age (Dordr) (2013) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; leopard cat; 1:100; fig 5	In order to identify and characterize Abeta deposits in the brains of Japanese Tsushima leopard cats, Invitrogen Mapt antibody (Thermo Scientific, AT8) was used in immunohistochemistry - paraffin section on leopard cat samples at 1:100 (fig 5). PLoS ONE (2012) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	western blot; mouse; fig 3	In order to investigate the contribution of Ang II to Alzheimer disease, Invitrogen Mapt antibody (Invitrogen, Tau-5) was used in western blot on mouse samples (fig 3). FEBS Lett (2012) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 0.25 ug/ml; fig 8	In order to discuss the pathological role of C9orf72 in neurodegeneration, Invitrogen Mapt antibody (Thermo Scientific, MN1020) was used in immunohistochemistry - paraffin section on human samples at 0.25 ug/ml (fig 8). Alzheimers Res Ther (2012) ncbi
mouse monoclonal (AT8) MN1020	western blot; rat; 1:1000; fig 1	In order to study the effect of protein phosphatase 2A modulation on neuronal autophagy, Invitrogen Mapt antibody (Pierce, AT-8) was used in western blot on rat samples at 1:1000 (fig 1). Neurobiol Aging (2013) ncbi
mouse monoclonal (Tau-5) AHB0042	immunohistochemistry; rat; 1:2000	In order to examine the brains of 6-month-old rats treated neonatally with the glutamatergic beta-N-methylamino-L-alanine, Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in immunohistochemistry on rat samples at 1:2000. Toxicol Sci (2012) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; 1:1000	In order to test if hypothermia could be used to assess tau kinase inhibitors efficacy, Invitrogen Mapt antibody (Pierce, AT8) was used in western blot on human samples at 1:1000. Sci Rep (2012) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	western blot; mouse; fig 1	In order to investigate interactions between MAP2 and PP2A/Balpha in the brain, Invitrogen Mapt antibody (BIOSOURCE, Tau-5) was used in western blot on mouse samples (fig 1). J Biol Chem (2012) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; fig 1	In order to examine the brains of cognitively unimpaired subjects for neurodegenerative changes, Invitrogen Mapt antibody (Thermoscientific, AT8) was used in immunohistochemistry - paraffin section on human samples (fig 1). Acta Neuropathol (2012) ncbi
mouse monoclonal (AT8) MN1020	western blot; human	In order to examine the brains of non-demented high pathology controls individuals for mechanisms that protect against Alzheimer's disease, Invitrogen Mapt antibody (Pierce, MN1020) was used in western blot on human samples . PLoS ONE (2011) ncbi
mouse monoclonal (Tau-5) AHB0042	immunohistochemistry; mouse; fig 3	In order to determine the distribution of tauopathy in different regions of the brain using the alpha-Syn overexpressing mouse model, Invitrogen Mapt antibody (Biosource, AHB0042) was used in immunohistochemistry on mouse samples (fig 3). BMC Neurosci (2011) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; human; 1:1000; fig 2	In order to test if neurite retraction in the SH-SY5Y model is associated with changes in other tau hyperphosphorylable residues, Invitrogen Mapt antibody (BioSource, AHB0042) was used in western blot on human samples at 1:1000 (fig 2). J Neurosci Res (2011) ncbi
mouse monoclonal (AT8) MN1020	immunocytochemistry; human; 1:100; fig 3 western blot; human; fig 4	In order to study the contribution of JNK in tau hyperphosphorylation, Invitrogen Mapt antibody (Thermo, MN1020) was used in immunocytochemistry on human samples at 1:100 (fig 3) and in western blot on human samples (fig 4). J Alzheimers Dis (2011) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; human; 1:500; fig 2	In order to examine tauopathy in mice that overexpress human alpha-synuclein as a model of Parkinson's disease, Invitrogen Mapt antibody (Invitrogen, AHB0042) was used in western blot on human samples at 1:500 (fig 2). Eur J Neurosci (2011) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; mouse; 1:500; fig 3	In order to study the tauopathic changes in the striatum of the alpha-synuclein A53T mutant mouse, Invitrogen Mapt antibody (Biosource, AHB0042) was used in western blot on mouse samples at 1:500 (fig 3). PLoS ONE (2011) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:1000; fig 4	In order to study the amyloid beta and tau pathology in APOE knockout mice, carrying human APOEepsilon3 or epsilon4 transgenes, after diet-induced insulin resistance with and without pioglitazone treatment, Invitrogen Mapt antibody (Pierce, AT8) was used in western blot on mouse samples at 1:1000 (fig 4). PLoS ONE (2011) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; human; fig 4	In order to generate a rat model using the mutant G2019S of LRRK2 to study Parkinson's disease, Invitrogen Mapt antibody (Pierce, AT8) was used in immunohistochemistry on human samples (fig 4). J Neurosci (2011) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; mouse; 1:20; fig 4 immunohistochemistry; mouse; 1:20	In order to investigate the influence of S100B ablation on Alzheimer histopathology in PSAPP mice, Invitrogen Mapt antibody (Pierce, MN1020) was used in immunohistochemistry - paraffin section on mouse samples at 1:20 (fig 4) and in immunohistochemistry on mouse samples at 1:20. J Neuroinflammation (2010) ncbi
mouse monoclonal (Tau-5) AHB0042	immunohistochemistry - paraffin section; rat; 1:1000; fig 5 western blot; rat; 1:2000; fig 4	In order to elucidate the molecular mechanisms of ischemic tolerance, Invitrogen Mapt antibody (Biosource, AHB0042) was used in immunohistochemistry - paraffin section on rat samples at 1:1000 (fig 5) and in western blot on rat samples at 1:2000 (fig 4). Neurol Sci (2011) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:2000; fig 4	In order to elucidate the mechanism of calpain during Alzheimer's disease progression, Invitrogen Mapt antibody (Pierce, MN1020) was used in western blot on mouse samples at 1:2000 (fig 4). J Biol Chem (2010) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; fruit fly ; 1:100; fig 2	In order to describe a way to image amyloid deposits in the Drosophila brain, Invitrogen Mapt antibody (Endogen, MN1020) was used in immunohistochemistry on fruit fly samples at 1:100 (fig 2). Nat Protoc (2010) ncbi
mouse monoclonal (PHF13.6) 35-5300	western blot; human; 1:500	In order to elucidate the between tau aggregation and the unfolded protein response in neurodegenerative disorders, Invitrogen Mapt antibody (Invitrogen, 355300) was used in western blot on human samples at 1:500. J Neurosci Res (2010) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; human; 1:1000	In order to elucidate the between tau aggregation and the unfolded protein response in neurodegenerative disorders, Invitrogen Mapt antibody (Biosource, AHB0042) was used in western blot on human samples at 1:1000. J Neurosci Res (2010) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	ELISA; human; fig 1a	In order to test if HFE polymorphisms are associated with alterations in tau phosphorylation in a human neuroblastoma cell line, Invitrogen Mapt antibody (Biosource International, Tau-5) was used in ELISA on human samples (fig 1a). Neurobiol Aging (2011) ncbi
mouse monoclonal (AT8) MN1020	western blot; human; fig 1c	In order to test if HFE polymorphisms are associated with alterations in tau phosphorylation in a human neuroblastoma cell line, Invitrogen Mapt antibody (Pierce Biotechnology, AT8) was used in western blot on human samples (fig 1c). Neurobiol Aging (2011) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	western blot; rat; 1:1000; fig 3	In order to assess the neuroprotective effects of delphinidin against Abeta-induced toxicity, Invitrogen Mapt antibody (Biosource, tau-5) was used in western blot on rat samples at 1:1000 (fig 3). Biosci Biotechnol Biochem (2009) ncbi
mouse monoclonal (AT8) MN1020	western blot; rat; 1:1000; fig 3	In order to assess the neuroprotective effects of delphinidin against Abeta-induced toxicity, Invitrogen Mapt antibody (Biosource, AT8) was used in western blot on rat samples at 1:1000 (fig 3). Biosci Biotechnol Biochem (2009) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	western blot; rat; 1:1000	In order to investigate the potential neuroprotective effects of caffeic acid against Abeta-induced toxicity, Invitrogen Mapt antibody (Biosource, tau-5) was used in western blot on rat samples at 1:1000. Life Sci (2009) ncbi
mouse monoclonal (AT8) MN1020	western blot; rat; 1:1000	In order to investigate the potential neuroprotective effects of caffeic acid against Abeta-induced toxicity, Invitrogen Mapt antibody (Biosource, AT8) was used in western blot on rat samples at 1:1000. Life Sci (2009) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	western blot; mouse; 1:1000	In order to investigate the neurotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin, Invitrogen Mapt antibody (Biosource, tau-5) was used in western blot on mouse samples at 1:1000. Toxicology (2009) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 1:1000	In order to investigate the neurotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin, Invitrogen Mapt antibody (Biosource, AT8) was used in western blot on mouse samples at 1:1000. Toxicology (2009) ncbi
mouse monoclonal (Tau-5) MA5-12808	immunocytochemistry; rat; 1:200	In order to develop an electrophysiologically active 3D neural construct with neurons and astrocytes encased in a bioactive extracellular matrix-based scaffold, Invitrogen Mapt antibody (NeoMarkers, MS247P) was used in immunocytochemistry on rat samples at 1:200. J Neural Eng (2008) ncbi
mouse monoclonal (AT8) MN1020	immunocytochemistry; rat; 1:500; fig 3 western blot; rat; 1:500; fig 3	In order to elucidate the relationship between Notch and cdk5 signaling, Invitrogen Mapt antibody (BioSource International, clone AT8) was used in immunocytochemistry on rat samples at 1:500 (fig 3) and in western blot on rat samples at 1:500 (fig 3). J Neurochem (2008) ncbi
mouse monoclonal (AT8) MN1020	western blot; rat; 1:1000; fig 6	In order to elucidate the neuroprotective mechanisms by which curcumin protects against Abeta-induced toxicity, Invitrogen Mapt antibody (Biosource, AT8) was used in western blot on rat samples at 1:1000 (fig 6). Food Chem Toxicol (2008) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	western blot; rat; 1:1000; fig 6	In order to elucidate the neuroprotective mechanisms by which curcumin protects against Abeta-induced toxicity, Invitrogen Mapt antibody (Biosource, tau-5) was used in western blot on rat samples at 1:1000 (fig 6). Food Chem Toxicol (2008) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; mouse; 1:1000; fig 3	In order to evaluate if OVX/stress affects levels of Alzheimer's disease-related molecules in the mouse hippocampus, Invitrogen Mapt antibody (Invitrogen, TAU- 5) was used in western blot on mouse samples at 1:1000 (fig 3). Neurosci Lett (2008) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	western blot; mouse; 1:1000; fig 5	In order to determine that Abeta deposition or oestrogen deficiency increases PP2A phosphorylation to compromise tau dephosphorylation and cause neurofibrillary tangle formation in Alzheimer's disease, Invitrogen Mapt antibody (Biosource, Tau-5) was used in western blot on mouse samples at 1:1000 (fig 5). J Cell Mol Med (2008) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry; mouse; 1:1000; fig 4	In order to examine the individual and combined effects of estrogen and progesterone on beta-amyloid accumulation, tau hyperphosphorylation, and hippocampal-dependent behavioral impairments, Invitrogen Mapt antibody (Pierce, AT8) was used in immunohistochemistry on mouse samples at 1:1000 (fig 4). J Neurosci (2007) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	western blot; rat; 1:5000	In order to evaluate five glycogen synthase kinase-3beta inhibitors and lithium in lowering phosphorylated tau and glycogen synthase kinase-3beta enzyme activity levels in 12-day old postnatal rats, Invitrogen Mapt antibody (BioSource/Invitrogen, tau-5) was used in western blot on rat samples at 1:5000. Br J Pharmacol (2007) ncbi
mouse monoclonal (Tau-5) AHB0042	immunohistochemistry - frozen section; human; 1:500 western blot; human; 1:500	In order to isolate cis-acting regulatory elements for the generation of transgenic zebrafish models of neurodegeneration, Invitrogen Mapt antibody (Biosource, AHB0042) was used in immunohistochemistry - frozen section on human samples at 1:500 and in western blot on human samples at 1:500. Nucleic Acids Res (2007) ncbi
mouse monoclonal (Tau-5) AHB0042	western blot; mouse; fig 4	In order to identify and investigate Reelin-regulated signaling pathways in the brain, Invitrogen Mapt antibody (Biosource, AHB0042) was used in western blot on mouse samples (fig 4). Mol Cell Biol (2007) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	western blot; rat; 1:1000; fig 3	In order to test if sex hormones prevent tau cleavage and Abeta toxicity, Invitrogen Mapt antibody (Biosource, tau-5) was used in western blot on rat samples at 1:1000 (fig 3). Neuroscience (2007) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	immunohistochemistry - paraffin section; human; 1:10,000; tbl 1 western blot; human; 1:10,000; tbl 1	In order to characterize a new mouse model of Alzheimer's disease, Invitrogen Mapt antibody (Biosource, Tau-5) was used in immunohistochemistry - paraffin section on human samples at 1:10,000 (tbl 1) and in western blot on human samples at 1:10,000 (tbl 1). Am J Pathol (2006) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	western blot; mouse	In order to assess the effects lithium chloride on cold water stress-induced changes in tau phosphorylation in the mouse hippocampus, Invitrogen Mapt antibody (Biosource, TAU-5) was used in western blot on mouse samples . J Neural Transm (Vienna) (2006) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	western blot; mouse; 1:1000	In order to elucidate how the removal of assembled neurofilaments from axons or misaccumulating neurofilaments in motor neuron cell bodies slows disease in a mouse model of amyotrophic lateral sclerosis, Invitrogen Mapt antibody (BioSource, Tau-5) was used in western blot on mouse samples at 1:1000. Proc Natl Acad Sci U S A (2005) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; fig 2	In order to report that the pathogenesis of motor neuron disease is independent of the Cdk5 activation by p35 or p25, Invitrogen Mapt antibody (Endogen, clone AT-8) was used in western blot on mouse samples (fig 2). J Neurochem (2004) ncbi
mouse monoclonal (AT8) MN1020	western blot; mouse; 5 ug/ml; fig 1	In order to report that tau is phosphorylated by Cdk5/p39 during brain development, Invitrogen Mapt antibody (Endogen, AT-8) was used in western blot on mouse samples at 5 ug/ml (fig 1). J Biol Chem (2003) ncbi
mouse monoclonal (Tau-5) MA5-12808 AHB0042	western blot; rat	In order to test if calpain cleave the cyclin-dependent kinase 5 activator p35 to a p25 fragment and results in tau hyperphosphorylation, Invitrogen Mapt antibody (BioSource, tau-5) was used in western blot on rat samples . Biochem Biophys Res Commun (2002) ncbi
mouse monoclonal (PHF13.6) 35-5300	immunohistochemistry - paraffin section; human; 1:200	In order to discuss classification of fronto-temporal dementias, Invitrogen Mapt antibody (Biosource, PHF-1) was used in immunohistochemistry - paraffin section on human samples at 1:200. Acta Neuropathol (2002) ncbi
mouse monoclonal (AT8) MN1020	immunohistochemistry - paraffin section; human; 1:200	In order to discuss classification of fronto-temporal dementias, Invitrogen Mapt antibody (Biosource, AT8) was used in immunohistochemistry - paraffin section on human samples at 1:200. Acta Neuropathol (2002) ncbi
mouse monoclonal (AT8) MN1020	western blot; rat; 1:500	In order to investigate the signal transduction pathway activated by fibrillar Abeta, Invitrogen Mapt antibody (Biosource, AT8) was used in western blot on rat samples at 1:500. J Neurochem (2000) ncbi

Abcam

domestic rabbit monoclonal (EPR1884(2)) ab170892	western blot; mouse; 1:3000; loading ...; fig s2	Abcam Mapt antibody (Abcam, ab170892) was used in western blot on mouse samples at 1:3000 (fig s2). Exp Ther Med (2022) ncbi
domestic rabbit polyclonal ab75603	other; human; fig 3e, s8d	Abcam Mapt antibody (Abcam, ab75603) was used in other on human samples (fig 3e, s8d). ACS Chem Neurosci (2022) ncbi
domestic rabbit monoclonal (EPR2731) ab109390	immunohistochemistry - paraffin section; mouse; 1:4000; loading ...; fig 2f	Abcam Mapt antibody (Abcam, ab109390) was used in immunohistochemistry - paraffin section on mouse samples at 1:4000 (fig 2f). Int J Biol Sci (2022) ncbi
domestic rabbit monoclonal (EPR2402) ab108387	western blot; mouse; loading ...; fig 5a	Abcam Mapt antibody (Abcam, ab108387) was used in western blot on mouse samples (fig 5a). EBioMedicine (2022) ncbi
mouse monoclonal (Tau-5) ab80579	western blot; mouse; loading ...; fig 5a western blot; human; loading ...; fig 1c, 1e, 1l, 2c	Abcam Mapt antibody (Abcam, ab80579) was used in western blot on mouse samples (fig 5a) and in western blot on human samples (fig 1c, 1e, 1l, 2c). EBioMedicine (2022) ncbi
domestic rabbit monoclonal (EPR2488) ab151559	western blot; mouse; 1:1000; loading ...; fig 4e	Abcam Mapt antibody (Abcam, ab151559) was used in western blot on mouse samples at 1:1000 (fig 4e). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (EPR2605) ab92676	western blot; human; 1:500; fig 1c	Abcam Mapt antibody (Abcam, ab92676) was used in western blot on human samples at 1:500 (fig 1c). Front Cell Dev Biol (2021) ncbi
mouse monoclonal (Tau-5) ab80579	immunocytochemistry; human; fig 2a western blot; human; 1:2000; fig 1a	Abcam Mapt antibody (Abcam, ab80579) was used in immunocytochemistry on human samples (fig 2a) and in western blot on human samples at 1:2000 (fig 1a). Front Cell Dev Biol (2021) ncbi
mouse monoclonal (Tau-5) ab80579	western blot; mouse; 1:1000; fig 8a	Abcam Mapt antibody (Abcam, Ab80579) was used in western blot on mouse samples at 1:1000 (fig 8a). Ann Neurol (2021) ncbi
domestic rabbit monoclonal ab109401	western blot; mouse; 1:1000; loading ...; fig 4d	Abcam Mapt antibody (abcam, ab109401) was used in western blot on mouse samples at 1:1000 (fig 4d). Front Neurol (2021) ncbi
mouse monoclonal (Tau-5) ab80579	western blot; rat; 1:1000; loading ...; fig 2a	Abcam Mapt antibody (Abcam, ab80579) was used in western blot on rat samples at 1:1000 (fig 2a). Signal Transduct Target Ther (2021) ncbi
mouse monoclonal (Tau-5) ab80579	western blot; mouse; loading ...; fig 1a	Abcam Mapt antibody (Abcam, ab80579) was used in western blot on mouse samples (fig 1a). Clin Transl Med (2021) ncbi
domestic rabbit monoclonal (EPR2731) ab109390	immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig s1c	Abcam Mapt antibody (Abcam, ab109390) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig s1c). Aging Cell (2021) ncbi
domestic rabbit monoclonal (E178) ab32057	western blot; mouse; fig 2c immunohistochemistry; human; loading ...; fig 1d	Abcam Mapt antibody (Abcam, E178) was used in western blot on mouse samples (fig 2c) and in immunohistochemistry on human samples (fig 1d). Sci Transl Med (2021) ncbi
domestic rabbit monoclonal (E178) ab32057	western blot; mouse; loading ...; fig 5n	Abcam Mapt antibody (Abcam, ab32057) was used in western blot on mouse samples (fig 5n). Redox Biol (2021) ncbi
mouse monoclonal (Tau-5) ab80579	western blot; mouse; 1:1000; loading ...	Abcam Mapt antibody (Abcam, ab80579) was used in western blot on mouse samples at 1:1000. Commun Biol (2021) ncbi
mouse monoclonal (Tau-5) ab80579	western blot; mouse; loading ...; fig 4a	Abcam Mapt antibody (Abcam, ab80579) was used in western blot on mouse samples (fig 4a). Cell (2021) ncbi
mouse monoclonal (Tau-5) ab80579	proximity ligation assay; mouse; 1:250; loading ...; fig s3 proximity ligation assay; human; 1:2000; loading ...; fig 1d	Abcam Mapt antibody (Abcam, ab80579) was used in proximity ligation assay on mouse samples at 1:250 (fig s3) and in proximity ligation assay on human samples at 1:2000 (fig 1d). Acta Neuropathol Commun (2021) ncbi
domestic rabbit monoclonal (EPR2731) ab109390	western blot; human; 1:10,000; fig 1d	Abcam Mapt antibody (Abcam, ab109390) was used in western blot on human samples at 1:10,000 (fig 1d). Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal (EPR2605) ab92676	immunohistochemistry; mouse; 1:400; loading ...; fig 2a	Abcam Mapt antibody (Abcam, ab92676) was used in immunohistochemistry on mouse samples at 1:400 (fig 2a). Oxid Med Cell Longev (2020) ncbi
domestic rabbit monoclonal (EPR2731) ab109390	western blot; human; 1:10,000; loading ...; fig 4a, s2b	Abcam Mapt antibody (Abcam, ab109390) was used in western blot on human samples at 1:10,000 (fig 4a, s2b). Aging (Albany NY) (2020) ncbi
mouse monoclonal (Tau-5) ab80579	western blot; mouse; loading ...; fig 1a, 1b	Abcam Mapt antibody (Abcam, ab80579) was used in western blot on mouse samples (fig 1a, 1b). Neuropsychiatr Dis Treat (2020) ncbi
chicken polyclonal ab75714	immunocytochemistry; mouse; 1:1000; loading ...; fig 2a	Abcam Mapt antibody (Abcam, ab75714) was used in immunocytochemistry on mouse samples at 1:1000 (fig 2a). Front Cell Neurosci (2020) ncbi
mouse monoclonal (Tau-5) ab80579	western blot; mouse; loading ...; fig 5e	Abcam Mapt antibody (Abcam, ab80579) was used in western blot on mouse samples (fig 5e). J Neuroinflammation (2020) ncbi
domestic rabbit monoclonal (EPR1884(2)) ab170892	western blot; mouse; loading ...; fig 2b, d-f	Abcam Mapt antibody (Abcam, ab170892) was used in western blot on mouse samples (fig 2b, d-f). Front Aging Neurosci (2019) ncbi
domestic rabbit monoclonal (EPR2731) ab109390	immunohistochemistry - paraffin section; rat; 1:1000; loading ...; fig 4a western blot; rat; 1:10,000; loading ...; fig 4b	Abcam Mapt antibody (Abcam, ab109390) was used in immunohistochemistry - paraffin section on rat samples at 1:1000 (fig 4a) and in western blot on rat samples at 1:10,000 (fig 4b). Brain Behav (2020) ncbi
domestic rabbit polyclonal ab51053	ELISA; human; loading ...; fig 1a	Abcam Mapt antibody (Abcam, ab51053) was used in ELISA on human samples (fig 1a). Acta Neuropathol Commun (2019) ncbi
mouse monoclonal (Tau-5) ab80579	ELISA; human; loading ...; fig 5a	Abcam Mapt antibody (Abcam, ab80579) was used in ELISA on human samples (fig 5a). Acta Neuropathol Commun (2019) ncbi
domestic rabbit monoclonal ab109401	western blot; human; loading ...; fig 5c	Abcam Mapt antibody (Abcam, ab109401) was used in western blot on human samples (fig 5c). PLoS ONE (2019) ncbi
mouse monoclonal (Tau-5) ab80579	western blot; human; 1:1000; loading ...; fig 1f	Abcam Mapt antibody (Abcam, ab80579) was used in western blot on human samples at 1:1000 (fig 1f). PLoS ONE (2019) ncbi
mouse monoclonal (Tau-5) ab80579	western blot; human; 1:1000; loading ...; fig 1b, 2a	Abcam Mapt antibody (Abcam, ab80579) was used in western blot on human samples at 1:1000 (fig 1b, 2a). Aging Cell (2020) ncbi
domestic rabbit monoclonal (E178) ab32057	western blot; mouse; 1:1000; loading ...; fig 2g	Abcam Mapt antibody (Abcam, ab32057) was used in western blot on mouse samples at 1:1000 (fig 2g). CNS Neurosci Ther (2020) ncbi
domestic rabbit monoclonal (EPR2488) ab151559	western blot; rhesus macaque; 1:1000; loading ...; fig 4b	Abcam Mapt antibody (Abcam, ab151559) was used in western blot on rhesus macaque samples at 1:1000 (fig 4b). Aging Cell (2019) ncbi
domestic rabbit monoclonal (EPR2731) ab109390	western blot; rhesus macaque; 1:10,000; loading ...; fig 4b	Abcam Mapt antibody (Abcam, ab109390) was used in western blot on rhesus macaque samples at 1:10,000 (fig 4b). Aging Cell (2019) ncbi
domestic rabbit polyclonal ab131354	western blot; mouse; 1:1000; loading ...; fig 2c	Abcam Mapt antibody (Abcam, ab131354) was used in western blot on mouse samples at 1:1000 (fig 2c). Neurobiol Dis (2019) ncbi
domestic rabbit monoclonal (EPR2731) ab109390	western blot; mouse; 1:1000; loading ...; fig 2c	Abcam Mapt antibody (Abcam, ab109390) was used in western blot on mouse samples at 1:1000 (fig 2c). Neurobiol Dis (2019) ncbi
mouse monoclonal (Tau-5) ab80579	immunoprecipitation; human; loading ...; fig 4b	Abcam Mapt antibody (AbCam, ab80579) was used in immunoprecipitation on human samples (fig 4b). elife (2019) ncbi
domestic rabbit monoclonal (EPR2605) ab92676	western blot; human; loading ...; fig 1a	Abcam Mapt antibody (Abcam, ab92676) was used in western blot on human samples (fig 1a). Cell Rep (2019) ncbi
domestic rabbit monoclonal (EPR2731) ab109390	immunohistochemistry - paraffin section; mouse; 1:800; loading ...; fig 4b	Abcam Mapt antibody (Abcam, ab109390) was used in immunohistochemistry - paraffin section on mouse samples at 1:800 (fig 4b). Front Aging Neurosci (2018) ncbi
domestic rabbit monoclonal (EPR2731) ab109390	western blot; mouse; loading ...; fig 2c	Abcam Mapt antibody (Abcam, ab109390) was used in western blot on mouse samples (fig 2c). Biochem Biophys Res Commun (2018) ncbi
domestic rabbit monoclonal ab76128	immunocytochemistry; mouse; 1:1000; loading ...; fig 1e	Abcam Mapt antibody (Abcam, ab76128) was used in immunocytochemistry on mouse samples at 1:1000 (fig 1e). Nucleic Acids Res (2018) ncbi
mouse monoclonal (Tau-5) ab80579	western blot; mouse western blot knockout validation; human; 1:1000; tbl 1 immunocytochemistry; human; 1:50; tbl 2	In order to validate antibodies against tau protein and its variants, Abcam Mapt antibody (Abcam, Tau5) was used in western blot on mouse samples , in western blot knockout validation on human samples at 1:1000 (tbl 1) and in immunocytochemistry on human samples at 1:50 (tbl 2). Mol Neurodegener (2017) ncbi
mouse monoclonal (Tau-5) ab80579	immunocytochemistry; mouse; 1:250; loading ...; fig 2a	Abcam Mapt antibody (Abcam, ab80579) was used in immunocytochemistry on mouse samples at 1:250 (fig 2a). J Immunol Methods (2017) ncbi
mouse monoclonal (Tau-5) ab80579	immunocytochemistry; rat; loading ...; fig 1f	Abcam Mapt antibody (Abcam, ab80579) was used in immunocytochemistry on rat samples (fig 1f). Mol Cell Neurosci (2017) ncbi
domestic rabbit monoclonal (E178) ab32057	western blot; mouse; 1:1000; loading ...	In order to characterize mice with a forebrain-specific loss of O-GlcNAc glycosylation, Abcam Mapt antibody (Abcam, 32057) was used in western blot on mouse samples at 1:1000. Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (EPR2401Y) ab81268	immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 5a western blot; mouse; 1:1000; loading ...; fig 6a	In order to explore the role of necrostatin-1 in Alzheimer's disease, Abcam Mapt antibody (Abcam, ab81268) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 5a) and in western blot on mouse samples at 1:1000 (fig 6a). EMBO Mol Med (2017) ncbi
domestic rabbit monoclonal (EPR2402) ab108387	western blot; human; 1:4000; loading ...; fig 4a	In order to demonstrate that microtubule affinity-regulating kinase is a target of methylene blue, Abcam Mapt antibody (Abcam, ab108387) was used in western blot on human samples at 1:4000 (fig 4a). Sci Rep (2016) ncbi
domestic rabbit monoclonal (EPR1884(2)) ab170892	western blot; human; 1:4000; loading ...; fig 4a	In order to demonstrate that microtubule affinity-regulating kinase is a target of methylene blue, Abcam Mapt antibody (Abcam, ab170892) was used in western blot on human samples at 1:4000 (fig 4a). Sci Rep (2016) ncbi
domestic rabbit monoclonal (EPR2731) ab109390	immunocytochemistry; rat; 1:100; loading ...; fig 4d western blot; rat; 1:1000; loading ...; fig 4e	Abcam Mapt antibody (Abcam, ab109390) was used in immunocytochemistry on rat samples at 1:100 (fig 4d) and in western blot on rat samples at 1:1000 (fig 4e). Sci Rep (2016) ncbi
mouse monoclonal (Tau-5) ab80579	immunocytochemistry; rat; 1:100; loading ...; fig 4d western blot; rat; 1:500; loading ...; fig 4e	Abcam Mapt antibody (Abcam, ab80579) was used in immunocytochemistry on rat samples at 1:100 (fig 4d) and in western blot on rat samples at 1:500 (fig 4e). Sci Rep (2016) ncbi
domestic rabbit monoclonal (E178) ab32057	immunohistochemistry - paraffin section; rhesus macaque; 1:500; fig 4	Abcam Mapt antibody (Abcam, 32057) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:500 (fig 4). J Neuroinflammation (2016) ncbi
mouse monoclonal (Tau-5) ab80579	immunohistochemistry; human; fig 3	Abcam Mapt antibody (Abcam, ab80579) was used in immunohistochemistry on human samples (fig 3). Aging Cell (2016) ncbi
mouse monoclonal (Tau-5) ab80579	immunocytochemistry; human; 1:100; fig 4	In order to research differentiation of functional glutamatergic neurons from placenta-derived multipotent cells by knocking down of heat-shock protein 27, Abcam Mapt antibody (Abcam, ab80579) was used in immunocytochemistry on human samples at 1:100 (fig 4). Sci Rep (2016) ncbi
mouse monoclonal (Tau-5) ab80579	western blot; rat; 1:1000; fig 8	In order to ascertain the effects of severe penetrating traumatic brain injury on APP and tau cleavage processing, Abcam Mapt antibody (Abcam, ab80579) was used in western blot on rat samples at 1:1000 (fig 8). PLoS ONE (2016) ncbi
mouse monoclonal (Tau-5) ab80579	immunohistochemistry - paraffin section; mouse; loading ...; fig 2c	Abcam Mapt antibody (abcam, ab80579) was used in immunohistochemistry - paraffin section on mouse samples (fig 2c). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (EPR2731) ab109390	western blot; human; 1:5000; fig 4c	In order to investigate the role of channel gating in mammalian proteasomes, Abcam Mapt antibody (Abcam, ab109390) was used in western blot on human samples at 1:5000 (fig 4c). Nat Commun (2016) ncbi
mouse monoclonal (Tau-5) ab80579	western blot; human; 1:800; fig 3 western blot; mouse; 1:800; fig 3	In order to elucidate modification microglial phenotype and neuroprotection in P301S tau transgenic mice via TREM2, Abcam Mapt antibody (Abcam, ab80579) was used in western blot on human samples at 1:800 (fig 3) and in western blot on mouse samples at 1:800 (fig 3). Neuropharmacology (2016) ncbi
mouse monoclonal (Tau-5) ab80579	western blot; human; 1:5000; fig 7	In order to use a pharmaceutical screen to discover new mechanisms of autophagy activation, Abcam Mapt antibody (Abcam, ab80579) was used in western blot on human samples at 1:5000 (fig 7). Nat Commun (2015) ncbi
domestic rabbit monoclonal (E178) ab32057	western blot; human; 1:5000; fig 3	In order to report that the di-phenyl-pyrazole anle138b binds to and inhibits tau aggregation in vitro and in vivo, Abcam Mapt antibody (Abcam, E178) was used in western blot on human samples at 1:5000 (fig 3). Acta Neuropathol (2015) ncbi
domestic rabbit monoclonal (E178) ab32057	western blot; human; fig 7	In order to provide evidence that GSK-3beta-dependent downregulation of gamma-taxilin and alphaNAC regulate hypoxia-induced ER stress responses, Abcam Mapt antibody (Abcam, ab 32057) was used in western blot on human samples (fig 7). Cell Death Dis (2015) ncbi
domestic rabbit monoclonal (EPR2731) ab109390	western blot; human; 1:1000	Abcam Mapt antibody (Abcam, ab109390) was used in western blot on human samples at 1:1000. Mol Psychiatry (2016) ncbi
domestic rabbit monoclonal (E178) ab32057	immunohistochemistry - frozen section; rat; 1:1000	Abcam Mapt antibody (Abcam, ab32057) was used in immunohistochemistry - frozen section on rat samples at 1:1000. PLoS ONE (2014) ncbi
mouse monoclonal (Tau-5) ab80579	ELISA; human; loading ...; fig 2a,b	Abcam Mapt antibody (Abcam, ab80579) was used in ELISA on human samples (fig 2a,b). Int J Mol Epidemiol Genet (2014) ncbi
domestic rabbit monoclonal (EPR2731) ab109390	western blot; mouse; 1:1000; fig 2	Abcam Mapt antibody (Abcam, ab109390) was used in western blot on mouse samples at 1:1000 (fig 2). Neuroreport (2014) ncbi
domestic rabbit monoclonal (E178) ab32057	western blot; mouse; 1:200; fig 2	Abcam Mapt antibody (Abcam, ab32057) was used in western blot on mouse samples at 1:200 (fig 2). Neuroreport (2014) ncbi
mouse monoclonal (Tau-5) ab80579	western blot; mouse; 1:800; fig 1	In order to investigate the contribution of IL-12/23 to disease using SAMP8 mice, Abcam Mapt antibody (Abcam, ab80579) was used in western blot on mouse samples at 1:800 (fig 1). J Alzheimers Dis (2014) ncbi
mouse monoclonal (Tau-5) ab80579	western blot; mouse; 1:2000	Abcam Mapt antibody (Abcam, ab80579) was used in western blot on mouse samples at 1:2000. J Biol Chem (2013) ncbi
mouse monoclonal (Tau-5) ab80579	immunoprecipitation; human western blot; human; fig 2a	Abcam Mapt antibody (Abcam, Tau5) was used in immunoprecipitation on human samples and in western blot on human samples (fig 2a). Mol Psychiatry (2013) ncbi

Santa Cruz Biotechnology

mouse monoclonal (A-10) sc-390476	western blot; mouse; 1:3000; loading ...; fig s2	Santa Cruz Biotechnology Mapt antibody (Santa Cruz, sc-390476) was used in western blot on mouse samples at 1:3000 (fig s2). Exp Ther Med (2022) ncbi
mouse monoclonal (A-12) sc-166062	flow cytometry; human; loading ...; fig 6b	Santa Cruz Biotechnology Mapt antibody (Santa Cruz Biotechnology, A-12) was used in flow cytometry on human samples (fig 6b). Cell Mol Gastroenterol Hepatol (2021) ncbi
mouse monoclonal (A-10) sc-390476	western blot; mouse; loading ...; fig 2d, 3b-d	Santa Cruz Biotechnology Mapt antibody (Santa Cruz, CA, United States, sc-390476) was used in western blot on mouse samples (fig 2d, 3b-d). Front Aging Neurosci (2019) ncbi
mouse monoclonal (A-10) sc-390476	immunocytochemistry; mouse; 1:800; loading ...; fig 6	Santa Cruz Biotechnology Mapt antibody (Santa, sc-390476) was used in immunocytochemistry on mouse samples at 1:800 (fig 6). Front Mol Neurosci (2019) ncbi
mouse monoclonal (PHF-13) sc-32275	western blot; rat; 1:50; loading ...; fig 7a	Santa Cruz Biotechnology Mapt antibody (Santa Cruz Biotechnology, sc-32275) was used in western blot on rat samples at 1:50 (fig 7a). Neuropharmacology (2019) ncbi
mouse monoclonal (A-10) sc-390476	western blot; rat; 1:1000; loading ...; fig 7a	Santa Cruz Biotechnology Mapt antibody (Santa Cruz Biotechnology, sc-390476) was used in western blot on rat samples at 1:1000 (fig 7a). Neuropharmacology (2019) ncbi
mouse monoclonal (Tau 46) sc-32274	western blot; mouse; 1:2000; loading ...; fig 8b	Santa Cruz Biotechnology Mapt antibody (Santa Cruz Biotechnology, sc-32274) was used in western blot on mouse samples at 1:2000 (fig 8b). J Cell Biol (2017) ncbi
mouse monoclonal (Tau-5) sc-58860	western blot; mouse; loading ...; fig 5b	In order to show that PTI-125 therapeutically alters filamin A and reverses proteopathy, Santa Cruz Biotechnology Mapt antibody (SantaCruz, SC-58860) was used in western blot on mouse samples (fig 5b). Neurobiol Aging (2017) ncbi
mouse monoclonal sc-32274 AC	ELISA; mouse; fig 2a	In order to analyze the effects of a panel of anti-tau antibodies on neuronal uptake and aggregation of tau, Santa Cruz Biotechnology Mapt antibody (Santa Cruz, Tau46) was used in ELISA on mouse samples (fig 2a). Am J Pathol (2017) ncbi
mouse monoclonal (Tau 46) sc-32274	ELISA; mouse; fig 2a	In order to analyze the effects of a panel of anti-tau antibodies on neuronal uptake and aggregation of tau, Santa Cruz Biotechnology Mapt antibody (Santa Cruz, Tau46) was used in ELISA on mouse samples (fig 2a). Am J Pathol (2017) ncbi
mouse monoclonal (Tau 46) sc-32274	western blot; mouse; loading ...; fig 6a	In order to report that reduced exosome secretion due to nSMase2 loss improves pathology and cognition in a mouse model of Alzheimer's disease, Santa Cruz Biotechnology Mapt antibody (Santa Cruz, Tau46) was used in western blot on mouse samples (fig 6a). J Neurosci (2016) ncbi
mouse monoclonal sc-32274 AC	western blot; mouse; loading ...; fig 6a	In order to report that reduced exosome secretion due to nSMase2 loss improves pathology and cognition in a mouse model of Alzheimer's disease, Santa Cruz Biotechnology Mapt antibody (Santa Cruz, Tau46) was used in western blot on mouse samples (fig 6a). J Neurosci (2016) ncbi
mouse monoclonal (D-8) sc-166060	other; human; 2 ug/ml	Santa Cruz Biotechnology Mapt antibody (Santa Cruz, SC-166060) was used in other on human samples at 2 ug/ml. J Alzheimers Dis (2016) ncbi
mouse monoclonal (Tau-5) sc-58860	immunohistochemistry; mouse western blot; mouse	Santa Cruz Biotechnology Mapt antibody (Santa Cruz, sc-58860) was used in immunohistochemistry on mouse samples and in western blot on mouse samples . Mol Neurodegener (2015) ncbi
mouse monoclonal (A-10) sc-390476	western blot; human; 1:1000	In order to study the effects of tau antibodies on in vitro tau phosphorylation, Santa Cruz Biotechnology Mapt antibody (Santa Cruz Biotechnology, sc-390476) was used in western blot on human samples at 1:1000. Exp Gerontol (2015) ncbi
mouse monoclonal (D-8) sc-166060	western blot; human; 1:1000	In order to study the effects of tau antibodies on in vitro tau phosphorylation, Santa Cruz Biotechnology Mapt antibody (Santa Cruz Biotechnology, sc-166060) was used in western blot on human samples at 1:1000. Exp Gerontol (2015) ncbi
mouse monoclonal (Tau-5) sc-58860	immunohistochemistry; mouse; 1:100 western blot; mouse; 1:100	In order to determine if tau phosphorylation contributes to spinal muscular atrophy pathogenesis, Santa Cruz Biotechnology Mapt antibody (Santa Cruz Biotechnology, Tau-5) was used in immunohistochemistry on mouse samples at 1:100 and in western blot on mouse samples at 1:100. J Neurosci (2015) ncbi

Synaptic Systems

mouse monoclonal (2,48E+07) 314 011	immunocytochemistry; mouse; 1:500; loading ...; fig 3b	Synaptic Systems Mapt antibody (Synaptic Systems, 314011) was used in immunocytochemistry on mouse samples at 1:500 (fig 3b). Biol Open (2021) ncbi
guinea-pigs polyclonal 314 004	immunocytochemistry; human; 1:500; loading ...; fig 2c	Synaptic Systems Mapt antibody (Synaptic systems, 314004) was used in immunocytochemistry on human samples at 1:500 (fig 2c). J Neural Transm (Vienna) (2021) ncbi

MyBioSource

domestic rabbit polyclonal

MBS857154

immunohistochemistry - frozen section; African green monkey; 1:500; loading ...; fig 2m

In order to evaluate cellular markers associated with neurodegenerative diseases in common marmoset (Callithrix jacchus) brains, MyBioSource Mapt antibody (BioScience, MBS857154) was used in immunohistochemistry - frozen section on African green monkey samples at 1:500 (fig 2m). Front Aging Neurosci (2016) ncbi

Cell Signaling Technology

domestic rabbit monoclonal (D9F4G) 12885	immunohistochemistry; mouse; 1:500; loading ...; fig s12b	Cell Signaling Technology Mapt antibody (Cell Signaling, 12885S) was used in immunohistochemistry on mouse samples at 1:500 (fig s12b). Sci Adv (2022) ncbi
domestic rabbit monoclonal (D9F4G) 12885	immunohistochemistry; mouse; loading ...; fig s9b	Cell Signaling Technology Mapt antibody (Cell Signaling Technologies, 12885S) was used in immunohistochemistry on mouse samples (fig s9b). Sci Transl Med (2021) ncbi
mouse monoclonal (PHF13) 9632	western blot; human; loading ...; fig 5a	Cell Signaling Technology Mapt antibody (Cell Signaling Technology, 9632) was used in western blot on human samples (fig 5a). Sci Adv (2021) ncbi
domestic rabbit monoclonal (D9F4G) 12885	western blot; rat; 1:1200	Cell Signaling Technology Mapt antibody (Cell Signaling, 12885) was used in western blot on rat samples at 1:1200. Acta Neuropathol Commun (2021) ncbi
mouse monoclonal (PHF13) 9632	western blot; rat; 1:1000	Cell Signaling Technology Mapt antibody (Cell Signaling, 9632) was used in western blot on rat samples at 1:1000. Acta Neuropathol Commun (2021) ncbi
mouse monoclonal (PHF13) 9632	immunohistochemistry - paraffin section; mouse; loading ...; fig 4c western blot; mouse; loading ...; fig 4a	Cell Signaling Technology Mapt antibody (Cell Signaling, 9632) was used in immunohistochemistry - paraffin section on mouse samples (fig 4c) and in western blot on mouse samples (fig 4a). Mol Neurodegener (2020) ncbi
mouse monoclonal (PHF13) 9632	western blot; mouse; loading ...; fig 5a	Cell Signaling Technology Mapt antibody (Cell Signaling, 9632s) was used in western blot on mouse samples (fig 5a). J Neurosci (2020) ncbi
mouse monoclonal (Tau46) 4019	western blot; mouse; loading ...; fig 1a	Cell Signaling Technology Mapt antibody (Cell Signaling, 4019) was used in western blot on mouse samples (fig 1a). Nature (2019) ncbi
mouse monoclonal (PHF13) 9632	western blot; mouse; loading ...; fig e1a	Cell Signaling Technology Mapt antibody (Cell Signaling, 9632) was used in western blot on mouse samples (fig e1a). Nature (2019) ncbi
mouse monoclonal (PHF13) 9632	western blot; mouse; 1:200; loading ...; fig 3a	Cell Signaling Technology Mapt antibody (CST, 9632) was used in western blot on mouse samples at 1:200 (fig 3a). Aging Cell (2019) ncbi
domestic rabbit polyclonal 11837	western blot; mouse; 1:1000; loading ...; fig 1s1c	Cell Signaling Technology Mapt antibody (Cell Signaling, 11837S) was used in western blot on mouse samples at 1:1000 (fig 1s1c). elife (2019) ncbi
domestic rabbit monoclonal (D9F4G) 12885	immunohistochemistry - free floating section; mouse; loading ...; fig s5a western blot; mouse; loading ...; fig s5i	Cell Signaling Technology Mapt antibody (Cell Signaling Technology, 12885) was used in immunohistochemistry - free floating section on mouse samples (fig s5a) and in western blot on mouse samples (fig s5i). Cell (2019) ncbi
mouse monoclonal (PHF13) 9632	immunohistochemistry - free floating section; mouse; loading ...; fig s5d western blot; mouse; loading ...; fig s5g	Cell Signaling Technology Mapt antibody (Cell Signaling Technology, 9632) was used in immunohistochemistry - free floating section on mouse samples (fig s5d) and in western blot on mouse samples (fig s5g). Cell (2019) ncbi
mouse monoclonal (PHF13) 9632	immunohistochemistry - paraffin section; rat; 1:500; loading ...; fig 14b, 14h	Cell Signaling Technology Mapt antibody (CST, 9632) was used in immunohistochemistry - paraffin section on rat samples at 1:500 (fig 14b, 14h). Histochem Cell Biol (2019) ncbi
domestic rabbit monoclonal (D7U2P) 15013	western blot; mouse; 1:1000; loading ...; fig s5f	Cell Signaling Technology Mapt antibody (Cell Signaling Technology, 15013) was used in western blot on mouse samples at 1:1000 (fig s5f). J Clin Invest (2019) ncbi
mouse monoclonal (PHF13) 9632	immunohistochemistry; mouse; loading ...; fig 1f	Cell Signaling Technology Mapt antibody (Cell Signaling, 9632) was used in immunohistochemistry on mouse samples (fig 1f). Cell Rep (2018) ncbi
mouse monoclonal (Tau46) 4019	immunohistochemistry; mouse; loading ...; fig 2a	Cell Signaling Technology Mapt antibody (Cell Signaling, 4019) was used in immunohistochemistry on mouse samples (fig 2a). J Clin Invest (2018) ncbi
mouse monoclonal (Tau46) 4019	western blot; rat; loading ...; fig 3b	Cell Signaling Technology Mapt antibody (Cell Signaling, 4019) was used in western blot on rat samples (fig 3b). J Biol Chem (2018) ncbi
domestic rabbit polyclonal 11834	immunohistochemistry - frozen section; rat; 1:500; loading ...; fig 3e western blot; rat; loading ...; fig 3b	Cell Signaling Technology Mapt antibody (Cell Signaling, 11834) was used in immunohistochemistry - frozen section on rat samples at 1:500 (fig 3e) and in western blot on rat samples (fig 3b). J Biol Chem (2018) ncbi
domestic rabbit polyclonal 11834	western blot; mouse; 1:75; loading ...; fig 3b	In order to test if bone loss is a component of an Alzheimer's disease prodrome, Cell Signaling Technology Mapt antibody (Cell Signaling, 11834S) was used in western blot on mouse samples at 1:75 (fig 3b). J Alzheimers Dis (2017) ncbi
mouse monoclonal (PHF13) 9632	western blot; human; 1:4000; loading ...; fig 4a	In order to demonstrate that microtubule affinity-regulating kinase is a target of methylene blue, Cell Signaling Technology Mapt antibody (Cell Signaling, 9632) was used in western blot on human samples at 1:4000 (fig 4a). Sci Rep (2016) ncbi
mouse monoclonal (PHF13) 9632	western blot; mouse; 1:200; loading ...; fig 3a	In order to discuss the contribution of 12/15-lipoxygenase to Alzheimer's disease, Cell Signaling Technology Mapt antibody (Cell Signaling, PHF13) was used in western blot on mouse samples at 1:200 (fig 3a). Biol Psychiatry (2017) ncbi
mouse monoclonal (Tau46) 4019	western blot; rat; 1:1000; fig 2	Cell Signaling Technology Mapt antibody (Cell Signaling, 4019P) was used in western blot on rat samples at 1:1000 (fig 2). Neural Regen Res (2016) ncbi
domestic rabbit polyclonal 11834	western blot; rat; 1:1000; fig 9	In order to ascertain the effects of severe penetrating traumatic brain injury on APP and tau cleavage processing, Cell Signaling Technology Mapt antibody (Cell signaling, 11834) was used in western blot on rat samples at 1:1000 (fig 9). PLoS ONE (2016) ncbi
mouse monoclonal (Tau46) 4019	western blot; mouse; fig 6	In order to analyze the mitigation that increases PHF1 levels and lipofuscin puncta and rescues memory deficits by TFEB overexpression in the P301S model of tauopathy, Cell Signaling Technology Mapt antibody (Cell Signaling Technology, 4019) was used in western blot on mouse samples (fig 6). Eneuro (2016) ncbi
mouse monoclonal (PHF13) 9632	western blot; human; fig 3	Cell Signaling Technology Mapt antibody (Cell Signaling, 9632) was used in western blot on human samples (fig 3). J Neurosci (2016) ncbi
domestic rabbit polyclonal 11834	western blot; human; fig 3	Cell Signaling Technology Mapt antibody (Cell Signaling, 11834) was used in western blot on human samples (fig 3). J Neurosci (2016) ncbi
mouse monoclonal (Tau46) 4019	western blot; human	In order to study the effect of G2019S on neuronal subtypes, Cell Signaling Technology Mapt antibody (Cell Signal, 4019) was used in western blot on human samples . Stem Cell Reports (2015) ncbi
domestic rabbit polyclonal 11837	western blot; mouse; 1:1500; fig 1	In order to test if short-term treadmill exercise changes tau modifications, Cell Signaling Technology Mapt antibody (Cell Signaling, 11837) was used in western blot on mouse samples at 1:1500 (fig 1). Neurosci Lett (2016) ncbi
mouse monoclonal (Tau46) 4019	western blot; mouse; 1:1000; fig 3	In order to analyze a mouse model where human neural stem cells alleviate Alzheimer-like pathology, Cell Signaling Technology Mapt antibody (Cell Signaling Technology, 4019) was used in western blot on mouse samples at 1:1000 (fig 3). Mol Neurodegener (2015) ncbi
mouse monoclonal (PHF13) 9632	western blot; mouse; 1:1000; fig 3	In order to analyze a mouse model where human neural stem cells alleviate Alzheimer-like pathology, Cell Signaling Technology Mapt antibody (Cell Signaling Technology, 9632) was used in western blot on mouse samples at 1:1000 (fig 3). Mol Neurodegener (2015) ncbi
mouse monoclonal (Tau46) 4019	western blot; mouse; fig 1	In order to study an increase in tau phosphorylation via P38 mitogen-activated protein kinase dye to glucose deprivation, Cell Signaling Technology Mapt antibody (Cell signaling, 4019) was used in western blot on mouse samples (fig 1). Aging Cell (2015) ncbi
mouse monoclonal (PHF13) 9632	western blot; mouse; fig 1	In order to study an increase in tau phosphorylation via P38 mitogen-activated protein kinase dye to glucose deprivation, Cell Signaling Technology Mapt antibody (Cell signaling, 9632) was used in western blot on mouse samples (fig 1). Aging Cell (2015) ncbi
mouse monoclonal (Tau46) 4019	western blot; human; 1:1000; fig 5	Cell Signaling Technology Mapt antibody (Cell Signaling, 4019) was used in western blot on human samples at 1:1000 (fig 5). BMC Genomics (2015) ncbi
mouse monoclonal (Tau46) 4019	western blot; rat; 1:1000	Cell Signaling Technology Mapt antibody (Cell Signaling Technology, 4019S) was used in western blot on rat samples at 1:1000. Mol Neurobiol (2016) ncbi
mouse monoclonal (PHF13) 9632	western blot; mouse; 1:200	In order to characterize the behavioral, biochemical, and neuropathologic effects of 8ISO in the triple transgenic mouse model of Alzheimer's disease, Cell Signaling Technology Mapt antibody (Cell Signaling, 9632) was used in western blot on mouse samples at 1:200. Neurobiol Aging (2015) ncbi

MilliporeSigma

mouse monoclonal (Tau46) T9450	western blot; rat; 1:500; loading ...; fig 4a	MilliporeSigma Mapt antibody (Sigma-Aldrich, T9450) was used in western blot on rat samples at 1:500 (fig 4a). Cell Rep (2022) ncbi
mouse monoclonal (Tau46) T9450	western blot; rat; 1:1000; loading ...; fig 2f	MilliporeSigma Mapt antibody (Sigma, T9450) was used in western blot on rat samples at 1:1000 (fig 2f). Signal Transduct Target Ther (2021) ncbi
mouse monoclonal (Tau46) T9450	immunocytochemistry; rat; 1:500; loading ...; fig 8e	MilliporeSigma Mapt antibody (Sigma, T9450) was used in immunocytochemistry on rat samples at 1:500 (fig 8e). Nat Commun (2019) ncbi
domestic rabbit polyclonal T6402	immunocytochemistry; human; loading ...; fig 3l	MilliporeSigma Mapt antibody (Sigma-Aldrich, T6402) was used in immunocytochemistry on human samples (fig 3l). Nat Med (2018) ncbi
domestic rabbit polyclonal T6402	western blot; mouse; 1:1000; loading ...; fig 2c	In order to investigate the expression patterns of HA synthases in the murine central nervous system, MilliporeSigma Mapt antibody (Sigma, T6402) was used in western blot on mouse samples at 1:1000 (fig 2c). J Alzheimers Dis (2017) ncbi
mouse monoclonal (Tau46) T9450	western blot; mouse; 1:4000; loading ...; fig 5b	In order to identify NFE2L2/NRF2 as a regulator of autophagy gene expression and study its role in Alzheimer disease, MilliporeSigma Mapt antibody (Sigma, T9450) was used in western blot on mouse samples at 1:4000 (fig 5b). Autophagy (2016) ncbi
mouse monoclonal (Tau46) T9450	western blot knockout validation; mouse; 1:500; loading ...; fig 1b	MilliporeSigma Mapt antibody (Sigma Aldrich, T9450) was used in western blot knockout validation on mouse samples at 1:500 (fig 1b). Neuroscience (2016) ncbi
domestic rabbit polyclonal T6402	immunocytochemistry; mouse; fig 7	MilliporeSigma Mapt antibody (Sigma, T-6402) was used in immunocytochemistry on mouse samples (fig 7). Acta Neuropathol (2016) ncbi
domestic rabbit polyclonal T6402	immunohistochemistry; rat; 1:750; loading ...; fig 3e	In order to use electroconducting microfibers to synergistically stimulate the proliferation and migration of glial progenitor cells, MilliporeSigma Mapt antibody (Sigma, T-6402) was used in immunohistochemistry on rat samples at 1:750 (fig 3e). Acta Biomater (2016) ncbi
domestic rabbit polyclonal SAB4501821	immunohistochemistry - frozen section; mouse; fig 4	In order to utilize an Alzheimer's disease model in mice to show colocalization of phosphorylated forms of CRMP2, WAVE1, and tau that identify an involvement of Cdk5 phosphorylation and an affect of ATRA treatment, MilliporeSigma Mapt antibody (Sigma, SAB4501821) was used in immunohistochemistry - frozen section on mouse samples (fig 4). J Neurosci Res (2016) ncbi
domestic rabbit polyclonal T6402	immunocytochemistry; human; 1:100	MilliporeSigma Mapt antibody (Sigma-Aldrich, T6402) was used in immunocytochemistry on human samples at 1:100. Methods Mol Biol (2016) ncbi
mouse monoclonal (Tau46) T9450	western blot; mouse	In order to study how extracellular proteins are cleared from the brain, MilliporeSigma Mapt antibody (Sigma, T9450) was used in western blot on mouse samples . J Neurosci (2014) ncbi

Articles Reviewed

Rangan P, Lobo F, Parrella E, Rochette N, Morselli M, Stephen T, et al. Fasting-mimicking diet cycles reduce neuroinflammation to attenuate cognitive decline in Alzheimer's models. Cell Rep. 2022;40:111417 pubmed publisher
Welch G, Boix C, Schmauch E, Davila Velderrain J, Victor M, Dileep V, et al. Neurons burdened by DNA double-strand breaks incite microglia activation through antiviral-like signaling in neurodegeneration. Sci Adv. 2022;8:eabo4662 pubmed publisher
Kasica N, Zhou X, Jester H, Holland C, Ryazanov A, Forshaw T, et al. Homozygous knockout of eEF2K alleviates cognitive deficits in APP/PS1 Alzheimer's disease model mice independent of brain amyloid β pathology. Front Aging Neurosci. 2022;14:959326 pubmed publisher
Easton A, Jensen M, Wang C, Hagedorn P, Li Y, WEED M, et al. Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies. Mol Ther Nucleic Acids. 2022;29:625-642 pubmed publisher
Hausrat T, Janiesch P, Breiden P, Lutz D, Hoffmeister Ullerich S, Hermans Borgmeyer I, et al. Disruption of tubulin-alpha4a polyglutamylation prevents aggregation of hyper-phosphorylated tau and microglia activation in mice. Nat Commun. 2022;13:4192 pubmed publisher
Nakamori M, Shimizu H, Ogawa K, Hasuike Y, Nakajima T, Sakurai H, et al. Cell type-specific abnormalities of central nervous system in myotonic dystrophy type 1. Brain Commun. 2022;4:fcac154 pubmed publisher
Liu H, Li Q, Zhang X, Shi Y, Li J. Effect of ginkgolide K on calcium channel activity in Alzheimer's disease. Exp Ther Med. 2022;23:426 pubmed publisher
Rauskolb S, Andreska T, Fries S, von Collenberg C, Blum R, Monoranu C, et al. Insulin-like growth factor 5 associates with human Aß plaques and promotes cognitive impairment. Acta Neuropathol Commun. 2022;10:68 pubmed publisher
Permanne B, Sand A, Ousson S, N xe9 ny M, Hantson J, Schubert R, et al. O-GlcNAcase Inhibitor ASN90 is a Multimodal Drug Candidate for Tau and α-Synuclein Proteinopathies. ACS Chem Neurosci. 2022;13:1296-1314 pubmed publisher
Wang C, Chen S, Guo H, Jiang H, Liu H, Fu H, et al. Forsythoside A Mitigates Alzheimer's-like Pathology by Inhibiting Ferroptosis-mediated Neuroinflammation via Nrf2/GPX4 Axis Activation. Int J Biol Sci. 2022;18:2075-2090 pubmed publisher
Zhou Q, Li S, Li M, Ke D, Wang Q, Yang Y, et al. Human tau accumulation promotes glycogen synthase kinase-3β acetylation and thus upregulates the kinase: A vicious cycle in Alzheimer neurodegeneration. EBioMedicine. 2022;78:103970 pubmed publisher
Marengo L, Armbrust F, Schoenherr C, Storck S, Schmitt U, Zampar S, et al. Meprin β knockout reduces brain Aβ levels and rescues learning and memory impairments in the APP/lon mouse model for Alzheimer's disease. Cell Mol Life Sci. 2022;79:168 pubmed publisher
Schiapparelli L, Sharma P, He H, Li J, Shah S, McClatchy D, et al. Proteomic screen reveals diverse protein transport between connected neurons in the visual system. Cell Rep. 2022;38:110287 pubmed publisher
Andr xe9 s Benito P, Carmona M, Jord xe1 n M, Fern xe1 ndez Irigoyen J, Santamar xed a E, Del Rio J, et al. Host Tau Genotype Specifically Designs and Regulates Tau Seeding and Spreading and Host Tau Transformation Following Intrahippocampal Injection of Identical Tau AD Inoculum. Int J Mol Sci. 2022;23: pubmed publisher
Zou Y, Gan C, Xin Z, Zhang H, Zhang Q, Lee T, et al. Programmed Cell Death Protein 1 Blockade Reduces Glycogen Synthase Kinase 3β Activity and Tau Hyperphosphorylation in Alzheimer's Disease Mouse Models. Front Cell Dev Biol. 2021;9:769229 pubmed publisher
Kasica N, Zhou X, Yang Q, Wang X, Yang W, Zimmermann H, et al. Antagonists targeting eEF2 kinase rescue multiple aspects of pathophysiology in Alzheimer's disease model mice. J Neurochem. 2022;160:524-539 pubmed publisher
Barker S, Raju R, Milman N, Wang J, Davila Velderrain J, Gunter Rahman F, et al. MEF2 is a key regulator of cognitive potential and confers resilience to neurodegeneration. Sci Transl Med. 2021;13:eabd7695 pubmed publisher
Gao C, Deng J, Zhang H, Li X, Gu S, Zheng M, et al. HSPA13 facilitates NF-κB-mediated transcription and attenuates cell death responses in TNFα signaling. Sci Adv. 2021;7:eabh1756 pubmed publisher
Mroczek K, Fernando S, Fisher P, Annesley S. Interactions and Cytotoxicity of Human Neurodegeneration- Associated Proteins Tau and α-Synuclein in the Simple Model Dictyostelium discoideum. Front Cell Dev Biol. 2021;9:741662 pubmed publisher
Villanueva E, Tresse E, Liu Y, Duarte J, Jimenez Duran G, Ejlerskov P, et al. Neuronal TNFα, Not α-Syn, Underlies PDD-Like Disease Progression in IFNβ-KO Mice. Ann Neurol. 2021;90:789-807 pubmed publisher
Yuste Checa P, Trinkaus V, Riera Tur I, Imamoglu R, Schaller T, Wang H, et al. The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model. Nat Commun. 2021;12:4863 pubmed publisher
Bampton A, Gatt A, Humphrey J, Cappelli S, Bhattacharya D, Foti S, et al. HnRNP K mislocalisation is a novel protein pathology of frontotemporal lobar degeneration and ageing and leads to cryptic splicing. Acta Neuropathol. 2021;142:609-627 pubmed publisher
Valencia A, Bieber V, Bajrami B, Marsh G, Hamann S, Wei R, et al. Antisense Oligonucleotide-Mediated Reduction of HDAC6 Does Not Reduce Tau Pathology in P301S Tau Transgenic Mice. Front Neurol. 2021;12:624051 pubmed publisher
Zheng J, Tian N, Liu F, Zhang Y, Su J, Gao Y, et al. A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies. Signal Transduct Target Ther. 2021;6:269 pubmed publisher
Cores A, Abril S, Michalska P, Duarte P, Olives A, Martín M, et al. Bisavenathramide Analogues as Nrf2 Inductors and Neuroprotectors in In Vitro Models of Oxidative Stress and Hyperphosphorylation. Antioxidants (Basel). 2021;10: pubmed publisher
Wu D, Gao D, Yu H, Pi G, Xiong R, Lei H, et al. Medial septum tau accumulation induces spatial memory deficit via disrupting medial septum-hippocampus cholinergic pathway. Clin Transl Med. 2021;11:e428 pubmed publisher
Guix F, Capitán A, Casadomé Perales Á, Palomares Perez I, López Del Castillo I, Miguel V, et al. Increased exosome secretion in neurons aging in vitro by NPC1-mediated endosomal cholesterol buildup. Life Sci Alliance. 2021;4: pubmed publisher
Sakakibara Y, Hirota Y, Ibaraki K, Takei K, Chikamatsu S, Tsubokawa Y, et al. Widespread Reduced Density of Noradrenergic Locus Coeruleus Axons in the App Knock-In Mouse Model of Amyloid-β Amyloidosis. J Alzheimers Dis. 2021;82:1513-1530 pubmed publisher
Frei J, Brandenburg C, Nestor J, Hodzic D, Plachez C, McNeill H, et al. Postnatal expression profiles of atypical cadherin FAT1 suggest its role in autism. Biol Open. 2021;10: pubmed publisher
Zhang J, Wu N, Wang S, Yao Z, Xiao F, Lu J, et al. Neuronal loss and microgliosis are restricted to the core of Aβ deposits in mouse models of Alzheimer's disease. Aging Cell. 2021;20:e13380 pubmed publisher
Subramanian M, Hyeon S, Das T, Suh Y, Kim Y, Lee J, et al. UBE4B, a microRNA-9 target gene, promotes autophagy-mediated Tau degradation. Nat Commun. 2021;12:3291 pubmed publisher
Qiu C, Albayram O, Kondo A, Wang B, Kim N, Arai K, et al. Cis P-tau underlies vascular contribution to cognitive impairment and dementia and can be effectively targeted by immunotherapy in mice. Sci Transl Med. 2021;13: pubmed publisher
López Gambero A, Rosell Valle C, Medina Vera D, Navarro J, Vargas A, Rivera P, et al. A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer's Disease, the 5XFAD Mouse. Int J Mol Sci. 2021;22: pubmed publisher
Zhang X, Zou L, Meng L, Xiong M, Pan L, Chen G, et al. Amphiphysin I cleavage by asparagine endopeptidase leads to tau hyperphosphorylation and synaptic dysfunction. elife. 2021;10: pubmed publisher
Galán Ganga M, Rodríguez Cueto C, Merchán Rubira J, Hernandez F, Avila J, Posada Ayala M, et al. Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration. Acta Neuropathol Commun. 2021;9:90 pubmed publisher
Liu Y, Cong P, Zhang T, Wang R, Wang X, Liu J, et al. Plasmalogen attenuates the development of hepatic steatosis and cognitive deficit through mechanism involving p75NTR inhibition. Redox Biol. 2021;43:102002 pubmed publisher
Dong Y, Liang F, Huang L, Fang F, Yang G, Tanzi R, et al. The anesthetic sevoflurane induces tau trafficking from neurons to microglia. Commun Biol. 2021;4:560 pubmed publisher
Park G, Lee J, Han H, An H, Jin Z, Jeong E, et al. Ablation of dynamin-related protein 1 promotes diabetes-induced synaptic injury in the hippocampus. Cell Death Dis. 2021;12:445 pubmed publisher
García Escudero V, Ruiz Gabarre D, Gargini R, Perez M, Garcia E, Cuadros R, et al. A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer's disease. Acta Neuropathol. 2021;142:159-177 pubmed publisher
Tseng J, Ajit A, Tabassum Z, Patel N, Tian X, Chen Y, et al. Tau seeds are subject to aberrant modifications resulting in distinct signatures. Cell Rep. 2021;35:109037 pubmed publisher
Shin M, Vázquez Rosa E, Koh Y, Dhar M, Chaubey K, Cintrón Pérez C, et al. Reducing acetylated tau is neuroprotective in brain injury. Cell. 2021;184:2715-2732.e23 pubmed publisher
Miguel J, Perez S, Malek Ahmadi M, Mufson E. Cerebellar Calcium-Binding Protein and Neurotrophin Receptor Defects in Down Syndrome and Alzheimer's Disease. Front Aging Neurosci. 2021;13:645334 pubmed publisher
Shili C, Habibi M, Sutton J, Barnes J, Burch Konda J, Pezeshki A. Effect of a Phytogenic Water Additive on Growth Performance, Blood Metabolites and Gene Expression of Amino Acid Transporters in Nursery Pigs Fed with Low-Protein/High-Carbohydrate Diets. Animals (Basel). 2021;11: pubmed publisher
Wang X, Kuang N, Chen Y, Liu G, Wang N, Kong F, et al. Transplantation of olfactory ensheathing cells promotes the therapeutic effect of neural stem cells on spinal cord injury by inhibiting necrioptosis. Aging (Albany NY). 2021;13:9056-9070 pubmed publisher
Perez Garcia G, De Gasperi R, Gama Sosa M, Perez G, Otero Pagan A, Pryor D, et al. Laterality and region-specific tau phosphorylation correlate with PTSD-related behavioral traits in rats exposed to repetitive low-level blast. Acta Neuropathol Commun. 2021;9:33 pubmed publisher
Sokratian A, Ziaee J, Kelly K, Chang A, Bryant N, Wang S, et al. Heterogeneity in α-synuclein fibril activity correlates to disease phenotypes in Lewy body dementia. Acta Neuropathol. 2021;141:547-564 pubmed publisher
Almeida M, Piehler T, Carstens K, Zhao M, Samadi M, Dudek S, et al. Distinct and dementia-related synaptopathy in the hippocampus after military blast exposures. Brain Pathol. 2021;31:e12936 pubmed publisher
Jansch C, Ziegler G, Forero A, Gredy S, W xe4 ldchen S, Vitale M, et al. Serotonin-specific neurons differentiated from human iPSCs form distinct subtypes with synaptic protein assembly. J Neural Transm (Vienna). 2021;128:225-241 pubmed publisher
Ly H, Verma N, Sharma S, Kotiya D, Despa S, Abner E, et al. The association of circulating amylin with β-amyloid in familial Alzheimer's disease. Alzheimers Dement (N Y). 2021;7:e12130 pubmed publisher
Zareba Paslawska J, Patra K, Kluzer L, Revesz T, Svenningsson P. Tau Isoform-Driven CBD Pathology Transmission in Oligodendrocytes in Humanized Tau Mice. Front Neurol. 2020;11:589471 pubmed publisher
Bengoa Vergniory N, Velentza Almpani E, Silva A, Scott C, Vargas Caballero M, Sastre M, et al. Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease. Acta Neuropathol Commun. 2021;9:18 pubmed publisher
Choi Y, Dunn Meynell A, Marchese M, Blumberg B, Gaindh D, Dowling P, et al. Erythropoietin-derived peptide treatment reduced neurological deficit and neuropathological changes in a mouse model of tauopathy. Alzheimers Res Ther. 2021;13:32 pubmed publisher
Hondius D, Koopmans F, Leistner C, Pita Illobre D, Peferoen Baert R, Marbus F, et al. The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer's disease. Acta Neuropathol. 2021;141:341-358 pubmed publisher
Choi G, Lee H, Chae C, Cho J, Jung Y, Kim J, et al. BNIP3L/NIX-mediated mitophagy protects against glucocorticoid-induced synapse defects. Nat Commun. 2021;12:487 pubmed publisher
Sobue A, Komine O, Hara Y, Endo F, Mizoguchi H, Watanabe S, et al. Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer's disease. Acta Neuropathol Commun. 2021;9:1 pubmed publisher
Biechele G, Franzmeier N, Blume T, Ewers M, Luque J, Eckenweber F, et al. Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases. J Neuroinflammation. 2020;17:374 pubmed publisher
Chiu C, Weng Y, Huang Y, Chen R, Liu Y, Yeh T, et al. (D620N) VPS35 causes the impairment of Wnt/β-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model. Cell Death Dis. 2020;11:1018 pubmed publisher
Wang Q, Ge X, Zhang J, Chen L. Effect of lncRNA WT1-AS regulating WT1 on oxidative stress injury and apoptosis of neurons in Alzheimer's disease via inhibition of the miR-375/SIX4 axis. Aging (Albany NY). 2020;12:23974-23995 pubmed publisher
Sun R, Hedl M, Abraham C. TNFSF15 Promotes Antimicrobial Pathways in Human Macrophages and These Are Modulated by TNFSF15 Disease-Risk Variants. Cell Mol Gastroenterol Hepatol. 2021;11:249-272 pubmed publisher
Tang S, Fesharaki Zadeh A, Takahashi H, Nies S, Smith L, Luo A, et al. Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy. Acta Neuropathol Commun. 2020;8:96 pubmed publisher
Silva M, Nandi G, Tentarelli S, Gurrell I, Jamier T, Lucente D, et al. Prolonged tau clearance and stress vulnerability rescue by pharmacological activation of autophagy in tauopathy neurons. Nat Commun. 2020;11:3258 pubmed publisher
Wander C, Tseng J, Song S, Al Housseiny H, Tart D, Ajit A, et al. The Accumulation of Tau-Immunoreactive Hippocampal Granules and Corpora Amylacea Implicates Reactive Glia in Tau Pathogenesis during Aging. iScience. 2020;23:101255 pubmed publisher
Ren P, Chen J, Li B, Zhang M, Yang B, Guo X, et al. Nrf2 Ablation Promotes Alzheimer's Disease-Like Pathology in APP/PS1 Transgenic Mice: The Role of Neuroinflammation and Oxidative Stress. Oxid Med Cell Longev. 2020;2020:3050971 pubmed publisher
LeBlang C, Medalla M, Nicoletti N, Hays E, Zhao J, Shattuck J, et al. Reduction of the RNA Binding Protein TIA1 Exacerbates Neuroinflammation in Tauopathy. Front Neurosci. 2020;14:285 pubmed publisher
Leong W, Xu W, Wang B, Gao S, Zhai X, Wang C, et al. PP2A subunit PPP2R2C is downregulated in the brains of Alzheimer's transgenic mice. Aging (Albany NY). 2020;12:6880-6890 pubmed publisher
Ma X, Zhu Y, Lu J, Xie J, Li C, Shin W, et al. Nicotinamide mononucleotide adenylyltransferase uses its NAD+ substrate-binding site to chaperone phosphorylated Tau. elife. 2020;9: pubmed publisher
Hu S, Hu M, Liu J, Zhang B, Zhang Z, Zhou F, et al. Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson's Disease. Neuropsychiatr Dis Treat. 2020;16:651-663 pubmed publisher
Yilmazer Hanke D, Mayer T, Müller H, Neugebauer H, Abaei A, Scheuerle A, et al. Histological correlates of postmortem ultra-high-resolution single-section MRI in cortical cerebral microinfarcts. Acta Neuropathol Commun. 2020;8:33 pubmed publisher
Xing Z, Zhang L, Zhang Y, Sun X, Sun X, Yu H, et al. DIP2B Interacts With α-Tubulin to Regulate Axon Outgrowth. Front Cell Neurosci. 2020;14:29 pubmed publisher
Shi H, Wang Q, Zheng M, Hao S, Lum J, Chen X, et al. Supplement of microbiota-accessible carbohydrates prevents neuroinflammation and cognitive decline by improving the gut microbiota-brain axis in diet-induced obese mice. J Neuroinflammation. 2020;17:77 pubmed publisher
Liao X, Cai F, Sun Z, Zhang Y, Wang J, Jiao B, et al. Identification of Alzheimer's disease-associated rare coding variants in the ECE2 gene. JCI Insight. 2020;5: pubmed publisher
Sun Y, Guo Y, Feng X, Jia M, Ai N, Dong Y, et al. The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer's disease. J Neuroinflammation. 2020;17:72 pubmed publisher
Rodriguez Ortiz C, Prieto G, Martini A, Forner S, Trujillo Estrada L, LaFerla F, et al. miR-181a negatively modulates synaptic plasticity in hippocampal cultures and its inhibition rescues memory deficits in a mouse model of Alzheimer's disease. Aging Cell. 2020;19:e13118 pubmed publisher
Yao X, Xian X, Fang M, Fan S, Li W. Loss of miR-369 Promotes Tau Phosphorylation by Targeting the Fyn and Serine/Threonine-Protein Kinase 2 Signaling Pathways in Alzheimer's Disease Mice. Front Aging Neurosci. 2019;11:365 pubmed publisher
Krishnan M, Hwang J, Kim M, Kim Y, Seo J, Jung J, et al. β-hydroxybutyrate Impedes the Progression of Alzheimer's Disease and Atherosclerosis in ApoE-Deficient Mice. Nutrients. 2020;12: pubmed publisher
Schrank S, McDaid J, Briggs C, Mustaly Kalimi S, Brinks D, Houcek A, et al. Human-Induced Neurons from Presenilin 1 Mutant Patients Model Aspects of Alzheimer's Disease Pathology. Int J Mol Sci. 2020;21: pubmed publisher
Kaalund S, Passamonti L, Allinson K, Murley A, Robbins T, Spillantini M, et al. Locus coeruleus pathology in progressive supranuclear palsy, and its relation to disease severity. Acta Neuropathol Commun. 2020;8:11 pubmed publisher
Bencze J, Szarka M, Bencs V, Szabó R, Módis L, Aarsland D, et al. Lemur Tyrosine Kinase 2 (LMTK2) Level Inversely Correlates with Phospho-Tau in Neuropathological Stages of Alzheimer's Disease. Brain Sci. 2020;10: pubmed publisher
Walker D, Tang T, Mendsaikhan A, Tooyama I, Serrano G, Sue L, et al. Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer's Disease Brains. Int J Mol Sci. 2020;21: pubmed publisher
Li J, Chiu J, Ramanjulu M, Blass B, Pratico D. A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles. Mol Neurodegener. 2020;15:1 pubmed publisher
Li C, Liu W, Li X, Zhang Z, Qi H, Liu S, et al. The novel GLP-1/GIP analogue DA5-CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD. Brain Behav. 2020;10:e01505 pubmed publisher
Inda M, Joshi S, Wang T, Bolaender A, Gandu S, Koren Iii J, et al. The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction. Nat Commun. 2020;11:319 pubmed publisher
Bowie E, Goetz S. TTBK2 and primary cilia are essential for the connectivity and survival of cerebellar Purkinje neurons. elife. 2020;9: pubmed publisher
Braak H, Del Tredici K. From the Entorhinal Region via the Prosubiculum to the Dentate Fascia: Alzheimer Disease-Related Neurofibrillary Changes in the Temporal Allocortex. J Neuropathol Exp Neurol. 2020;79:163-175 pubmed publisher
He Z, McBride J, Xu H, Changolkar L, Kim S, Zhang B, et al. Transmission of tauopathy strains is independent of their isoform composition. Nat Commun. 2020;11:7 pubmed publisher
Arenas F, Castro F, Núñez S, Gay G, Garcia Ruiz C, Fernandez Checa J. STARD1 and NPC1 expression as pathological markers associated with astrogliosis in post-mortem brains from patients with Alzheimer's disease and Down syndrome. Aging (Albany NY). 2020;12:571-592 pubmed publisher
Shafei R, Woollacott I, Mummery C, Bocchetta M, Guerreiro R, Bras J, et al. Two pathologically confirmed cases of novel mutations in the MAPT gene causing frontotemporal dementia. Neurobiol Aging. 2020;87:141.e15-141.e20 pubmed publisher
Fan Q, He W, Gayen M, Benoit M, Luo X, Hu X, et al. Activated CX3CL1/Smad2 Signals Prevent Neuronal Loss and Alzheimer's Tau Pathology-Mediated Cognitive Dysfunction. J Neurosci. 2020;40:1133-1144 pubmed publisher
Casci I, Krishnamurthy K, Kour S, Tripathy V, Ramesh N, Anderson E, et al. Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization. Nat Commun. 2019;10:5583 pubmed publisher
Ercan Herbst E, Ehrig J, Schöndorf D, Behrendt A, Klaus B, Gomez Ramos B, et al. A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain. Acta Neuropathol Commun. 2019;7:192 pubmed publisher
Kirabali T, Rigotti S, Siccoli A, Liebsch F, Shobo A, Hock C, et al. The amyloid-β degradation intermediate Aβ34 is pericyte-associated and reduced in brain capillaries of patients with Alzheimer's disease. Acta Neuropathol Commun. 2019;7:194 pubmed publisher
Pires G, McElligott S, Drusinsky S, Halliday G, Potier M, Wisniewski T, et al. Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies. Acta Neuropathol Commun. 2019;7:195 pubmed publisher
Sonntag T, Moresco J, Yates J, Montminy M. The KLDpT activation loop motif is critical for MARK kinase activity. PLoS ONE. 2019;14:e0225727 pubmed publisher
Yu L, Boyle P, Dawe R, Bennett D, Arfanakis K, Schneider J. Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons. Neurology. 2020;94:e142-e152 pubmed publisher
Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt S, Vieira Saecker A, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;: pubmed publisher
Ye J, Yin Y, Liu H, Fang L, Tao X, Wei L, et al. Tau inhibits PKA by nuclear proteasome-dependent PKAR2α elevation with suppressed CREB/GluA1 phosphorylation. Aging Cell. 2020;19:e13055 pubmed publisher
Faraco G, Hochrainer K, Segarra S, Schaeffer S, Santisteban M, Menon A, et al. Dietary salt promotes cognitive impairment through tau phosphorylation. Nature. 2019;: pubmed publisher
di Meco A, Pratico D. Early-life exposure to high-fat diet influences brain health in aging mice. Aging Cell. 2019;18:e13040 pubmed publisher
Yagensky O, Kohansal Nodehi M, Gunaseelan S, Rabe T, Zafar S, Zerr I, et al. Increased expression of heme-binding protein 1 early in Alzheimer's disease is linked to neurotoxicity. elife. 2019;8: pubmed publisher
Zhang R, Liu Y, Chen Y, Li Q, Marshall C, Wu T, et al. Aquaporin 4 deletion exacerbates brain impairments in a mouse model of chronic sleep disruption. CNS Neurosci Ther. 2020;26:228-239 pubmed publisher
Fiock K, Smith J, Crary J, Hefti M. β-amyloid and tau pathology in the aging feline brain. J Comp Neurol. 2020;528:108-113 pubmed publisher
Kroth H, Oden F, Molette J, Schieferstein H, Capotosti F, Mueller A, et al. Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies. Eur J Nucl Med Mol Imaging. 2019;46:2178-2189 pubmed publisher
Latimer C, Burke B, Liachko N, Currey H, Kilgore M, Gibbons L, et al. Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort. Acta Neuropathol Commun. 2019;7:9 pubmed publisher
Gamache J, Benzow K, Forster C, Kemper L, Hlynialuk C, Furrow E, et al. Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice. Nat Commun. 2019;10:2479 pubmed publisher
Zhang J, Chen B, Lu J, Wu Y, Wang S, Yao Z, et al. Brains of rhesus monkeys display Aβ deposits and glial pathology while lacking Aβ dimers and other Alzheimer's pathologies. Aging Cell. 2019;18:e12978 pubmed publisher
Libard S, Alafuzoff I. Alzheimer's disease neuropathological change and loss of matrix/neuropil in patients with idiopathic Normal Pressure Hydrocephalus, a model of Alzheimer's disease. Acta Neuropathol Commun. 2019;7:3 pubmed publisher
Sartori M, Mendes T, Desai S, Lasorsa A, Herledan A, Malmanche N, et al. BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr348 phosphorylation. Acta Neuropathol. 2019;: pubmed publisher
Chang H, Di T, Wang Y, Zeng X, Li G, Wan Q, et al. Seipin deletion in mice enhances phosphorylation and aggregation of tau protein through reduced neuronal PPARγ and insulin resistance. Neurobiol Dis. 2019;127:350-361 pubmed publisher
Silva M, Ferguson F, Cai Q, Donovan K, Nandi G, Patnaik D, et al. Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models. elife. 2019;8: pubmed publisher
Falcon B, Zivanov J, Zhang W, Murzin A, Garringer H, Vidal R, et al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature. 2019;568:420-423 pubmed publisher
Stejskalova Z, Rohan Z, Rusina R, Tesar A, Kukal J, Kovacs G, et al. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation. BMC Neurol. 2019;19:42 pubmed publisher
Martorell A, Paulson A, Suk H, Abdurrob F, Drummond G, Guan W, et al. Multi-sensory Gamma Stimulation Ameliorates Alzheimer's-Associated Pathology and Improves Cognition. Cell. 2019;177:256-271.e22 pubmed publisher
Mammone T, Chidlow G, Casson R, Wood J. Improved immunohistochemical detection of phosphorylated mitogen-activated protein kinases in the injured rat optic nerve head. Histochem Cell Biol. 2019;151:435-456 pubmed publisher
Upadhyay A, Hosseinibarkooie S, Schneider S, Kaczmarek A, Torres Benito L, Mendoza Ferreira N, et al. Neurocalcin Delta Knockout Impairs Adult Neurogenesis Whereas Half Reduction Is Not Pathological. Front Mol Neurosci. 2019;12:19 pubmed publisher
Pierzynowska K, Podlacha M, Gaffke L, Majkutewicz I, Mantej J, Wegrzyn A, et al. Autophagy-dependent mechanism of genistein-mediated elimination of behavioral and biochemical defects in the rat model of sporadic Alzheimer's disease. Neuropharmacology. 2019;148:332-346 pubmed publisher
Beckelman B, Yang W, Kasica N, Zimmermann H, Zhou X, Keene C, et al. Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer's disease model mice. J Clin Invest. 2019;129:820-833 pubmed publisher
Paonessa F, Evans L, Solanki R, Larrieu D, Wray S, Hardy J, et al. Microtubules Deform the Nuclear Membrane and Disrupt Nucleocytoplasmic Transport in Tau-Mediated Frontotemporal Dementia. Cell Rep. 2019;26:582-593.e5 pubmed publisher
Merezhko M, Brunello C, Yan X, Vihinen H, Jokitalo E, Uronen R, et al. Secretion of Tau via an Unconventional Non-vesicular Mechanism. Cell Rep. 2018;25:2027-2035.e4 pubmed publisher
Thygesen C, Ilkjær L, Kempf S, Hemdrup A, von Linstow C, Babcock A, et al. Diverse Protein Profiles in CNS Myeloid Cells and CNS Tissue From Lipopolysaccharide- and Vehicle-Injected APPSWE/PS1ΔE9 Transgenic Mice Implicate Cathepsin Z in Alzheimer's Disease. Front Cell Neurosci. 2018;12:397 pubmed publisher
Nie S, Tan Y, Zhang Z, Chen G, Xiong J, Hu D, et al. Bilateral Implantation of Shear Stress Modifier in ApoE Knockout Mouse Induces Cognitive Impairment and Tau Abnormalities. Front Aging Neurosci. 2018;10:303 pubmed publisher
Quaranta V, Rainer C, Nielsen S, Raymant M, Ahmed M, Engle D, et al. Macrophage-Derived Granulin Drives Resistance to Immune Checkpoint Inhibition in Metastatic Pancreatic Cancer. Cancer Res. 2018;78:4253-4269 pubmed publisher
Wang C, Najm R, Xu Q, Jeong D, Walker D, Balestra M, et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat Med. 2018;24:647-657 pubmed publisher
Li H, Ren Y, Mao K, Hua F, Yang Y, Wei N, et al. FTO is involved in Alzheimer's disease by targeting TSC1-mTOR-Tau signaling. Biochem Biophys Res Commun. 2018;498:234-239 pubmed publisher
zur Nedden S, Eith R, Schwarzer C, Zanetti L, Seitter H, Fresser F, et al. Protein kinase N1 critically regulates cerebellar development and long-term function. J Clin Invest. 2018;128:2076-2088 pubmed publisher
Hou Y, Lautrup S, Cordonnier S, Wang Y, Croteau D, Zavala E, et al. NAD+ supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. Proc Natl Acad Sci U S A. 2018;115:E1876-E1885 pubmed publisher
Cramer P, Gentzel R, Tanis K, Vardigan J, Wang Y, Connolly B, et al. Aging African green monkeys manifest transcriptional, pathological, and cognitive hallmarks of human Alzheimer's disease. Neurobiol Aging. 2018;64:92-106 pubmed publisher
Brici D, G tz J, Nisbet R. A Novel Antibody Targeting Tau Phosphorylated at Serine 235 Detects Neurofibrillary Tangles. J Alzheimers Dis. 2018;61:899-905 pubmed publisher
Yu J, Chen M, Huang H, Zhu J, Song H, Zhu J, et al. Dynamic m6A modification regulates local translation of mRNA in axons. Nucleic Acids Res. 2018;46:1412-1423 pubmed publisher
Ercan E, Eid S, Weber C, Kowalski A, Bichmann M, Behrendt A, et al. A validated antibody panel for the characterization of tau post-translational modifications. Mol Neurodegener. 2017;12:87 pubmed publisher
Gasparotto J, Girardi C, Somensi N, Ribeiro C, Moreira J, Michels M, et al. Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment. J Biol Chem. 2018;293:226-244 pubmed publisher
Yadirgi G, Stickings P, Rajagopal S, Liu Y, Sesardic D. Immuno-detection of cleaved SNAP-25 from differentiated mouse embryonic stem cells provides a sensitive assay for determination of botulinum A toxin and antitoxin potency. J Immunol Methods. 2017;451:90-99 pubmed publisher
Qu X, Yuan F, Corona C, Pasini S, Pero M, Gundersen G, et al. Stabilization of dynamic microtubules by mDia1 drives Tau-dependent Aβ1-42 synaptotoxicity. J Cell Biol. 2017;216:3161-3178 pubmed publisher
Tseng J, Xie L, Song S, Xie Y, Allen L, Ajit D, et al. The Deacetylase HDAC6 Mediates Endogenous Neuritic Tau Pathology. Cell Rep. 2017;20:2169-2183 pubmed publisher
Siedlak S, Jiang Y, Huntley M, Wang L, Gao J, Xie F, et al. TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease. J Alzheimers Dis. 2017;58:1027-1033 pubmed publisher
Wang H, Lee K, Pei Z, Khan A, Bakshi K, Burns L. PTI-125 binds and reverses an altered conformation of filamin A to reduce Alzheimer's disease pathogenesis. Neurobiol Aging. 2017;55:99-114 pubmed publisher
Nobuhara C, DeVos S, Commins C, Wegmann S, Moore B, Roe A, et al. Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in Vitro. Am J Pathol. 2017;187:1399-1412 pubmed publisher
Li J, Barrero C, Merali S, Pratico D. Five lipoxygenase hypomethylation mediates the homocysteine effect on Alzheimer's phenotype. Sci Rep. 2017;7:46002 pubmed publisher
Chen S, Sun J, Zhao G, Guo A, Chen Y, Fu R, et al. Liraglutide Improves Water Maze Learning and Memory Performance While Reduces Hyperphosphorylation of Tau and Neurofilaments in APP/PS1/Tau Triple Transgenic Mice. Neurochem Res. 2017;42:2326-2335 pubmed publisher
Maphis N, Jiang S, Binder J, Wright C, Gopalan B, Lamb B, et al. Whole Genome Expression Analysis in a Mouse Model of Tauopathy Identifies MECP2 as a Possible Regulator of Tau Pathology. Front Mol Neurosci. 2017;10:69 pubmed publisher
Wu X, Kosaraju J, Tam K. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3? activity in SH-SY5Y cells. Eur J Pharm Sci. 2017;110:101-108 pubmed publisher
Zhang Z, Obianyo O, Dall E, Du Y, Fu H, Liu X, et al. Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease. Nat Commun. 2017;8:14740 pubmed publisher
Loss O, Stephenson F. Developmental changes in trak-mediated mitochondrial transport in neurons. Mol Cell Neurosci. 2017;80:134-147 pubmed publisher
Trzeciakiewicz H, Tseng J, Wander C, Madden V, Tripathy A, Yuan C, et al. A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy. Sci Rep. 2017;7:44102 pubmed publisher
Li Y, Li Z, Jin T, Wang Z, Zhao P. Tau Pathology Promotes the Reorganization of the Extracellular Matrix and Inhibits the Formation of Perineuronal Nets by Regulating the Expression and the Distribution of Hyaluronic Acid Synthases. J Alzheimers Dis. 2017;57:395-409 pubmed publisher
He X, Li Z, Rizak J, Wu S, Wang Z, He R, et al. Resveratrol Attenuates Formaldehyde Induced Hyperphosphorylation of Tau Protein and Cytotoxicity in N2a Cells. Front Neurosci. 2016;10:598 pubmed publisher
Bodea L, Evans H, Van der Jeugd A, Ittner L, Delerue F, Kril J, et al. Accelerated aging exacerbates a pre-existing pathology in a tau transgenic mouse model. Aging Cell. 2017;16:377-386 pubmed publisher
Fu H, Rodriguez G, Herman M, Emrani S, Nahmani E, Barrett G, et al. Tau Pathology Induces Excitatory Neuron Loss, Grid Cell Dysfunction, and Spatial Memory Deficits Reminiscent of Early Alzheimer's Disease. Neuron. 2017;93:533-541.e5 pubmed publisher
Shin S, Kim J, Lee J, Son Y, Lee M, Kim H, et al. Docosahexaenoic acid-mediated protein aggregates may reduce proteasome activity and delay myotube degradation during muscle atrophy in vitro. Exp Mol Med. 2017;49:e287 pubmed publisher
Wang P, Joberty G, Buist A, Vanoosthuyse A, Stancu I, Vasconcelos B, et al. Tau interactome mapping based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo. Acta Neuropathol. 2017;133:731-749 pubmed publisher
Takahashi H, Klein Z, Bhagat S, Kaufman A, Kostylev M, Ikezu T, et al. Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network. Acta Neuropathol. 2017;133:785-807 pubmed publisher
Rodriguez Callejas J, Fuchs E, Perez Cruz C. Evidence of Tau Hyperphosphorylation and Dystrophic Microglia in the Common Marmoset. Front Aging Neurosci. 2016;8:315 pubmed publisher
Yoshida K, Hata Y, Kinoshita K, Takashima S, Tanaka K, Nishida N. Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series. Acta Neuropathol. 2017;133:809-823 pubmed publisher
Stepanov V, Svedberg M, Jia Z, Krasikova R, Lemoine L, Okamura N, et al. Development of [11C]/[3H]THK-5351 - A potential novel carbon-11 tau imaging PET radioligand. Nucl Med Biol. 2017;46:50-53 pubmed publisher
van der Zee J, Gijselinck I, Van Mossevelde S, Perrone F, Dillen L, Heeman B, et al. TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis. Hum Mutat. 2017;38:297-309 pubmed publisher
Hwang A, Trzeciakiewicz H, Friedmann D, Yuan C, Marmorstein R, Lee V, et al. Conserved Lysine Acetylation within the Microtubule-Binding Domain Regulates MAP2/Tau Family Members. PLoS ONE. 2016;11:e0168913 pubmed publisher
Wang A, Jensen E, Rexach J, Vinters H, Hsieh Wilson L. Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration. Proc Natl Acad Sci U S A. 2016;113:15120-15125 pubmed publisher
Atasoy İ, Dursun E, Gezen Ak D, Metin Armağan D, Ozturk M, Yilmazer S. Both secreted and the cellular levels of BDNF attenuated due to tau hyperphosphorylation in primary cultures of cortical neurons. J Chem Neuroanat. 2017;80:19-26 pubmed publisher
Lipton S, Rezaie T, Nutter A, Lopez K, Parker J, Kosaka K, et al. Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2/ARE pathway in Alzheimer's disease models. Cell Death Dis. 2016;7:e2499 pubmed publisher
Shively S, Edgerton S, Iacono D, Purohit D, Qu B, Haroutunian V, et al. Localized cortical chronic traumatic encephalopathy pathology after single, severe axonal injury in human brain. Acta Neuropathol. 2017;133:353-366 pubmed publisher
LÃ³pez de Maturana R, Lang V, Zubiarrain A, Sousa A, VÃ¡zquez N, Gorostidi A, et al. Mutations in LRRK2 impair NF-ÎºB pathway in iPSC-derived neurons. J Neuroinflammation. 2016;13:295 pubmed
Yang S, Lee D, Shin J, Lee S, Baek S, Kim J, et al. Nec-1 alleviates cognitive impairment with reduction of Aβ and tau abnormalities in APP/PS1 mice. EMBO Mol Med. 2017;9:61-77 pubmed publisher
Noy S, Krawitz S, Del Bigio M. Chronic Traumatic Encephalopathy-Like Abnormalities in a Routine Neuropathology Service. J Neuropathol Exp Neurol. 2016;75:1145-1154 pubmed publisher
Dengler Crish C, Smith M, Wilson G. Early Evidence of Low Bone Density and Decreased Serotonergic Synthesis in the Dorsal Raphe of a Tauopathy Model of Alzheimer's Disease. J Alzheimers Dis. 2017;55:1605-1619 pubmed publisher
Ling H, Kovacs G, Vonsattel J, DAVEY K, Mok K, Hardy J, et al. Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology. Brain. 2016;139:3237-3252 pubmed
Jan A, Jansonius B, Delaidelli A, Somasekharan S, Bhanshali F, Vandal M, et al. eEF2K inhibition blocks Aβ42 neurotoxicity by promoting an NRF2 antioxidant response. Acta Neuropathol. 2017;133:101-119 pubmed publisher
Van Hummel A, Bi M, Ippati S, van der Hoven J, Volkerling A, Lee W, et al. No Overt Deficits in Aged Tau-Deficient C57Bl/6.Mapttm1(EGFP)Kit GFP Knockin Mice. PLoS ONE. 2016;11:e0163236 pubmed publisher
Sun W, Lee S, Huang X, Liu S, Inayathullah M, Kim K, et al. Attenuation of synaptic toxicity and MARK4/PAR1-mediated Tau phosphorylation by methylene blue for Alzheimer's disease treatment. Sci Rep. 2016;6:34784 pubmed publisher
Sadick J, Boutin M, Hoffman Kim D, Darling E. Protein characterization of intracellular target-sorted, formalin-fixed cell subpopulations. Sci Rep. 2016;6:33999 pubmed publisher
Soo Hoo L, Banna C, Radeke C, Sharma N, Albertolle M, Low S, et al. The SNARE Protein Syntaxin 3 Confers Specificity for Polarized Axonal Trafficking in Neurons. PLoS ONE. 2016;11:e0163671 pubmed publisher
Mansuroglu Z, Benhelli Mokrani H, Marcato V, Sultan A, Violet M, Chauderlier A, et al. Loss of Tau protein affects the structure, transcription and repair of neuronal pericentromeric heterochromatin. Sci Rep. 2016;6:33047 pubmed publisher
Qin Y, Liu Y, Hao W, Decker Y, Tomic I, Menger M, et al. Stimulation of TLR4 Attenuates Alzheimer's Disease-Related Symptoms and Pathology in Tau-Transgenic Mice. J Immunol. 2016;197:3281-3292 pubmed
Yoshitake J, Soeda Y, Ida T, Sumioka A, Yoshikawa M, Matsushita K, et al. Modification of Tau by 8-Nitroguanosine 3',5'-Cyclic Monophosphate (8-Nitro-cGMP): EFFECTS OF NITRIC OXIDE-LINKED CHEMICAL MODIFICATION ON TAU AGGREGATION. J Biol Chem. 2016;291:22714-22720 pubmed
Schmidt A, Kannan P, Chougnet C, Danzer S, Miller L, Jobe A, et al. Intra-amniotic LPS causes acute neuroinflammation in preterm rhesus macaques. J Neuroinflammation. 2016;13:238 pubmed publisher
Begum A, Aguilar J, Elias L, Hong Y. Silver nanoparticles exhibit coating and dose-dependent neurotoxicity in glutamatergic neurons derived from human embryonic stem cells. Neurotoxicology. 2016;57:45-53 pubmed publisher
Zimova I, Brezovakova V, Hromádka T, Weisová P, Cubinkova V, Valachova B, et al. Human Truncated Tau Induces Mature Neurofibrillary Pathology in a Mouse Model of Human Tauopathy. J Alzheimers Dis. 2016;54:831-43 pubmed publisher
Steffen J, Krohn M, Paarmann K, Schwitlick C, BrÃ¼ning T, Marreiros R, et al. Revisiting rodent models: Octodon degus as Alzheimer's disease model?. Acta Neuropathol Commun. 2016;4:91 pubmed publisher
Fujita K, Motoki K, Tagawa K, Chen X, Hama H, Nakajima K, et al. HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer's disease. Sci Rep. 2016;6:31895 pubmed publisher
Dinkins M, Enasko J, Hernandez C, Wang G, Kong J, Helwa I, et al. Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse. J Neurosci. 2016;36:8653-67 pubmed publisher
di Meco A, Li J, Blass B, Abou Gharbia M, Lauretti E, PraticÃ² D. 12/15-Lipoxygenase Inhibition Reverses Cognitive Impairment, Brain Amyloidosis, and Tau Pathology by Stimulating Autophagy in Aged Triple Transgenic Mice. Biol Psychiatry. 2017;81:92-100 pubmed publisher
Salta E, Sierksma A, Vanden Eynden E, De Strooper B. miR-132 loss de-represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain. EMBO Mol Med. 2016;8:1005-18 pubmed publisher
Kim H, Lee K, Kim A, Choi M, Choi K, Kang M, et al. A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition. Dis Model Mech. 2016;9:839-48 pubmed publisher
Zhao Y, Song J, Ma X, Zhang B, Li D, Pang H. Rosiglitazone ameliorates diffuse axonal injury by reducing loss of tau and up-regulating caveolin-1 expression. Neural Regen Res. 2016;11:944-50 pubmed publisher
Lee S, Le Pichon C, Adolfsson O, Gafner V, Pihlgren M, Lin H, et al. Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial Engagement. Cell Rep. 2016;16:1690-1700 pubmed publisher
Ayyadevara S, Balasubramaniam M, Parcon P, Barger S, Griffin W, Alla R, et al. Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer's hippocampus from normal controls. Aging Cell. 2016;15:924-39 pubmed publisher
Cheng Y, Huang C, Lee Y, Tien L, Ku W, Chien R, et al. Knocking down of heat-shock protein 27 directs differentiation of functional glutamatergic neurons from placenta-derived multipotent cells. Sci Rep. 2016;6:30314 pubmed publisher
CARTAGENA C, Mountney A, Hwang H, Swiercz A, Rammelkamp Z, Boutte A, et al. Subacute Changes in Cleavage Processing of Amyloid Precursor Protein and Tau following Penetrating Traumatic Brain Injury. PLoS ONE. 2016;11:e0158576 pubmed publisher
Pajares M, Jiménez Moreno N, García Yagüe A, Escoll M, De Ceballos M, Van Leuven F, et al. Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes. Autophagy. 2016;12:1902-1916 pubmed
Manassero G, Guglielmotto M, Zamfir R, Borghi R, Colombo L, Salmona M, et al. Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein. Aging Cell. 2016;15:914-23 pubmed publisher
Chen X, Wagener J, Ghribi O, Geiger J. Role of Endolysosomes in Skeletal Muscle Pathology Observed in a Cholesterol-Fed Rabbit Model of Alzheimer's Disease. Front Aging Neurosci. 2016;8:129 pubmed publisher
Li T, Braunstein K, Zhang J, Lau A, Sibener L, Deeble C, et al. The neuritic plaque facilitates pathological conversion of tau in an Alzheimer's disease mouse model. Nat Commun. 2016;7:12082 pubmed publisher
Gelpi E, Hoftberger R, Graus F, Ling H, Holton J, Dawson T, et al. Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol. 2016;132:531-43 pubmed publisher
Sohn P, Tracy T, Son H, Zhou Y, Leite R, Miller B, et al. Acetylated tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment. Mol Neurodegener. 2016;11:47 pubmed publisher
Takeda S, Commins C, DeVos S, Nobuhara C, Wegmann S, Roe A, et al. Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients. Ann Neurol. 2016;80:355-67 pubmed publisher
Adams S, Tilton K, Kozubek J, Seshadri S, Delalle I. Subcellular Changes in Bridging Integrator 1 Protein Expression in the Cerebral Cortex During the Progression of Alzheimer Disease Pathology. J Neuropathol Exp Neurol. 2016;75:779-790 pubmed
FernÃ¡ndez Nogales M, Santos Galindo M, MerchÃ¡n Rubira J, Hoozemans J, RÃ¡bano A, Ferrer I, et al. Tau-positive nuclear indentations in P301S tauopathy mice. Brain Pathol. 2017;27:314-322 pubmed publisher
Herring A, Münster Y, Akkaya T, Moghaddam S, Deinsberger K, Meyer J, et al. Kallikrein-8 inhibition attenuates Alzheimer's disease pathology in mice. Alzheimers Dement. 2016;12:1273-1287 pubmed publisher
Herring A, MÃ¼nster Y, Metzdorf J, Bolczek B, KrÃ¼ssel S, Krieter D, et al. Late running is not too late against Alzheimer's pathology. Neurobiol Dis. 2016;94:44-54 pubmed publisher
Shively S, Horkayne Szakaly I, Jones R, Kelly J, Armstrong R, Perl D. Characterisation of interface astroglial scarring in the human brain after blast exposure: a post-mortem case series. Lancet Neurol. 2016;15:944-953 pubmed publisher
Ando K, Tomimura K, Sazdovitch V, Suain V, Yilmaz Z, Authelet M, et al. Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease. Neurobiol Dis. 2016;94:32-43 pubmed publisher
Wang H, Wang R, Carrera I, Xu S, Lakshmana M. TFEB Overexpression in the P301S Model of Tauopathy Mitigates Increased PHF1 Levels and Lipofuscin Puncta and Rescues Memory Deficits. Eneuro. 2016;3: pubmed publisher
Makioka K, Yamazaki T, Takatama M, Ikeda M, Murayama S, Okamoto K, et al. Immunolocalization of Tom1 in relation to protein degradation systems in Alzheimer's disease. J Neurol Sci. 2016;365:101-7 pubmed publisher
Geiszler P, Barron M, Pardon M. Impaired burrowing is the most prominent behavioral deficit of aging htau mice. Neuroscience. 2016;329:98-111 pubmed publisher
Dourlen P, Fernandez Gomez F, Dupont C, Grenier Boley B, Bellenguez C, Obriot H, et al. Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology. Mol Psychiatry. 2017;22:874-883 pubmed publisher
Kii I, Sumida Y, Goto T, Sonamoto R, Okuno Y, Yoshida S, et al. Selective inhibition of the kinase DYRK1A by targeting its folding process. Nat Commun. 2016;7:11391 pubmed publisher
Bouvier D, Jones E, Quesseveur G, Davoli M, A Ferreira T, Quirion R, et al. High Resolution Dissection of Reactive Glial Nets in Alzheimer's Disease. Sci Rep. 2016;6:24544 pubmed publisher
Yetman M, Fowler S, Jankowsky J. Humanized Tau Mice with Regionalized Amyloid Exhibit Behavioral Deficits but No Pathological Interaction. PLoS ONE. 2016;11:e0153724 pubmed publisher
Yan X, Nykänen N, Brunello C, Haapasalo A, Hiltunen M, Uronen R, et al. FRMD4A-cytohesin signaling modulates the cellular release of tau. J Cell Sci. 2016;129:2003-15 pubmed publisher
Kawakami I, Kobayashi Z, Arai T, Yokota O, Nonaka T, Aoki N, et al. Chorea as a clinical feature of the basophilic inclusion body disease subtype of fused-in-sarcoma-associated frontotemporal lobar degeneration. Acta Neuropathol Commun. 2016;4:36 pubmed publisher
Krishnan V, White Z, McMahon C, Hodgetts S, Fitzgerald M, Shavlakadze T, et al. A Neurogenic Perspective of Sarcopenia: Time Course Study of Sciatic Nerves From Aging Mice. J Neuropathol Exp Neurol. 2016;75:464-78 pubmed publisher
Polanco J, Scicluna B, Hill A, Götz J. Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner. J Biol Chem. 2016;291:12445-66 pubmed publisher
Yadav P, Selvaraj B, Bender F, Behringer M, Moradi M, Sivadasan R, et al. Neurofilament depletion improves microtubule dynamics via modulation of Stat3/stathmin signaling. Acta Neuropathol. 2016;132:93-110 pubmed publisher
Connell J, Allison R, Reid E. Quantitative Gait Analysis Using a Motorized Treadmill System Sensitively Detects Motor Abnormalities in Mice Expressing ATPase Defective Spastin. PLoS ONE. 2016;11:e0152413 pubmed publisher
Griñan Ferré C, Sarroca S, Ivanova A, Puigoriol Illamola D, Aguado F, Camins A, et al. Epigenetic mechanisms underlying cognitive impairment and Alzheimer disease hallmarks in 5XFAD mice. Aging (Albany NY). 2016;8:664-84 pubmed publisher
Chanu S, Sarkar S. Targeted Downregulation of dMyc Suppresses Pathogenesis of Human Neuronal Tauopathies in Drosophila by Limiting Heterochromatin Relaxation and Tau Hyperphosphorylation. Mol Neurobiol. 2017;54:2706-2719 pubmed publisher
Ortuno D, Carlisle H, Miller S. Does inactivation of USP14 enhance degradation of proteasomal substrates that are associated with neurodegenerative diseases?. F1000Res. 2016;5:137 pubmed publisher
Merlini M, Wanner D, Nitsch R. Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy. Acta Neuropathol. 2016;131:737-52 pubmed publisher
Choi W, de Poot S, Lee J, Kim J, Han D, Kim Y, et al. Open-gate mutants of the mammalian proteasome show enhanced ubiquitin-conjugate degradation. Nat Commun. 2016;7:10963 pubmed publisher
Gorsky M, Burnouf S, Dols J, Mandelkow E, Partridge L. Acetylation mimic of lysine 280 exacerbates human Tau neurotoxicity in vivo. Sci Rep. 2016;6:22685 pubmed publisher
Piras A, Collin L, GrÃ¼ninger F, Graff C, RÃ¶nnbÃ¤ck A. Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol Commun. 2016;4:22 pubmed publisher
Maeda S, Djukic B, Taneja P, Yu G, Lo I, Davis A, et al. Expression of A152T human tau causes age-dependent neuronal dysfunction and loss in transgenic mice. EMBO Rep. 2016;17:530-51 pubmed publisher
Perez S, Sherwood C, Cranfield M, Erwin J, Mudakikwa A, Hof P, et al. Early Alzheimer's disease-type pathology in the frontal cortex of wild mountain gorillas (Gorilla beringei beringei). Neurobiol Aging. 2016;39:195-201 pubmed publisher
Guillot F, Kemppainen S, Lavasseur G, Miettinen P, Laroche S, Tanila H, et al. Brain-Specific Basal and Novelty-Induced Alternations in PI3K-Akt and MAPK/ERK Signaling in a Middle-Aged AÎ²PP/PS1 Mouse Model of Alzheimer's Disease. J Alzheimers Dis. 2016;51:1157-73 pubmed publisher
Urnukhsaikhan E, Cho H, Mishig Ochir T, Seo Y, Park J. Pulsed electromagnetic fields promote survival and neuronal differentiation of human BM-MSCs. Life Sci. 2016;151:130-138 pubmed publisher
Mariano M, Hartmann R, Engel M. Systematic diversification of benzylidene heterocycles yields novel inhibitor scaffolds selective for Dyrk1A, Clk1 and CK2. Eur J Med Chem. 2016;112:209-216 pubmed publisher
Stern R, Tripodis Y, Baugh C, Fritts N, Martin B, Chaisson C, et al. Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy. J Alzheimers Dis. 2016;51:1099-109 pubmed publisher
Collazos Castro J, GarcÃa Rama C, Alves Sampaio A. Glial progenitor cell migration promotes CNS axon growth on functionalized electroconducting microfibers. Acta Biomater. 2016;35:42-56 pubmed publisher
Garcia RatÃ©s S, Morrill P, Tu H, Pottiez G, Badin A, Tormo Garcia C, et al. (I) Pharmacological profiling of a novel modulator of the Î±7 nicotinic receptor: Blockade of a toxic acetylcholinesterase-derived peptide increased in Alzheimer brains. Neuropharmacology. 2016;105:487-499 pubmed publisher
Winston C, NoÃ«l A, Neustadtl A, Parsadanian M, Barton D, Chellappa D, et al. Dendritic Spine Loss and Chronic White Matter Inflammation in a Mouse Model of Highly Repetitive Head Trauma. Am J Pathol. 2016;186:552-67 pubmed publisher
Ahn M, Kalume F, Pitstick R, Oehler A, Carlson G, Dearmond S. Brain Aggregates: An Effective In Vitro Cell Culture System Modeling Neurodegenerative Diseases. J Neuropathol Exp Neurol. 2016;75:256-62 pubmed publisher
Van der Jeugd A, Vermaercke B, Halliday G, Staufenbiel M, GÃ¶tz J. Impulsivity, decreased social exploration, and executive dysfunction in a mouse model of frontotemporal dementia. Neurobiol Learn Mem. 2016;130:34-43 pubmed publisher
Gentry E, Henderson B, Arrant A, Gearing M, Feng Y, Riddle N, et al. Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration. J Neurosci. 2016;36:1316-23 pubmed publisher
Jiang T, Zhang Y, Chen Q, Gao Q, Zhu X, Zhou J, et al. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice. Neuropharmacology. 2016;105:196-206 pubmed publisher
Peng Y, Kim M, Hullinger R, O Riordan K, Burger C, Pehar M, et al. Improved proteostasis in the secretory pathway rescues Alzheimer's disease in the mouse. Brain. 2016;139:937-52 pubmed publisher
Piedrahita D, Castro Álvarez J, Boudreau R, Villegas Lanau A, Kosik K, Gallego Gómez J, et al. Î²-Secretase 1's Targeting Reduces Hyperphosphorilated Tau, Implying Autophagy Actors in 3xTg-AD Mice. Front Cell Neurosci. 2015;9:498 pubmed publisher
El Khoury N, Gratuze M, Petry F, Papon M, Julien C, Marcouiller F, et al. Hypothermia mediates age-dependent increase of tau phosphorylation in db/db mice. Neurobiol Dis. 2016;88:55-65 pubmed publisher
Liu H, Shi H, Huang F, Peterson K, Wu H, Lan Y, et al. Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway. Sci Rep. 2016;6:19137 pubmed publisher
Rosenberger A, Morrema T, Gerritsen W, van Haastert E, Snkhchyan H, Hilhorst R, et al. Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer's disease pathology. J Neuroinflammation. 2016;13:4 pubmed publisher
Sandoval Hernández A, Buitrago L, Moreno H, Cardona Gómez G, Arboleda G. Role of Liver X Receptor in AD Pathophysiology. PLoS ONE. 2015;10:e0145467 pubmed publisher
Platt T, Beckett T, Kohler K, Niedowicz D, Murphy M. Obesity, diabetes, and leptin resistance promote tau pathology in a mouse model of disease. Neuroscience. 2016;315:162-74 pubmed publisher
Myeku N, CLELLAND C, Emrani S, Kukushkin N, Yu W, Goldberg A, et al. Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling. Nat Med. 2016;22:46-53 pubmed publisher
Kailainathan S, Piers T, Yi J, Choi S, Fahey M, Borger E, et al. Activation of a synapse weakening pathway by human Val66 but not Met66 pro-brain-derived neurotrophic factor (proBDNF). Pharmacol Res. 2016;104:97-107 pubmed publisher
Nagamine S, Yamazaki T, Makioka K, Fujita Y, Ikeda M, Takatama M, et al. Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains. Neuropathology. 2016;36:333-45 pubmed publisher
MÃ¼ller Schiffmann A, Herring A, Abdel Hafiz L, Chepkova A, SchÃ¤ble S, Wedel D, et al. Amyloid-Î² dimers in the absence of plaque pathology impair learning and synaptic plasticity. Brain. 2016;139:509-25 pubmed publisher
Chambers J, Tokuda T, Uchida K, Ishii R, Tatebe H, Takahashi E, et al. The domestic cat as a natural animal model of Alzheimer's disease. Acta Neuropathol Commun. 2015;3:78 pubmed publisher
Schwab A, Ebert A. Neurite Aggregation and Calcium Dysfunction in iPSC-Derived Sensory Neurons with Parkinson's Disease-Related LRRK2 G2019S Mutation. Stem Cell Reports. 2015;5:1039-1052 pubmed publisher
Watanabe K, Uemura K, Asada M, Maesako M, Akiyama H, Shimohama S, et al. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease. Mol Brain. 2015;8:82 pubmed publisher
Gyoneva S, Kim D, Katsumoto A, Kokiko Cochran O, Lamb B, Ransohoff R. Ccr2 deletion dissociates cavity size and tau pathology after mild traumatic brain injury. J Neuroinflammation. 2015;12:228 pubmed publisher
Hromadkova L, Kolarova M, Jankovicova B, Bartos A, Ricny J, Bilkova Z, et al. Identification and characterization of natural antibodies against tau protein in an intravenous immunoglobulin product. J Neuroimmunol. 2015;289:121-9 pubmed publisher
Pamphlett R, Kum Jew S. Locus ceruleus neurons in people with autism contain no histochemically-detectable mercury. Biometals. 2016;29:171-5 pubmed publisher
Elahi M, Motoi Y, Matsumoto S, Hasan Z, Ishiguro K, Hattori N. Short-term treadmill exercise increased tau insolubility and neuroinflammation in tauopathy model mice. Neurosci Lett. 2016;610:207-12 pubmed publisher
Puvenna V, Engeler M, Banjara M, Brennan C, Schreiber P, Dadas A, et al. Is phosphorylated tau unique to chronic traumatic encephalopathy? Phosphorylated tau in epileptic brain and chronic traumatic encephalopathy. Brain Res. 2016;1630:225-40 pubmed publisher
Grant N, Coates P, Woods Y, Bray S, Morrice N, Hastie C, et al. Phosphorylation of a splice variant of collapsin response mediator protein 2 in the nucleus of tumour cells links cyclin dependent kinase-5 to oncogenesis. BMC Cancer. 2015;15:885 pubmed publisher
Sabogal GuÃ¡queta A, Osorio E, Cardona GÃ³mez G. Linalool reverses neuropathological and behavioral impairments in old triple transgenic Alzheimer's mice. Neuropharmacology. 2016;102:111-20 pubmed publisher
Taniguchi Watanabe S, Arai T, Kametani F, Nonaka T, Masuda Suzukake M, Tarutani A, et al. Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau. Acta Neuropathol. 2016;131:267-280 pubmed publisher
Wang Y, Zhang Y, Hu W, Xie S, Gong C, Iqbal K, et al. Rapid alteration of protein phosphorylation during postmortem: implication in the study of protein phosphorylation. Sci Rep. 2015;5:15709 pubmed publisher
Chauhan S, Ahmed Z, Bradfute S, Arko Mensah J, Mandell M, Won Choi S, et al. Pharmaceutical screen identifies novel target processes for activation of autophagy with a broad translational potential. Nat Commun. 2015;6:8620 pubmed publisher
Yamada K, Patel T, HochgrÃ¤fe K, Mahan T, Jiang H, Stewart F, et al. Analysis of in vivo turnover of tau in a mouse model of tauopathy. Mol Neurodegener. 2015;10:55 pubmed publisher
Nishikawa T, Takahashi T, Nakamori M, Hosomi N, Maruyama H, Miyazaki Y, et al. The identification of raft-derived tau-associated vesicles that are incorporated into immature tangles and paired helical filaments. Neuropathol Appl Neurobiol. 2016;42:639-653 pubmed publisher
Takeda S, Wegmann S, Cho H, DeVos S, Commins C, Roe A, et al. Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer's disease brain. Nat Commun. 2015;6:8490 pubmed publisher
Radford H, Moreno J, Verity N, Halliday M, Mallucci G. PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia. Acta Neuropathol. 2015;130:633-42 pubmed publisher
Wagner J, Krauss S, Shi S, Ryazanov S, Steffen J, Miklitz C, et al. Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies. Acta Neuropathol. 2015;130:619-31 pubmed publisher
Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci. 2015;18:1584-93 pubmed publisher
Watamura N, Toba J, Yoshii A, Nikkuni M, Ohshima T. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment. J Neurosci Res. 2016;94:15-26 pubmed publisher
Min S, Chen X, Tracy T, Li Y, Zhou Y, Wang C, et al. Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits. Nat Med. 2015;21:1154-62 pubmed publisher
Violet M, Chauderlier A, Delattre L, Tardivel M, Chouala M, Sultan A, et al. Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo. Neurobiol Dis. 2015;82:540-551 pubmed publisher
Smith P, Hernandez Rapp J, Jolivette F, Lecours C, Bisht K, Goupil C, et al. miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo. Hum Mol Genet. 2015;24:6721-35 pubmed publisher
Richter M, Mewes A, Fritsch M, KrÃ¼gel U, Hoffmann R, Singer D. Doubly Phosphorylated Peptide Vaccines to Protect Transgenic P301S Mice against Alzheimer's Disease Like Tau Aggregation. Vaccines (Basel). 2014;2:601-23 pubmed publisher
Henstridge C, Jackson R, Kim J, Herrmann A, Wright A, Harris S, et al. Post-mortem brain analyses of the Lothian Birth Cohort 1936: extending lifetime cognitive and brain phenotyping to the level of the synapse. Acta Neuropathol Commun. 2015;3:53 pubmed publisher
Montine T, Monsell S, Beach T, Bigio E, Bu Y, Cairns N, et al. Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease. Alzheimers Dement. 2016;12:164-169 pubmed publisher
Lee I, Jung K, Kim I, Lee H, Kim M, Yun S, et al. Human neural stem cells alleviate Alzheimer-like pathology in a mouse model. Mol Neurodegener. 2015;10:38 pubmed publisher
Du L, Chang L, Ardiles A, Tapia Rojas C, Araya J, Inestrosa N, et al. Alzheimer's Disease-Related Protein Expression in the Retina of Octodon degus. PLoS ONE. 2015;10:e0135499 pubmed publisher
Smolek T, Madari A, Farbáková J, Kandrac O, Jadhav S, Cente M, et al. Tau hyperphosphorylation in synaptosomes and neuroinflammation are associated with canine cognitive impairment. J Comp Neurol. 2016;524:874-95 pubmed publisher
RÃ¡bano A, Cuadros R, Merino SerrÃ¡is P, Rodal I, Benavides Piccione R, GÃ³mez E, et al. Protocols for Monitoring the Development of Tau Pathology in Alzheimer's Disease. Methods Mol Biol. 2016;1303:143-60 pubmed publisher
Ohnishi T, Yanazawa M, Sasahara T, Kitamura Y, Hiroaki H, Fukazawa Y, et al. Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly. Proc Natl Acad Sci U S A. 2015;112:E4465-74 pubmed publisher
Lauretti E, PraticÃ² D. Glucose deprivation increases tau phosphorylation via P38 mitogen-activated protein kinase. Aging Cell. 2015;14:1067-74 pubmed publisher
de Paula C, Santiago F, de Oliveira A, Oliveira F, Almeida M, Carrettiero D. The Co-chaperone BAG2 Mediates Cold-Induced Accumulation of Phosphorylated Tau in SH-SY5Y Cells. Cell Mol Neurobiol. 2016;36:593-602 pubmed publisher
RÃ¼ben K, Wurzlbauer A, Walte A, Sippl W, Bracher F, Becker W. Selectivity Profiling and Biological Activity of Novel Î²-Carbolines as Potent and Selective DYRK1 Kinase Inhibitors. PLoS ONE. 2015;10:e0132453 pubmed publisher
Zeineh M, Chen Y, Kitzler H, Hammond R, Vogel H, Rutt B. Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease. Neurobiol Aging. 2015;36:2483-500 pubmed publisher
Kim J, Kim S, Lee Y. Fas-associated factor 1 promotes in neurofibrillary tangle-mediated cell death of basal forebrain cholinergic neurons in P301L transgenic mice. Neuroreport. 2015;26:767-72 pubmed publisher
Ziskin J, Greicius M, Zhu W, Okumu A, Adams C, Plowey E. Neuropathologic analysis of Tyr69His TTR variant meningovascular amyloidosis with dementia. Acta Neuropathol Commun. 2015;3:43 pubmed publisher
Hamm M, Bailey R, Shaw G, Yen S, Lewis J, Giasson B. Physiologically relevant factors influence tau phosphorylation by leucine-rich repeat kinase 2. J Neurosci Res. 2015;93:1567-80 pubmed publisher
Sun L, Ban T, Liu C, Chen Q, Wang X, Yan M, et al. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation. J Neurochem. 2015;134:1139-51 pubmed publisher
Tan X, Xue Y, Ma T, Wang X, Li J, Lan L, et al. Partial eNOS deficiency causes spontaneous thrombotic cerebral infarction, amyloid angiopathy and cognitive impairment. Mol Neurodegener. 2015;10:24 pubmed publisher
Di Meco A, Joshi Y, Lauretti E, PraticÃ² D. Maternal dexamethasone exposure ameliorates cognition and tau pathology in the offspring of triple transgenic AD mice. Mol Psychiatry. 2016;21:403-10 pubmed publisher
Iacono D, Geraci Erck M, Peng H, Rabin M, Kurlan R. Reduced Number of Pigmented Neurons in the Substantia Nigra of Dystonia Patients? Findings from Extensive Neuropathologic, Immunohistochemistry, and Quantitative Analyses. Tremor Other Hyperkinet Mov (N Y). 2015;5: pubmed publisher
Sheik Mohideen S, Yamasaki Y, Omata Y, Tsuda L, Yoshiike Y. Nontoxic singlet oxygen generator as a therapeutic candidate for treating tauopathies. Sci Rep. 2015;5:10821 pubmed publisher
Petrov D, Pedrós I, Artiach G, Sureda F, Barroso E, Pallas M, et al. High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents. Biochim Biophys Acta. 2015;1852:1687-99 pubmed publisher
Wang D, Kinoshita Y, Kinoshita C, Uo T, Sopher B, Cudaback E, et al. Loss of endophilin-B1 exacerbates Alzheimer's disease pathology. Brain. 2015;138:2005-19 pubmed publisher
De Zio D, Molinari F, Rizza S, Gatta L, Ciotti M, Salvatore A, et al. Apaf1-deficient cortical neurons exhibit defects in axonal outgrowth. Cell Mol Life Sci. 2015;72:4173-91 pubmed publisher
Sankaranarayanan S, Barten D, Vana L, Devidze N, Yang L, Cadelina G, et al. Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models. PLoS ONE. 2015;10:e0125614 pubmed publisher
Loeffler D, Smith L, Klaver A, MartiÄ‡ S. Effects of antibodies to phosphorylated and non-phosphorylated tau on in vitro tau phosphorylation at Serine-199: Preliminary report. Exp Gerontol. 2015;67:15-8 pubmed publisher
Song L, Lu S, Ouyang X, Melchor J, Lee J, Terracina G, et al. Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology. Mol Neurodegener. 2015;10:14 pubmed publisher
Hotokezaka Y, Katayama I, van Leyen K, Nakamura T. GSK-3Î²-dependent downregulation of Î³-taxilin and Î±NAC merge to regulate ER stress responses. Cell Death Dis. 2015;6:e1719 pubmed publisher
Miller N, Feng Z, Edens B, Yang B, Shi H, Sze C, et al. Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy. J Neurosci. 2015;35:6038-50 pubmed publisher
Kan M, Lee J, Wilson J, Everhart A, Brown C, Hoofnagle A, et al. Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease. J Neurosci. 2015;35:5969-82 pubmed publisher
Corbel C, Zhang B, Le Parc A, Baratte B, Colas P, Couturier C, et al. Tamoxifen inhibits CDK5 kinase activity by interacting with p35/p25 and modulates the pattern of tau phosphorylation. Chem Biol. 2015;22:472-482 pubmed publisher
Gassen N, Hartmann J, Zannas A, Kretzschmar A, Zschocke J, Maccarrone G, et al. FKBP51 inhibits GSK3Î² and augments the effects of distinct psychotropic medications. Mol Psychiatry. 2016;21:277-89 pubmed publisher
Sepúlveda Díaz J, Alavi Naini S, Huynh M, Ouidja M, Yanicostas C, Chantepie S, et al. HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology. Brain. 2015;138:1339-54 pubmed publisher
Maphis N, Xu G, Kokiko Cochran O, Jiang S, Cardona A, Ransohoff R, et al. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. Brain. 2015;138:1738-55 pubmed publisher
Erro Aguirre M, Zelaya M, SÃ¡nchez Ruiz de Gordoa J, TuÃ±Ã³n M, Lanciego J. Midbrain catecholaminergic neurons co-express Î±-synuclein and tau in progressive supranuclear palsy. Front Neuroanat. 2015;9:25 pubmed publisher
Takeuchi R, Toyoshima Y, Tada M, Tanaka H, Shimizu H, Shiga A, et al. Globular Glial Mixed Four Repeat Tau and TDP-43 Proteinopathy with Motor Neuron Disease and Frontotemporal Dementia. Brain Pathol. 2016;26:82-94 pubmed publisher
Aubry S, Shin W, Crary J, Lefort R, Qureshi Y, Lefebvre C, et al. Assembly and interrogation of Alzheimer's disease genetic networks reveal novel regulators of progression. PLoS ONE. 2015;10:e0120352 pubmed publisher
Filipcik P, Cente M, Zilka N, Smolek T, Hanes J, Kučerák J, et al. Intraneuronal accumulation of misfolded tau protein induces overexpression of Hsp27 in activated astrocytes. Biochim Biophys Acta. 2015;1852:1219-29 pubmed publisher
Li R, Xu D, Ma T. Lovastatin suppresses the aberrant tau phosphorylation from FTDP-17 mutation and okadaic acid-induction in rat primary neurons. Neuroscience. 2015;294:14-20 pubmed publisher
Hossini A, Megges M, Prigione A, Lichtner B, Toliat M, Wruck W, et al. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks. BMC Genomics. 2015;16:84 pubmed publisher
Tapia Rojas C, Aranguiz F, Varela Nallar L, Inestrosa N. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease. Brain Pathol. 2016;26:62-74 pubmed publisher
Leinenga G, GÃ¶tz J. Scanning ultrasound removes amyloid-Î² and restores memory in an Alzheimer's disease mouse model. Sci Transl Med. 2015;7:278ra33 pubmed publisher
Collins J, King A, Woodhouse A, Kirkcaldie M, Vickers J. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease. Exp Neurol. 2015;267:219-29 pubmed publisher
Garza Manero S, Arias C, BermÃºdez Rattoni F, Vaca L, Zepeda A. Identification of age- and disease-related alterations in circulating miRNAs in a mouse model of Alzheimer's disease. Front Cell Neurosci. 2015;9:53 pubmed publisher
Jay T, Miller C, Cheng P, Graham L, Bemiller S, Broihier M, et al. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. J Exp Med. 2015;212:287-95 pubmed publisher
Falke H, Chaikuad A, Becker A, LoaÃ«c N, Lozach O, Abu Jhaisha S, et al. 10-iodo-11H-indolo[3,2-c]quinoline-6-carboxylic acids are selective inhibitors of DYRK1A. J Med Chem. 2015;58:3131-43 pubmed publisher
Reis R, Hennessy E, Murray C, Griffin Ã, Cunningham C. At the centre of neuronal, synaptic and axonal pathology in murine prion disease: degeneration of neuroanatomically linked thalamic and brainstem nuclei. Neuropathol Appl Neurobiol. 2015;41:780-97 pubmed publisher
Bennett R, Brody D. Array tomography for the detection of non-dilated, injured axons in traumatic brain injury. J Neurosci Methods. 2015;245:25-36 pubmed publisher
Sabogal GuÃ¡queta A, MuÃ±oz Manco J, RamÃrez Pineda J, Lamprea Rodriguez M, Osorio E, Cardona GÃ³mez G. The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice. Neuropharmacology. 2015;93:134-45 pubmed publisher
Porquet D, AndrÃ©s Benito P, GriÃ±Ã¡n FerrÃ© C, Camins A, Ferrer I, Canudas A, et al. Amyloid and tau pathology of familial Alzheimer's disease APP/PS1 mouse model in a senescence phenotype background (SAMP8). Age (Dordr). 2015;37:9747 pubmed publisher
Zhang J, Tan H, Jiang W, Zuo Z. The choice of general anesthetics may not affect neuroinflammation and impairment of learning and memory after surgery in elderly rats. J Neuroimmune Pharmacol. 2015;10:179-89 pubmed publisher
Spilsbury A, Miwa S, Attems J, Saretzki G. The role of telomerase protein TERT in Alzheimer's disease and in tau-related pathology in vitro. J Neurosci. 2015;35:1659-74 pubmed publisher
Apostolova L, Zarow C, Biado K, Hurtz S, Boccardi M, Somme J, et al. Relationship between hippocampal atrophy and neuropathology markers: a 7T MRI validation study of the EADC-ADNI Harmonized Hippocampal Segmentation Protocol. Alzheimers Dement. 2015;11:139-50 pubmed publisher
Tian H, Davidowitz E, Lopez P, He P, Schulz P, Moe J, et al. Isolation and characterization of antibody fragments selective for toxic oligomeric tau. Neurobiol Aging. 2015;36:1342-55 pubmed publisher
Yang Y, Shepherd C, Halliday G. Aneuploidy in Lewy body diseases. Neurobiol Aging. 2015;36:1253-60 pubmed publisher
Petraglia A, Plog B, Dayawansa S, Dashnaw M, Czerniecka K, Walker C, et al. The pathophysiology underlying repetitive mild traumatic brain injury in a novel mouse model of chronic traumatic encephalopathy. Surg Neurol Int. 2014;5:184 pubmed publisher
Maurya S, Mishra J, Abbas S, Bandyopadhyay S. Cypermethrin Stimulates GSK3Î²-Dependent AÎ² and p-tau Proteins and Cognitive Loss in Young Rats: Reduced HB-EGF Signaling and Downstream Neuroinflammation as Critical Regulators. Mol Neurobiol. 2016;53:968-82 pubmed publisher
Postupna N, Keene C, Crane P, Gonzalez Cuyar L, Sonnen J, Hewitt J, et al. Cerebral cortical AÎ²42 and PHF-Ï„ in 325 consecutive brain autopsies stratified by diagnosis, location, and APOE. J Neuropathol Exp Neurol. 2015;74:100-9 pubmed publisher
Serrano F, Tapia Rojas C, Carvajal F, Hancke J, Cerpa W, Inestrosa N. Andrographolide reduces cognitive impairment in young and mature AÎ²PPswe/PS-1 mice. Mol Neurodegener. 2014;9:61 pubmed publisher
Melis V, Zabke C, Stamer K, Magbagbeolu M, Schwab K, Marschall P, et al. Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer's disease and frontotemporal lobar degeneration. Cell Mol Life Sci. 2015;72:2199-222 pubmed publisher
Denton K, Xu C, Li X. Modeling Axonal Phenotypes with Human Pluripotent Stem Cells. Methods Mol Biol. 2016;1353:309-21 pubmed publisher
Iliff J, Chen M, Plog B, Zeppenfeld D, Soltero M, Yang L, et al. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J Neurosci. 2014;34:16180-93 pubmed publisher
Lauretti E, di Meco A, Chu J, PraticÃ² D. Modulation of AD neuropathology and memory impairments by the isoprostane F2Î± is mediated by the thromboxane receptor. Neurobiol Aging. 2015;36:812-20 pubmed publisher
Hohsfield L, Daschil N, OrÃ¤dd G, StrÃ¶mberg I, Humpel C. Vascular pathology of 20-month-old hypercholesterolemia mice in comparison to triple-transgenic and APPSwDI Alzheimer's disease mouse models. Mol Cell Neurosci. 2014;63:83-95 pubmed
HÃ¶llerhage M, Deck R, de Andrade A, Respondek G, Xu H, RÃ¶sler T, et al. Piericidin A aggravates Tau pathology in P301S transgenic mice. PLoS ONE. 2014;9:e113557 pubmed publisher
Ohia Nwoko O, Montazari S, Lau Y, Eriksen J. Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice. Mol Neurodegener. 2014;9:54 pubmed publisher
Ryu J, Horkayne Szakaly I, Xu L, Pletnikova O, Leri F, Eberhart C, et al. The problem of axonal injury in the brains of veterans with histories of blast exposure. Acta Neuropathol Commun. 2014;2:153 pubmed publisher
Falcon B, Cavallini A, Angers R, Glover S, Murray T, Barnham L, et al. Conformation determines the seeding potencies of native and recombinant Tau aggregates. J Biol Chem. 2015;290:1049-65 pubmed publisher
Huang C, Ho Y, Ng O, Irwin M, Chang R, Wong G. Dexmedetomidine directly increases tau phosphorylation. J Alzheimers Dis. 2015;44:839-50 pubmed publisher
Saidi L, Polydoro M, Kay K, Sanchez L, Mandelkow E, Hyman B, et al. Carboxy terminus heat shock protein 70 interacting protein reduces tau-associated degenerative changes. J Alzheimers Dis. 2015;44:937-47 pubmed publisher
Thomzig A, Wagenführ K, Daus M, Joncic M, Schulz Schaeffer W, Thanheiser M, et al. Decontamination of medical devices from pathological amyloid-?-, tau- and ?-synuclein aggregates. Acta Neuropathol Commun. 2014;2:151 pubmed publisher
Dammer E, Lee A, Duong D, Gearing M, Lah J, Levey A, et al. Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins. Proteomics. 2015;15:508-519 pubmed publisher
Castro Alvarez J, Uribe Arias S, Kosik K, Cardona GÃ³mez G. Long- and short-term CDK5 knockdown prevents spatial memory dysfunction and tau pathology of triple transgenic Alzheimer's mice. Front Aging Neurosci. 2014;6:243 pubmed publisher
Forny Germano L, Lyra e Silva N, Batista A, Brito Moreira J, Gralle M, Boehnke S, et al. Alzheimer's disease-like pathology induced by amyloid-Î² oligomers in nonhuman primates. J Neurosci. 2014;34:13629-43 pubmed publisher
Å polcovÃ¡ A, MikulÃ¡Å¡kovÃ¡ B, KrÅ¡kovÃ¡ K, GajdoÅ¡echovÃ¡ L, ZÃ³rad Å, Olszanecki R, et al. Deficient hippocampal insulin signaling and augmented Tau phosphorylation is related to obesity- and age-induced peripheral insulin resistance: a study in Zucker rats. BMC Neurosci. 2014;15:111 pubmed publisher
Moreau K, Fleming A, Imarisio S, Lopez Ramirez A, Mercer J, Jimenez Sanchez M, et al. PICALM modulates autophagy activity and tau accumulation. Nat Commun. 2014;5:4998 pubmed publisher
Wang Y, Yang R, Gu J, Yin X, Jin N, Xie S, et al. Cross talk between PI3K-AKT-GSK-3Î² and PP2A pathways determines tau hyperphosphorylation. Neurobiol Aging. 2015;36:188-200 pubmed publisher
Lee S, Xu G, Jay T, Bhatta S, Kim K, Jung S, et al. Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway. J Neurosci. 2014;34:12538-46 pubmed publisher
Lue L, Schmitz C, Serrano G, Sue L, Beach T, Walker D. TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices. Brain Pathol. 2015;25:469-80 pubmed publisher
Dunn H, Ager R, Baglietto Vargas D, Cheng D, Kitazawa M, Cribbs D, et al. Restoration of lipoxin A4 signaling reduces Alzheimer's disease-like pathology in the 3xTg-AD mouse model. J Alzheimers Dis. 2015;43:893-903 pubmed publisher
Yarchoan M, Toledo J, Lee E, Arvanitakis Z, Kazi H, Han L, et al. Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies. Acta Neuropathol. 2014;128:679-89 pubmed publisher
Collin L, Bohrmann B, Göpfert U, Oroszlan Szovik K, Ozmen L, Grüninger F. Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease. Brain. 2014;137:2834-46 pubmed publisher
Kohler C, Dinekov M, Götz J. Granulovacuolar degeneration and unfolded protein response in mouse models of tauopathy and A? amyloidosis. Neurobiol Dis. 2014;71:169-79 pubmed publisher
Polito V, Li H, Martini Stoica H, Wang B, Yang L, Xu Y, et al. Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB. EMBO Mol Med. 2014;6:1142-60 pubmed publisher
Zhou Y, Hayashi I, Wong J, Tugusheva K, Renger J, Zerbinatti C. Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer's disease. PLoS ONE. 2014;9:e103187 pubmed publisher
Gheyara A, Ponnusamy R, Djukic B, Craft R, Ho K, Guo W, et al. Tau reduction prevents disease in a mouse model of Dravet syndrome. Ann Neurol. 2014;76:443-56 pubmed publisher
Ittner A, Bertz J, Suh L, Stevens C, Götz J, Ittner L. Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice. J Neurochem. 2015;132:135-45 pubmed publisher
Fernández Nogales M, Cabrera J, Santos Galindo M, Hoozemans J, Ferrer I, Rozemuller A, et al. Huntington's disease is a four-repeat tauopathy with tau nuclear rods. Nat Med. 2014;20:881-5 pubmed publisher
Rao M, McBrayer M, Campbell J, Kumar A, Hashim A, Sershen H, et al. Specific calpain inhibition by calpastatin prevents tauopathy and neurodegeneration and restores normal lifespan in tau P301L mice. J Neurosci. 2014;34:9222-34 pubmed publisher
Aldrin Kirk P, Davidsson M, Holmqvist S, Li J, Bjorklund T. Novel AAV-based rat model of forebrain synucleinopathy shows extensive pathologies and progressive loss of cholinergic interneurons. PLoS ONE. 2014;9:e100869 pubmed publisher
Richens J, Vere K, Light R, Soria D, Garibaldi J, Smith A, et al. Practical detection of a definitive biomarker panel for Alzheimer's disease; comparisons between matched plasma and cerebrospinal fluid. Int J Mol Epidemiol Genet. 2014;5:53-70 pubmed
Pedr s I, Petrov D, Allgaier M, Sureda F, Barroso E, Beas Zarate C, et al. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease. Biochim Biophys Acta. 2014;1842:1556-66 pubmed publisher
Shilling D, Müller M, Takano H, Mak D, Abel T, Coulter D, et al. Suppression of InsP3 receptor-mediated Ca2+ signaling alleviates mutant presenilin-linked familial Alzheimer's disease pathogenesis. J Neurosci. 2014;34:6910-23 pubmed publisher
Petry F, Pelletier J, Bretteville A, Morin F, Calon F, Hébert S, et al. Specificity of anti-tau antibodies when analyzing mice models of Alzheimer's disease: problems and solutions. PLoS ONE. 2014;9:e94251 pubmed publisher
Hales C, Seyfried N, Dammer E, Duong D, Yi H, Gearing M, et al. U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer's disease due to autosomal dominant genetic mutations and trisomy 21. Mol Neurodegener. 2014;9:15 pubmed publisher
Maurin H, Lechat B, Borghgraef P, Devijver H, Jaworski T, Van Leuven F. Terminal hypothermic Tau.P301L mice have increased Tau phosphorylation independently of glycogen synthase kinase 3?/?. Eur J Neurosci. 2014;40:2442-53 pubmed publisher
Liu X, Zhou J, Abid M, Yan H, Huang H, Wan L, et al. Berberine attenuates axonal transport impairment and axonopathy induced by Calyculin A in N2a cells. PLoS ONE. 2014;9:e93974 pubmed publisher
Lu T, Aron L, Zullo J, Pan Y, Kim H, Chen Y, et al. REST and stress resistance in ageing and Alzheimer's disease. Nature. 2014;507:448-54 pubmed publisher
Stancu I, Ris L, Vasconcelos B, Marinangeli C, Goeminne L, Laporte V, et al. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer's disease. FASEB J. 2014;28:2620-31 pubmed publisher
Zhang Y, Chen L, Shen G, Zhao Q, Shangguan L, He M. GRK5 dysfunction accelerates tau hyperphosphorylation in APP (swe) mice through impaired cholinergic activity. Neuroreport. 2014;25:542-7 pubmed publisher
Kim H, Chang K, Ha T, Kim J, Ha S, Shin K, et al. S100A9 knockout decreases the memory impairment and neuropathology in crossbreed mice of Tg2576 and S100A9 knockout mice model. PLoS ONE. 2014;9:e88924 pubmed publisher
Dujardin S, Lécolle K, Caillierez R, Bégard S, Zommer N, Lachaud C, et al. Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies. Acta Neuropathol Commun. 2014;2:14 pubmed publisher
Bodi I, Curran O, Selway R, Elwes R, Burrone J, Laxton R, et al. Two cases of multinodular and vacuolating neuronal tumour. Acta Neuropathol Commun. 2014;2:7 pubmed publisher
Xiong Z, Thangavel R, Kempuraj D, Yang E, Zaheer S, Zaheer A. Alzheimer's disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brain. J Alzheimers Dis. 2014;40:297-308 pubmed publisher
Ridwan S, Bauer H, Frauenknecht K, Hefti K, von Pein H, Sommer C. Distribution of the hematopoietic growth factor G-CSF and its receptor in the adult human brain with specific reference to Alzheimer's disease. J Anat. 2014;224:377-91 pubmed publisher
Liu C, Götz J. Profiling murine tau with 0N, 1N and 2N isoform-specific antibodies in brain and peripheral organs reveals distinct subcellular localization, with the 1N isoform being enriched in the nucleus. PLoS ONE. 2013;8:e84849 pubmed publisher
Notter T, Panzanelli P, PFISTER S, Mircsof D, Fritschy J. A protocol for concurrent high-quality immunohistochemical and biochemical analyses in adult mouse central nervous system. Eur J Neurosci. 2014;39:165-75 pubmed publisher
Medeiros R, Castello N, Cheng D, Kitazawa M, Baglietto Vargas D, Green K, et al. ?7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles. Am J Pathol. 2014;184:520-9 pubmed publisher
Wang C, Klechikov A, Gharibyan A, Wärmländer S, Jarvet J, Zhao L, et al. The role of pro-inflammatory S100A9 in Alzheimer's disease amyloid-neuroinflammatory cascade. Acta Neuropathol. 2014;127:507-22 pubmed publisher
Marchese M, Cowan D, Head E, Ma D, Karimi K, Ashthorpe V, et al. Autoimmune manifestations in the 3xTg-AD model of Alzheimer's disease. J Alzheimers Dis. 2014;39:191-210 pubmed publisher
Wilson R, Nag S, Boyle P, Hizel L, Yu L, Buchman A, et al. Brainstem aminergic nuclei and late-life depressive symptoms. JAMA Psychiatry. 2013;70:1320-8 pubmed publisher
Tan M, Yu J, Jiang T, Zhu X, Guan H, Tan L. IL12/23 p40 inhibition ameliorates Alzheimer's disease-associated neuropathology and spatial memory in SAMP8 mice. J Alzheimers Dis. 2014;38:633-46 pubmed publisher
Perez S, Raghanti M, Hof P, Kramer L, Ikonomovic M, Lacor P, et al. Alzheimer's disease pathology in the neocortex and hippocampus of the western lowland gorilla (Gorilla gorilla gorilla). J Comp Neurol. 2013;521:4318-38 pubmed publisher
Manich G, del Valle J, Cabezón I, Camins A, Pallas M, Pelegri C, et al. Presence of a neo-epitope and absence of amyloid beta and tau protein in degenerative hippocampal granules of aged mice. Age (Dordr). 2014;36:151-65 pubmed publisher
Ordóñez Gutiérrez L, Torres J, Gavin R, Anton M, Arroba Espinosa A, Espinosa J, et al. Cellular prion protein modulates ?-amyloid deposition in aged APP/PS1 transgenic mice. Neurobiol Aging. 2013;34:2793-804 pubmed publisher
Zhang X, Hernandez I, Rei D, Mair W, Laha J, Cornwell M, et al. Diaminothiazoles modify Tau phosphorylation and improve the tauopathy in mouse models. J Biol Chem. 2013;288:22042-56 pubmed publisher
Clippinger A, D Alton S, Lin W, Gendron T, Howard J, Borchelt D, et al. Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy. Acta Neuropathol. 2013;126:39-50 pubmed publisher
Park Y, Ko J, Jang Y, Kwon Y. Activation of AMP-activated protein kinase alleviates homocysteine-mediated neurotoxicity in SH-SY5Y cells. Neurochem Res. 2013;38:1561-71 pubmed publisher
Wu T, Lu Y, Chuang C, Wu C, Chiang A, Krantz D, et al. Loss of vesicular dopamine release precedes tauopathy in degenerative dopaminergic neurons in a Drosophila model expressing human tau. Acta Neuropathol. 2013;125:711-25 pubmed publisher
Barros Miñones L, Martín de Saavedra D, Perez Alvarez S, Orejana L, Suquía V, Goni Allo B, et al. Inhibition of calpain-regulated p35/cdk5 plays a central role in sildenafil-induced protection against chemical hypoxia produced by malonate. Biochim Biophys Acta. 2013;1832:705-17 pubmed publisher
Chapuis J, Hansmannel F, Gistelinck M, Mounier A, Van Cauwenberghe C, Kolen K, et al. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry. 2013;18:1225-34 pubmed publisher
Hebron M, Algarzae N, Lonskaya I, Moussa C. Fractalkine signaling and Tau hyper-phosphorylation are associated with autophagic alterations in lentiviral Tau and A?1-42 gene transfer models. Exp Neurol. 2014;251:127-38 pubmed publisher
Kohler C, Dinekov M, Götz J. Active glycogen synthase kinase-3 and tau pathology-related tyrosine phosphorylation in pR5 human tau transgenic mice. Neurobiol Aging. 2013;34:1369-79 pubmed publisher
Leboucher A, Laurent C, Fernandez Gomez F, Burnouf S, Troquier L, Eddarkaoui S, et al. Detrimental effects of diet-induced obesity on ? pathology are independent of insulin resistance in ? transgenic mice. Diabetes. 2013;62:1681-8 pubmed publisher
Porquet D, Casadesus G, Bayod S, Vicente A, Canudas A, Vilaplana J, et al. Dietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8. Age (Dordr). 2013;35:1851-65 pubmed publisher
Chambers J, Uchida K, Harada T, Tsuboi M, Sato M, Kubo M, et al. Neurofibrillary tangles and the deposition of a beta amyloid peptide with a novel N-terminal epitope in the brains of wild Tsushima leopard cats. PLoS ONE. 2012;7:e46452 pubmed publisher
Tian M, Zhu D, Xie W, Shi J. Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains. FEBS Lett. 2012;586:3737-45 pubmed publisher
Satoh J, Tabunoki H, Ishida T, Saito Y, Arima K. Dystrophic neurites express C9orf72 in Alzheimer's disease brains. Alzheimers Res Ther. 2012;4:33 pubmed publisher
Magnaudeix A, Wilson C, Page G, Bauvy C, Codogno P, Leveque P, et al. PP2A blockade inhibits autophagy and causes intraneuronal accumulation of ubiquitinated proteins. Neurobiol Aging. 2013;34:770-90 pubmed publisher
Karlsson O, Berg A, Lindström A, Hanrieder J, Arnerup G, Roman E, et al. Neonatal exposure to the cyanobacterial toxin BMAA induces changes in protein expression and neurodegeneration in adult hippocampus. Toxicol Sci. 2012;130:391-404 pubmed publisher
Bretteville A, Marcouiller F, Julien C, El Khoury N, Petry F, Poitras I, et al. Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors. Sci Rep. 2012;2:480 pubmed publisher
Sontag J, Nunbhakdi Craig V, White C, Halpain S, Sontag E. The protein phosphatase PP2A/B? binds to the microtubule-associated proteins Tau and MAP2 at a motif also recognized by the kinase Fyn: implications for tauopathies. J Biol Chem. 2012;287:14984-93 pubmed publisher
Elobeid A, Soininen H, Alafuzoff I. Hyperphosphorylated tau in young and middle-aged subjects. Acta Neuropathol. 2012;123:97-104 pubmed publisher
Maarouf C, Daugs I, Kokjohn T, Walker D, Hunter J, Kruchowsky J, et al. Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging. PLoS ONE. 2011;6:e27291 pubmed publisher
Kaul T, Credle J, Haggerty T, Oaks A, Masliah E, Sidhu A. Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease. BMC Neurosci. 2011;12:79 pubmed publisher
Maldonado H, RamÃrez E, Utreras E, Pando M, Kettlun A, Chiong M, et al. Inhibition of cyclin-dependent kinase 5 but not of glycogen synthase kinase 3-Î² prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T-cell leukemia virus type I-infected lymphocytes. J Neurosci Res. 2011;89:1489-98 pubmed publisher
Ploia C, Antoniou X, Sclip A, Grande V, Cardinetti D, Colombo A, et al. JNK plays a key role in tau hyperphosphorylation in Alzheimer's disease models. J Alzheimers Dis. 2011;26:315-29 pubmed publisher
Haggerty T, Credle J, Rodriguez O, Wills J, Oaks A, Masliah E, et al. Hyperphosphorylated Tau in an ?-synuclein-overexpressing transgenic model of Parkinson's disease. Eur J Neurosci. 2011;33:1598-610 pubmed publisher
Wills J, Credle J, Haggerty T, Lee J, Oaks A, Sidhu A. Tauopathic changes in the striatum of A53T ?-synuclein mutant mouse model of Parkinson's disease. PLoS ONE. 2011;6:e17953 pubmed publisher
To A, Ribe E, Chuang T, Schroeder J, Lovestone S. The ?3 and ?4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone treated mice. PLoS ONE. 2011;6:e16991 pubmed publisher
Dusonchet J, Kochubey O, Stafa K, Young S, Zufferey R, Moore D, et al. A rat model of progressive nigral neurodegeneration induced by the Parkinson's disease-associated G2019S mutation in LRRK2. J Neurosci. 2011;31:907-12 pubmed publisher
Roltsch E, Holcomb L, Young K, Marks A, Zimmer D. PSAPP mice exhibit regionally selective reductions in gliosis and plaque deposition in response to S100B ablation. J Neuroinflammation. 2010;7:78 pubmed publisher
Nakajima T, Ochi S, Oda C, Ishii M, Ogawa K. Ischemic preconditioning attenuates of ischemia-induced degradation of spectrin and tau: implications for ischemic tolerance. Neurol Sci. 2011;32:229-39 pubmed publisher
Liang B, Duan B, Zhou X, Gong J, Luo Z. Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Biol Chem. 2010;285:27737-44 pubmed publisher
Berg I, Nilsson K, Thor S, Hammarstrom P. Efficient imaging of amyloid deposits in Drosophila models of human amyloidoses. Nat Protoc. 2010;5:935-44 pubmed publisher
Spatara M, Robinson A. Transgenic mouse and cell culture models demonstrate a lack of mechanistic connection between endoplasmic reticulum stress and tau dysfunction. J Neurosci Res. 2010;88:1951-61 pubmed publisher
Hall E, Lee S, Mairuae N, Simmons Z, Connor J. Expression of the HFE allelic variant H63D in SH-SY5Y cells affects tau phosphorylation at serine residues. Neurobiol Aging. 2011;32:1409-19 pubmed publisher
Kim H, Sul D, Lim J, Lee D, Joo S, Hwang K, et al. Delphinidin ameliorates beta-amyloid-induced neurotoxicity by inhibiting calcium influx and tau hyperphosphorylation. Biosci Biotechnol Biochem. 2009;73:1685-9 pubmed
Sul D, Kim H, Lee D, Joo S, Hwang K, Park S. Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation. Life Sci. 2009;84:257-62 pubmed publisher
Sul D, Kim H, Cho E, Lee M, Kim H, Jung W, et al. 2,3,7,8-TCDD neurotoxicity in neuroblastoma cells is caused by increased oxidative stress, intracellular calcium levels, and tau phosphorylation. Toxicology. 2009;255:65-71 pubmed publisher
Irons H, Cullen D, Shapiro N, Lambert N, Lee R, LaPlaca M. Three-dimensional neural constructs: a novel platform for neurophysiological investigation. J Neural Eng. 2008;5:333-41 pubmed publisher
Kanungo J, Zheng Y, Amin N, Pant H. The Notch signaling inhibitor DAPT down-regulates cdk5 activity and modulates the distribution of neuronal cytoskeletal proteins. J Neurochem. 2008;106:2236-48 pubmed publisher
Park S, Kim H, Cho E, Kwon B, Phark S, Hwang K, et al. Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation. Food Chem Toxicol. 2008;46:2881-7 pubmed publisher
Fukuzaki E, Takuma K, Himeno Y, Yoshida S, Funatsu Y, Kitahara Y, et al. Enhanced activity of hippocampal BACE1 in a mouse model of postmenopausal memory deficits. Neurosci Lett. 2008;433:141-5 pubmed publisher
Liu R, Zhou X, Tanila H, Bjorkdahl C, Wang J, Guan Z, et al. Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology. J Cell Mol Med. 2008;12:241-57 pubmed publisher
Carroll J, Rosario E, Chang L, Stanczyk F, Oddo S, LaFerla F, et al. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci. 2007;27:13357-65 pubmed
Selenica M, Jensen H, Larsen A, Pedersen M, Helboe L, Leist M, et al. Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation. Br J Pharmacol. 2007;152:959-79 pubmed
Bai Q, Garver J, Hukriede N, Burton E. Generation of a transgenic zebrafish model of Tauopathy using a novel promoter element derived from the zebrafish eno2 gene. Nucleic Acids Res. 2007;35:6501-16 pubmed
Jossin Y, Goffinet A. Reelin signals through phosphatidylinositol 3-kinase and Akt to control cortical development and through mTor to regulate dendritic growth. Mol Cell Biol. 2007;27:7113-24 pubmed
Park S, Tournell C, Sinjoanu R, Ferreira A. Caspase-3- and calpain-mediated tau cleavage are differentially prevented by estrogen and testosterone in beta-amyloid-treated hippocampal neurons. Neuroscience. 2007;144:119-27 pubmed
Schindowski K, Bretteville A, Leroy K, Bégard S, Brion J, Hamdane M, et al. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am J Pathol. 2006;169:599-616 pubmed
Yoshida S, Maeda M, Kaku S, Ikeya H, Yamada K, Nakaike S. Lithium inhibits stress-induced changes in tau phosphorylation in the mouse hippocampus. J Neural Transm (Vienna). 2006;113:1803-14 pubmed
Lobsiger C, Garcia M, Ward C, Cleveland D. Altered axonal architecture by removal of the heavily phosphorylated neurofilament tail domains strongly slows superoxide dismutase 1 mutant-mediated ALS. Proc Natl Acad Sci U S A. 2005;102:10351-6 pubmed
Takahashi S, Kulkarni A. Mutant superoxide dismutase 1 causes motor neuron degeneration independent of cyclin-dependent kinase 5 activation by p35 or p25. J Neurochem. 2004;88:1295-304 pubmed
Takahashi S, Saito T, Hisanaga S, Pant H, Kulkarni A. Tau phosphorylation by cyclin-dependent kinase 5/p39 during brain development reduces its affinity for microtubules. J Biol Chem. 2003;278:10506-15 pubmed
Kerokoski P, Suuronen T, Salminen A, Soininen H, Pirttila T. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation. Biochem Biophys Res Commun. 2002;298:693-8 pubmed
Forno L, Langston J, Herrick M, Wilson J, Murayama S. Ubiquitin-positive neuronal and tau 2-positive glial inclusions in frontotemporal dementia of motor neuron type. Acta Neuropathol. 2002;103:599-606 pubmed
Rapoport M, Ferreira A. PD98059 prevents neurite degeneration induced by fibrillar beta-amyloid in mature hippocampal neurons. J Neurochem. 2000;74:125-33 pubmed

articles

contribute

If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.

questions and comments